Black Box Corporation 10-Q
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 30, 2006
OR
     
 
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number: 0-18706
Black Box Corporation
(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of incorporation or organization)
  95-3086563
(I.R.S. Employer Identification No.)
     
1000 Park Drive, Lawrence, Pennsylvania
(Address of principal executive offices)
  15055
(Zip Code)
Registrant’s telephone number, including area code: 724-746-5500
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. o Yes þ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ      Accelerated filer o      Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).o Yes þ No
As of July 16, 2007, there were 17,527,227 shares of common stock, par value $.001 (the “common stock”), outstanding.
 

 


 

BLACK BOX CORPORATION
INDEX
             
        Page
 
EXPLANATORY NOTE     3  
   
 
       
PART I. FINANCIAL INFORMATION        
   
 
       
Item 1.          
   
 
       
        11  
   
 
       
        12  
   
 
       
        13  
   
 
       
        14  
   
 
       
Item 2.       40  
   
 
       
Item 3.       58  
   
 
       
Item 4.       59  
   
 
       
PART II. OTHER INFORMATION        
   
 
       
Item 1.       60  
   
 
       
Item 1A.       60  
   
 
       
Item 2.       62  
   
 
       
Item 6.       62  
   
 
       
SIGNATURE     64  
   
 
       
EXHIBIT INDEX     65  
 EX-10.1
 EX-10.2
 EX-10.3
 EX-10.4
 EX-10.5
 EX-21.1
 EX-31.1
 EX-31.2
 EX-32.1

2


Table of Contents

EXPLANATORY NOTE
In this Quarterly Report on Form 10-Q for the three (3) and nine (9) month period ended December 30, 2006 (“Form 10-Q”), Black Box Corporation (“Black Box” or the “Company”) is restating its Consolidated Balance Sheets as of March 31, 2006, Consolidated Statements of Income and Consolidated Statements of Cash Flows for the three (3) and nine (9) month periods ended December 31, 2005 and the related Notes to the Consolidated Financial Statements. This Form 10-Q also includes the amendment of “Management’s Discussion and Analysis of Financial Condition and Results of Operations” presented in the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2005 as it relates to the three (3) and nine (9) month periods ended December 31, 2005. All restated information identified above is collectively referred to as the “Restatement.” References herein to “Fiscal Year” or “Fiscal” mean the Company’s Fiscal Year ended March 31 for the year referenced.
The Restatement reflects adjustments arising from the determinations of the Audit Committee (“the Audit Committee”) of the Company’s Board of Directors (the “Board”), with the assistance of outside legal counsel, and the Company’s management to record additional non-cash charges for stock-based compensation expense and the related income tax effects, relating to certain stock option grants during the period from 1992 through September, 2006. Additionally, the Company has recorded an adjustment to its financial statements for the quarter ended September 30, 2006 to reflect the proper accounting treatment for an interest rate swap.
Following the filing of this Form 10-Q, the Company will file its Annual Report on Form 10-K for the period ended March 31, 2007 (the “FY07 Form 10-K”). In the FY07 Form 10-K, the Company will restate its Consolidated Balance Sheet at March 31, 2006, its Consolidated Statements of Income for the years ended March 31, 2006 and 2005, its Consolidated Statements of Changes in Stockholders’ Equity for the years ended March 31, 2006, 2005 and as of April 1, 2004, its Consolidated Statements of Cash Flows for the years ended March 31, 2006 and 2005, its quarterly financial data as of and for the quarters ended in the fiscal year ended March 31, 2006 and its Selected Financial Data as of and for the years ended March 31, 2006, 2005, 2004 and 2003.
The Company has not amended and does not intend to amend any of its other previously-filed reports on Form 10-K or Form 10-Q for the periods affected by the Restatement other than those specifically stated above and its Quarterly Report on Form 10-Q/A for the three (3) month period ended June 30, 2006 and Quarterly Report on Form 10-Q/A for the three (3) and six (6) month period ended September 30, 2006. As previously disclosed, the consolidated financial statements and related financial information contained in such previously filed reports should no longer be relied upon.
Restatement through March 31, 2006
Background
On November 13, 2006, Black Box received a letter of informal inquiry from the Enforcement Division of the Securities and Exchange Commission (the “SEC”) relating to the Company’s stock option practices from January 1, 1997 to present. As a result, the Audit Committee, with the assistance of outside legal counsel, commenced an independent review of the Company’s historical stock option grant practices and related accounting for stock option grants during the period from 1992 to the present (the “Review Period”).
On February 1, 2007, the Company announced that, while the review of option grant practices was continuing, it believed that it would need to record additional non-cash charges for stock-based compensation expense relating to certain stock option grants and, accordingly, cautioned investors about relying on its historical financial statements until the Company could determine with certainty whether a restatement would be required and, if so, the extent of any such restatement and the periods affected.
On March 19, 2007, although the Audit Committee had not yet completed its review, the Audit Committee concluded that the exercise price of certain stock option grants differed from the fair market value of the underlying shares on the appropriate measurement date. At that time, the Company and the Audit Committee announced that it was currently expected that the Company’s additional non-cash, pre-tax charges for stock-based compensation expense relating to certain stock option grants would approximate $63 million for the Review Period. In addition, the Company and the Audit Committee concluded that the Company would need to restate its previously-issued financial statements contained in reports previously filed by the Company with the SEC. Accordingly, on March 19, 2007, the Company and the Audit Committee concluded that the Company’s previously-issued financial statements and other historical financial information and related disclosures for the Review Period, including applicable reports of its current or former independent registered public accounting firms and related press releases, should not be relied upon.
On May 25, 2007, the Company was advised by the Enforcement Division of the SEC that a Formal Order of Private Investigation arising out of the Company’s stock option practices had been entered and on May 29, 2007 the Company received a subpoena that was issued by the SEC.
On May 31, 2007, the Company announced that, as a result of the ongoing review of stock option practices, Company management and

3


Table of Contents

the Audit Committee expected that the Company’s additional non-cash, pre-tax charges for stock-based compensation expense relating to certain stock option grants would approximate $70 million for the Review Period.
Findings of the Audit Committee
During the Review Period, the Company granted stock options pursuant to an employee stock option plan and a director stock option plan to acquire approximately 10.9 million shares of common stock. Such plans at all relevant times provided for option grants to be approved by a designated committee of non-employee directors or, in the case of the director stock option plan, by the Board. Approximately 2,000 stock option grants were awarded during the Review Period with 69 recorded grant dates. No stock options have been granted since September, 2006. The Audit Committee reviewed all stock options granted during the Review Period, including option grants to the Company’s directors, officers and rank and file employees (including grants to new employees, grants awarded in connection with Company acquisitions and grants made as individual or group performance awards). The Audit Committee’s review of the Company’s stock option granting practices included a comprehensive examination of reasonably available relevant physical and electronic documents as well as interviews with current and former directors, officers and Company personnel.
The Audit Committee’s review was initially focused on determining whether the Company’s prior stock option granting practices were in compliance with the plans’ granting provisions and applicable law or called into question its accounting for such options. Once it became evident that such issues and accounting implications existed, the inquiry focused on those matters necessary: to determine whether any accounting charges were material and whether a restatement of the Company’s previously-issued financial statements would be required; to establish a basis for effecting any required restatement; to assure that, on as timely a basis as possible, the Company could file any required curative disclosures with the SEC and assure its continued eligibility for listing on The NASDAQ Stock Market (“NASDAQ”); and to provide an informed basis for the Company’s response to the identified issues, including appropriate corrective and remedial actions.
The following information summarizes certain of the findings of the Audit Committee. The findings identified approximately $71.5 million of unrecorded expense at the time of grant (i.e., the difference between the fair market value of the common stock on the appropriate measurement date and the stated exercise price), net of forfeitures, during the Review Period, of which $70.0 million was recorded in the Company’s Consolidated Financial Statements through March 31, 2006 and $1.5 million of unrecorded expense at the time of grant will be included, beginning at April 1, 2006, in the Company’s computation of compensation expense in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 123 (revised 2004) “Share-Based Payment” (“SFAS 123(R)”). The following summarizes the unrecorded expense at the time of grant by time period and category of recipient:
   
$4.2 million for the period from Fiscal 1993 through Fiscal 1997 ($0.2 million for directors, $2.5 million for officers and $1.5 million for rank and file employees)
 
   
$45.6 million for the period from Fiscal 1998 through August 2002 ($1.1 million for directors, $25.7 million for officers and $18.7 million for rank and file employees)
 
   
$21.8 million for the period from August 2002 to the present ($0.04 million for directors, $0.6 million for officers and $21.1 million for rank and file employees)
The Audit Committee’s additional key findings are summarized below:
Lack of Adequate Documentation: For a majority of grants issued by the Company during the Review Period, there is either no or inadequate documentation of approval actions that satisfies the requisites for establishing a measurement date under Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB 25”). Of the 69 recorded grant dates, there are documented approval actions by the Board or the Option or Compensation Committee of the Board (the “Compensation Committee”) with respect to particular grants for 12 dates. In the period December 1992 to May 1996, neither the minutes of the Compensation Committee nor of the Board reflect any action to approve specific grants. In some instances, evidence of single director (the chairman of the Compensation Committee) approval actions exists. This absence of non-employee director level documentation also applies to a majority of grants with a recorded grant date after 1996. In some cases, Compensation Committee minutes contain a reference to reports on the status of the option pool but do not document any action to approve specific grants. Approval documentation for certain grants has internal inconsistencies or conflicts with other documents thereby rendering this documentation unreliable as a basis for establishing a measurement date. In some cases, the only existing documentation is the executed option agreement and/or the entry of the option grant into the option database. Notwithstanding these approval documentation inadequacies, the Company entered into option agreements with grantees and has honored such grants.
Grant Approvals: During the Review Period, relatively few option grants were approved in complete compliance with the Company’s stock option plans. Available documentation reflects that the Company approved option grants in a variety of ways. With respect to the employee stock option plan, grants were approved by the Compensation Committee as contemplated by the plan at various times, by the

4


Table of Contents

full Board in 1998 and 1999, by a single director (the chairman of the Compensation Committee) on nine recorded grant dates during the period 1994 through 2001 and by the Company’s Chief Executive Officer (“CEO”) at various times. With respect to the director stock option plan, grants were generally approved by the designated Board committee and, in a few cases, by the chairman of the Compensation Committee. In one instance in 2000, there is no conclusive documentary evidence of the approval of director grants other than the signed director option agreements.
The delegation of authority by the Compensation Committee to the CEO with respect to grants to rank and file employees was not fully documented. However, there was an understood and accepted practice between the CEO and the Compensation Committee whereby the CEO made certain awards to individual employees. In some instances, this involved the allocation among rank and file employees of blocks of shares approved by the Compensation Committee; in three (3) such instances, the number of shares ultimately awarded pursuant to this process exceeded the approved size of the block, which was contrary to the understanding of the Compensation Committee members. Further, contrary to the understanding of Committee members, the award and/or documentation of those individual grants often significantly lagged the approval of the block grant. In August 2005, the Compensation Committee specifically acknowledged a prior grant of delegated authority to the CEO to make option grants to rank and file employees and ratified all prior awards by the CEO. In some cases, documentation of approval action is either inconclusive or missing, and the Company therefore has been unable to determine what entity or person actually approved specific grants.
Option Pricing: The recorded grant dates for a majority of grants do not match the applicable measurement dates as determined under APB 25. The grants of options with exercise prices lower than the fair market values of the stock on the actual measurement dates did not satisfy the fair market pricing requirement in the Company’s plans, as amended in 1998, and were not consistent with the Company’s disclosures in SEC filings stating that the exercise price of options was equal to the fair market value of the stock on the date of the grant.
The relationship between the stated exercise price of options and the fair market value of the Company’s stock on the date of the identifiable approval actions varied from grant to grant. In some cases, the exercise price of grants reflected the fair market value of the underlying shares on the date of any documented approval action. In other cases, the exercise prices reflected the fair market value of the underlying shares on a date either prior or subsequent to any such documented approval action and the exercise price was lower than the fair market value on the date of any such action. In several such cases before August 2002, the use of such grant dates and lower exercise prices (together with other available evidence) supports a finding that the recorded grant dates and corresponding exercise prices were selected with the benefit of hindsight. For certain grants where the mismatch between the recorded grant date and the approval action was only a matter of days, however, the mismatch appears to have been attributable to inaccurate recording or administrative delays. In some cases, the apparent approval action did not identify all grantees; for example, there are cases where a block grant was approved subject to a later determination of individual grant recipients and grants were recorded with a grant date, and corresponding exercise price, that matched the date of the apparent approval of the block grant and the fair market value of the common stock on that date although individual grant recipients may have been identified some time after approval of the block grant. Finally, in some cases, the approval action for specific grants is not adequately documented. Where the recorded grant date did not satisfy the requisites for a measurement date under APB 25, the Company relied on default methodologies to determine an appropriate measurement date.
Internal Controls: As outlined above, the Company’s historical administration of its options program lacked discipline as it relates to proper adherence to the plan requirements, corporate recordkeeping and documentation. Since November 2003, however, the Company has properly administered the stock option program as it relates to awards to directors and officers. During the investigation, the Company identified control gaps related to grants made throughout the Review Period. As of March 31, 2007, the Company implemented additional procedures to its process that are focused on formalized documentation of appropriate approvals and determination of grant terms to employees.
Procedural and Remedial Actions
The Audit Committee and other relevant Board committees are committed to a continued review and implementation of procedural enhancements and remedial actions in light of the foregoing findings. Consistent with its obligation to act in the best interests of the Company taking into account all relevant facts and circumstances, the Audit Committee is continuing to assess the appropriateness of a broad range of possible procedural enhancements and potential remedial measures in light of the findings of its investigation. While the Audit Committee has not completed its consideration of all such steps, procedural enhancements may include recommendations regarding improved stock option administration procedures and controls, training and monitoring compliance with those procedures, corporate recordkeeping, corporate risk assessment, evaluation of the internal compliance environment and other remedial steps that may be appropriate. The Audit Committee is also expected to address issues of individual conduct or responsibility, including those of the Board, CEOs and Chief Financial Officers (“CFOs”) serving during the Review Period. Potential remedial measures may include an evaluation of the role of and possible claims or other remedial actions against current and former Company personnel who may be found to have been responsible for identified problems during the Review Period. The Audit Committee expects to recommend to the Board and/or its appropriate committees procedural enhancements and remedial measures that appropriately address the issues raised by its findings. In advance of action by the Audit Committee, as noted above, the Company has implemented additional procedures to its process for approving stock option grants that are focused on formalized documentation of appropriate approvals and determination of grant terms to employees.

5


Table of Contents

Restatement Methodologies
As of April 1, 2006, the Company adopted SFAS 123(R) using the modified prospective transition method. Under this transition method, compensation expense is to be recognized for all share-based compensation awards granted after the date of adoption and for all unvested awards existing on the date of adoption. Prior to April 1, 2006, the Company accounted for stock-based compensation awards to directors, officers and rank and file employees using the intrinsic value method in accordance with APB 25 as allowed under SFAS No. 123 “Accounting for Stock-Based Compensation” (“SFAS 123”). Under the intrinsic value method, no share-based compensation expense related to stock options was required to be recognized if the exercise price of the stock option was at least equal to the fair market value of the common stock on the “measurement date.” APB 25 defines the measurement date as the first date on which are known both (1) the number of shares that an individual grant recipient is entitled to receive and (2) the option or purchase price, if any.
In light of the Audit Committee’s review of the Company’s stock option granting practices during the Review Period and as to those cases in which the Company previously used a recorded grant date as the measurement date that the Company determined could no longer be relied upon, the Company has developed and applied the following methodologies to remeasure those stock option grants and record the relevant charges in accordance with APB 25 by considering the following sources of information: (i) meeting minutes of the Board and of committees thereof and related materials, (ii) Unanimous Written Consents of the Board and of committees thereof, (iii) the dates on which stock option grants were entered into the Company’s stock option database (“create date”), (iv) relevant email correspondence reflecting stock option grant approval actions, (v) individual stock option agreements and related materials, (vi) employee and Board offer letters, (vii) documents relating to acquisitions, (viii) reports on Form 4 filed with the SEC and (ix) guidance of the Office of the Chief Accountant of the SEC on stock option matters as set forth in its letter dated September 19, 2006.
Grants with Appropriate Committee Approval. With respect to grants of approximately 1.0 million shares, or approximately 9% of the total grants in the Review Period, the Company has evidence to support the approval of the grant under the stock option plans by the relevant committee of the Board, and such evidence includes the number of options each individual was entitled to receive and the option price. However, the relationship between these documented approval actions and the originally-recorded grant dates and exercise prices for the options so approved varied during the Review Period. In some cases, grants were recorded with a grant date and a corresponding exercise price that matched the date of the approval action or were otherwise consistent with the terms of the approval actions. In other cases, however, the recorded grant dates and corresponding exercise prices of the grants reflected the fair market value of the common stock on a date prior to the committee’s documented approval actions. The Company has restated the compensation expense for stock option grants relating to approximately 0.4 million shares of common stock by using the date of the documented approval action as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $1.8 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.07 million relates to director options, $1.3 million relates to officer options and $0.4 million relates to rank and file employee options.
Grants with Other Approvals. With respect to grants of approximately 1.9 million shares, or approximately 18% of the total grants in the Review Period, the Company has evidence to support the approval of the grant by the Board, an outside director or the Company’s CEO and the identification of the number of options each individual was entitled to receive together with the option price. These grants are distinguished from the grants described in the prior paragraph in that the nature of the approval was not fully consistent with the terms of the relevant stock option plan. As with the grants discussed in the preceding paragraph, the relationship between these documented approval actions and the originally-recorded grant dates and exercise prices for the options so approved varied during the Review Period. In some cases, grants were recorded with a grant date and a corresponding exercise price that matched the date of the approval action or were otherwise consistent with the terms of the approval action. In other cases, however, the recorded grant dates and corresponding exercise prices of the grants reflected the fair market value of the Company’s stock on a date prior to the approval action. The Company has restated the compensation expense for stock option grants relating to approximately 1.6 million shares of common stock by using the date of the documented approval action as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $7.6 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.5 million relates to director options, $2.6 million relates to officer options and $4.5 million relates to rank and file employee options.
Grants Lacking Adequate Documentation. With respect to grants of approximately 7.9 million shares (5.0 million shares to rank and file employees), or 73.0% of the total grants in the Review Period, the Company has been unable to locate adequate documentation of approval actions that would satisfy the requisites for a measurement date under APB 25. For these grants, management considered all available relevant information to form a reasonable conclusion as to the most reasonable measurement date. For all grants in this category, the Company has established default methodologies for determining the most appropriate measurement date under APB 25.
With respect to grants entered into the Company’s stock option database after September 9, 1999, when the database began to reflect a “create date” which is the date on which a grant was entered into the system, the Company has determined to use the individual “create

6


Table of Contents

date” for each grant as the APB 25 measurement date, which was in most cases different from the originally-recorded grant date. The Company believes that this “create date” is the most appropriate methodology in the absence of sufficient evidence of approvals for these grants as it represents the earliest point in time at which the evidence shows that all requisites for the establishment of the measurement date had been satisfied. Such “create dates” preceded, often by a significant amount of time, the execution of stock option agreements, which, generally, were manually signed by the Company’s CEO and manually signed and dated by the grantee. In addition, in almost all cases, a grant entered into the database, which established the “create date,” ultimately resulted in the creation of a stock option agreement reflecting such grant. Accordingly, while execution of the stock option agreements constituted a clear acknowledgement by the grantee and the Company of the grantee’s legal entitlement to the grant the Company believes the “create date” more accurately reflects the date of approval than does the signed option agreement. The Company has restated the compensation expense for stock option grants relating to approximately 4.2 million shares of common stock by using the “create date” as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $49.8 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.5 million relates to director options, $17.2 million relates to officer options and $32.2 million relates to rank and file employee options. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to such create dates included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the create date for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted for which the “create date” methodology was utilized to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.09 million to $73.8 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $49.8 million, net of forfeitures, included in the Restatement.
For options entered into the Company’s option database before September 9, 1999, the Company determined the measurement date generally by reference to signed option agreements (or the deemed signature date for certain options as discussed below). The executed option agreements (hereinafter “signed option agreements”), manually signed by the Company’s CEO and manually signed and dated by the grantee, constituted an acknowledgement by the grantee and the Company of the grantee’s legal entitlement to the grant and, in the absence of authoritative information as to when all the requisites for the establishment of the measurement date had been satisfied, provides a measurement date framework based on entitlement. The Company has restated the compensation expense for stock option grants relating to approximately 1.4 million shares of common stock by using the signed option agreements as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $6.4 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.3 million relates to director options, $3.6 million relates to officer options and $2.5 million relates to rank and file employee options. The Company believes this methodology was the most appropriate in the absence of sufficient evidence of approvals for these grants as it represents the earliest point in time at which the evidence shows that all requisites for the establishment of the measurement date had been satisfied for these grants. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to the dating of signed option agreements included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the date of the grantee’s signature on the stock option agreement for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted for which the signed option agreements methodology was utilized to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.03 million to $9.6 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $6.4 million, net of forfeitures, included in the Restatement.
In those cases where no reliably-dated signed option agreement could be located and where no post-September 9, 1999 “create date” exists (stock option grants totaling approximately 0.9 million shares), the Company used the average period between recorded grant date and date of the signatures on all other grantee signed option agreements with the same grant date as the measurement date. For example, if there were four stock option grants with a grant date of January 1, 1996, the Company had the signed option agreements for three of these stock option grants and the average number of days between the grant date and the signature dates of these three signed option agreements was 20 days, January 21, 1996 was used as the measurement date for the grant for which no signed option agreement could be located. The Company has restated the compensation expense for stock option grants relating to approximately 0.7 million shares of common stock using this “average days to sign agreement” method. The total additional non-cash, pre-tax charge for these grants is approximately $4.4 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.06 million relates to director options, $4.2 million relates to officer options and $0.2 million relates to rank and file employee options. The Company believes this methodology was the most appropriate in the absence of sufficient evidence of approvals for these grants because it gives a reasonable approximation of the measurement date related to these options in light of the available evidence. The Company conducted a sensitivity analysis by comparing the Company’s current default methodology (i.e., “average days to sign agreement”) with another default methodology. For this analysis, the Company identified the range of potential grant dates defined by the earliest signed option agreement and the latest signed option agreement. The Company then identified the

7


Table of Contents

low and high closing prices of the common stock over the range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $2.6 million to $5.9 million, net of forfeitures. The Company’s analyses indicate that stock-based compensation expense computed using other identified alternative default methodologies would not materially differ from stock-based compensation expense computed using the “average days to sign agreement” methodology. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to the average days to sign agreements also included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the average days to sign agreement for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.03 million to $6.1 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $4.4 million, net of forfeitures, included in the Restatement.
Given the volatility of the common stock during much of the Review Period, the use of methodologies and measurement dates different from those described above could have resulted in a higher or lower cumulative compensation expense which would have caused net income or loss to be different from the amounts reported in the restated consolidated financial statements. The Company’s procedures for evaluating the appropriateness of measurement dates fixed using the default methodologies described above also included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the appropriate measurement date for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $9.3 million to $99.3 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $70.0 million, net of forfeitures, included in the Restatement.
Other adjustments through March 31, 2006
From 1994 through 1998, the Company did not properly account for stock options for one officer that were modified after the grant date pursuant to a separation agreement. Some of these modifications were not identified in the Company’s financial reporting processes and were therefore not properly reflected in its financial statements. As a result, the Company has recorded a non-cash charge for stock-based compensation of $1.0 million during Fiscal 1999.
Summary
In summary, the Company recorded cumulative non-cash charges for stock-based compensation of $70.9 million through March 31, 2006, offset in part by a cumulative income tax benefit of $27.7 million, for a total after-tax charge of $43.2 million. These charges had no impact on net sales or cash and cash equivalents as previously reported in the Company’s financial statements; as a result, no changes to these items are reflected in the Restatement. Non-cash charges for stock-based compensation expense have been recorded as adjustments to “Selling, General, and Administrative Expenses” within the Company’s Consolidated Statements of Income.
1Q07 and 2Q07 Restatement
Stock-based compensation expense
In addition to the Restatement noted above through March 31, 2006, the Company has recorded a non-cash charge for stock-based compensation of $0.8 million and $2.4 million for the three (3) and six (6) month periods ended September 30, 2006, offset in part by income tax benefits of $0.3 million and $1.0 million, or total after-tax charges of $0.5 million and $1.4 million. This charge was recorded to reflect additional non-cash, stock-based compensation expense recognized under the fair value method (SFAS 123(R)) because the exercise price for certain stock option grants prior to, but not vested as of March 31, 2006, differed from the fair market value of the underlying shares on the appropriate measurement date, some of which occurred during Fiscal 2007.
Accounting for derivatives
On July 26, 2006, the Company entered into an interest rate swap to reduce its exposure from fluctuating interest rates. SFAS No.133 “Accounting for Derivative Instruments and Hedging Activities” (“SFAS 133”) requires that all derivative instruments be recorded on the balance sheet as either an asset or liability measured at their fair value, and that changes in the derivatives’ fair value be recognized currently in earnings unless specific hedge accounting criteria are met. From inception of the hedge, the Company had applied a method

8


Table of Contents

of cash flow hedge accounting under SFAS 133 to account for the interest rate swap that allowed the Company to assume no ineffectiveness in such agreements, called the “short-cut” method.
Subsequently, the Company analyzed its eligibility for the short-cut method in light of certain clarifications delivered by the Office of the Chief Accountant of the SEC, and determined that its interest rate swap did not qualify for the short-cut method under SFAS 133 because certain prepayment features relating to the underlying actual debt were not identical to those contained in the interest rate swap. Because the Company’s documentation at hedge inception reflected the short-cut method rather than the long haul method for determining hedge ineffectiveness, the derivative did not meet the requirements for a cash flow hedge. Documentation for the long haul method of accounting at hedge inception cannot be retrospectively applied under SFAS 133. Therefore, fluctuations in the interest rate swap’s fair value should have been recorded through the Company’s Consolidated Statement of Income instead of through “Other Comprehensive Income (Loss)”, which is a component of stockholders’ equity. The adjustment for 2Q07 will decrease reported net income and increase “Other Comprehensive Income” by approximately $1.4 million. This change in accounting for this derivative instrument could result in significant volatility in the Company’s reported net income and earnings per share due to increases and decreases in the fair value of the interest rate swap. However, the derivative instrument remains highly effective and the change in accounting for this derivative instrument does not impact operating cash flows or total stockholders equity.
The table below reflects the impact of the additional non-cash charges for stock-based compensation expense and the non-cash charge related to the interest rate swap on the Company’s Consolidated Statements of Income, including the cumulative adjustment to Retained Earnings as of March 31, 2006 and September 30, 2006 on the Company’s Consolidated Balance Sheet. See Note 3 of the Notes to Consolidated Financial Statements for reference to footnote disclosure that reconciles the previously filed annual financial information to the restated annual financial information. All dollar amounts are presented in thousands except per share amounts. Per share amounts may not total due to rounding.
                                                                 
    (As                     Adjust-             (As             (As  
    previously     Adjust-     Income     ment,     (As     previously             Restated)  
    reported)     ment,     Tax     Net of     Restated)     reported)     Adjust-     Diluted  
    Net Income     Pre-Tax     Benefit     Tax     Net Income     Diluted EPS     ment     EPS  
 
FY 94
  $ 13,370     $ 43     $ (19)     $ 24     $ 13,346     $ 0.83     $ --     $ 0.83  
FY 95
    14,515       461       (144)       317       14,198       0.89       (0.02)       0.87  
FY 96
    18,278       406       (151)       255       18,023       1.10       (0.01)       1.09  
FY 97
    24,792       1,172       (456)       716       24,076       1.40       (0.04)       1.36  
FY 98
    32,404       3,595       (1,393)       2,202       30,202       1.79       (0.12)       1.67  
FY 99
    38,145       4,506       (1,732)       2,774       35,371       2.09       (0.15)       1.94  
FY 00
    48,852       5,778       (2,209)       3,569       45,283       2.60       (0.19)       2.41  
FY 01
    64,190       10,290       (3,953)       6,337       57,853       3.22       (0.32)       2.90  
FY 02
    62,042       11,333       (4,381)       6,952       55,090       2.97       (0.33)       2.64  
FY 03
    48,685       8,927       (2,328)       6,599       42,086       2.39       (0.32)       2.07  
FY 04
    47,243       8,197       (4,156)       4,041       43,202       2.52       (0.22)       2.30  
FY 05
    29,912       5,178       (2,312)       2,866       27,046       1.68       (0.16)       1.52  
                                 
 
                                                               
Cumulative
03/31/05
  $ 442,428     $ 59,886     $ (23,234)     $ 36,652     $ 405,776     $ 23.48     $ (1.89)     $ 21.59  
 
                                                               
1Q06
    7,394       1,120       (442)       678       6,716       0.43       (0.04)       0.39  
2Q06
    12,797       1,126       (444)       682       12,115       0.74       (0.04)       0.70  
3Q06
    12,511       2,431       (959)       1,472       11,039       0.70       (0.08)       0.62  
4Q06
    4,656       6,368       (2,612)       3,756       900       0.26       (0.21)       0.05  
                                 
 
                                                               
FY 06
  $ 37,358     $ 11,045     $ (4,457)     $ 6,588     $ 30,770     $ 2.13     $ (0.37)     $ 1.76  
 
                                                               
Cumulative
03/31/06
  $ 479,786     $ 70,931     $ (27,691)     $ 43,240     $ 436,546     $ 25.61     $ (2.26)     $ 23.35  
 
                                                               
1Q07
    7,807       1,629       (635)       994       6,813       0.43       (0.06)       0.37  
2Q07
    13,079       2,210       (806)       1,404       11,675       0.74       (0.08)       0.66  
                                 
2QYTD07
  $ 20,886     $ 3,839     $ (1,441)     $ 2,398     $ 18,488     $ 1.18     $ (0.14)     $ 1.04  
                                 
 
Cumulative
09/30/06
  $ 500,672     $ 74,770     $ (29,132)     $ 45,638     $ 455,034     $ 26.78     $ (2.39)     $ 24.39  
                 
Income Tax Considerations
In the course of the investigation, the Company determined that a number of officers may have exercised options for which the application of Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), may apply. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes because the Company

9


Table of Contents

incorrectly applied the measurement date as defined in APB 25. If such options are deemed to be granted at less than fair market value, pursuant to Section 162(m) of the Code (“Section 162(m)”), any compensation to officers, including proceeds from options exercised in any given tax year, in excess of $1.0 million will be disallowed as a deduction for tax purposes. The Company estimates that the potential tax effected liability for any such disallowed Section 162(m) deduction would approximate $3.6 million. The Company may also incur interest and penalties if it were to incur any such tax liability, which could be material.
In addition, the Company is considering the application of Section 409A of the Code (“Section 409A”) to those options for which it incorrectly applied the measurement date as defined in APB 25. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes and thus subject to Section 409A. Accordingly, the Company may adopt measures to address the application of Section 409A. The Company does not currently know what impact Section 409A will have, or any such measures, if adopted, would have, on its results of operations, financial position or cash flows, although such impact could be material.
Expenses Incurred by the Company
The Company has incurred expenses for legal fees and external audit firm fees, in the aggregate amount of approximately $0.6 million, in the fiscal year ended March 31, 2007, in relation to (i) the Audit Committee’s review of the Company’s historical stock option practices and related accounting for stock option grants, (ii) the informal inquiry and formal order of investigation by the Securities and Exchange Commission regarding its past stock option practices, (iii) the derivative action relating to the Company’s historical stock option practices filed against the Company as a nominal defendant and certain of the Company’s current and former directors and officers as to whom it may have indemnification obligations and (iv) related matters. Further, the Company expects to incur significant additional expense related to the foregoing matters in the fiscal year ending March 31, 2008. It is anticipated that certain of those expenses will be reimbursed under the Company’s directors’ & officers’ indemnification insurance.

10


Table of Contents

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
BLACK BOX CORPORATION
CONSOLIDATED BALANCE SHEETS (1)
                 
            (As Restated)  
In thousands, except par value   December 30, 2006     March 31, 2006  
    (Unaudited)     (Unaudited)  
 
Assets
               
Cash and cash equivalents
  $ 15,362     $ 11,207  
Accounts Receivable, net of allowance for doubtful accounts of $13,750 and $9,517
    184,403       116,713  
Inventories, net
    74,077       53,926  
Costs/estimated earnings in excess of billings on uncompleted contracts
    59,200       23,803  
Deferred tax asset
    10,456       8,973  
Prepaid and other current assets
    26,045       16,502  
         
Total current assets
    369,543       231,124  
 
               
Property, plant and equipment, net
    39,252       35,124  
Goodwill, net
    588,556       468,724  
Intangibles:
               
Customer relationships, net
    55,962       24,657  
Other intangibles, net
    36,493       30,783  
Deferred tax asset
    17,920       19,909  
Other assets
    4,192       5,091  
         
Total assets
  $ 1,111,918     $ 815,412  
         
 
               
Liabilities
               
Accounts payable
  $ 75,982     $ 44,943  
Accrued compensation and benefits
    23,443       13,954  
Deferred revenue
    48,998       22,211  
Restructuring reserve
    10,168       3,292  
Billings in excess of costs/estimated earnings on uncompleted contracts
    21,444       8,648  
Current maturities of long-term debt
    587       1,049  
Other liabilities
    62,042       37,358  
         
Total current liabilities
    242,664       131,455  
 
               
Long-term debt
    253,938       122,673  
Other liabilities
    26,754       8,293  
         
Total liabilities
    523,356       262,421  
 
               
Stockholders’ Equity
               
Preferred Stock authorized 5,000, par value $1.00, none issued
    --       --  
Common Stock authorized 100,000, par value $.001, 17,448 and 17,593 shares outstanding
    25       25  
Additional paid-in capital
    437,096       418,141  
Treasury stock, at cost 7,436 and 6,935 shares
    (317,030)       (296,824)  
Accumulated other comprehensive income
    24,025       13,036  
Retained earnings
    444,446       418,613  
         
Total stockholders’ equity
    588,562       552,991  
         
 
               
Total liabilities and stockholders’ equity
  $ 1,111,918     $ 815,412  
         
 
(1)
See Note 3 of the Notes to the Consolidated Financial Statements
See Notes to the Consolidated Financial Statements

11


Table of Contents

BLACK BOX CORPORATION
CONSOLIDATED STATEMENTS OF INCOME (1)
                                 
    (Unaudited)     (Unaudited)  
    Three months ended     Nine months ended  
    December 30 and 31     December 30 and 31  
            (As Restated)             (As Restated)  
In thousands, except per share amounts   2006     2005     2006     2005  
 
Revenues:
                               
Hotline products
  $ 57,770     $ 52,771     $ 165,058     $ 160,279  
On-Site services
    207,036       129,364       601,468       386,188  
         
Total
    264,806       182,135       766,526       546,467  
 
                               
Cost of Sales:
                               
Hotline products
    29,887       26,308       83,195       79,011  
On-Site services
    138,234       82,425       401,766       249,232  
         
Total
    168,121       108,733       484,961       328,243  
 
                               
Gross profit
    96,685       73,402       281,565       218,224  
 
                               
Selling, general & administrative expenses
    73,940       52,872       217,741       156,685  
Restructuring and other charges
    --       --       --       5,290  
Intangibles amortization
    2,677       1,349       6,114       4,235  
         
 
                               
Operating income
    20,068       19,181       57,710       52,014  
 
                               
Interest expense (income), net
    4,061       2,397       13,222       6,686  
Other expenses (income), net
    (122)       114       65       79  
         
 
                               
Income before provision for income taxes
    16,129       16,670       44,423       45,249  
 
                               
Provision for income taxes
    5,636       5,631       15,442       15,379  
         
 
                               
Net income
  $ 10,493     $ 11,039     $ 28,981     $ 29,870  
         
 
                               
Earnings per common share:
                               
Basic
  $ 0.60     $ 0.64     $ 1.66     $ 1.75  
         
Diluted
  $ 0.59     $ 0.62     $ 1.63     $ 1.72  
         
 
                               
Weighted average common shares outstanding
                               
Basic
    17,398       17,286       17,451       17,050  
         
Diluted
    17,780       17,786       17,809       17,362  
         
 
                               
Dividends per share
  $ 0.06     $ 0.06     $ 0.18     $ 0.18  
         
(1)  
See Note 3 of the Notes to the Consolidated Financial Statements
See Notes to the Consolidated Financial Statements

12


Table of Contents

BLACK BOX CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS (1)
                 
    (Unaudited)  
    Nine months ended  
    December 30 and 31  
            (As Restated)  
In thousands   2006     2005  
     
Operating Activities
               
Net income
  $ 28,981     $ 29,870  
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
               
Intangibles amortization and depreciation
    15,333       11,013  
Deferred taxes
    (730)       487  
Stock compensation expense
    7,476       4,677  
Tax benefit from exercised stock options
    662       (1,068)  
Change in fair value of interest rate swap
    1,308       --  
Changes in operating assets and liabilities:
               
Accounts receivable, net
    (644)       73  
Inventories, net
    (6,629)       5,673  
All other current assets excluding deferred tax asset
    707       (3,678)  
Liabilities exclusive of long term debt
    (21,868)       (8,135)  
         
Net cash provided by (used for) operating activities
  $ 24,596     $ 38,912  
 
               
Investing Activities
               
Capital expenditures
  $ (3,475)     $ (3,151)  
Capital disposals
    543       1,232  
Acquisition of businesses (payments)/recoveries
    (132,878)       (40,682)  
Prior merger-related (payments)/recoveries
    (1,431)       (378)  
         
Net cash provided by (used for) investing activities
  $ (137,241)     $ (42,979)  
 
               
Financing Activities
               
Proceeds from borrowings
  $ 314,021     $ 157,280  
Repayment of borrowings
    (184,946)       (164,698)  
Repayment on discounted lease rentals
    (27)       (847)  
Proceeds from exercise of options
    12,141       16,344  
Payment of dividends
    (3,157)       (3,049)  
Purchase of treasury stock
    (20,206)       (14)  
         
Net cash provided by (used for) financing activities
  $ 117,826     $ 5,016  
 
               
Foreign currency exchange impact on cash
  $ (1,026)     $ (398)  
         
 
               
Increase / (decrease) in cash and cash equivalents
  $ 4,155     $ 551  
 
               
Cash and cash equivalents at beginning of period
  $ 11,207     $ 11,592  
         
 
               
Cash and cash equivalents at end of period
  $ 15,362     $ 12,143  
         
 
               
Supplemental Cash Flow:
               
Cash paid for interest
  $ 11,264     $ 5,817  
Cash paid for income taxes
    13,850       13,539  
Non-cash financing activities:
               
Dividends payable
    1,047       1,044  
Capital leases
    349       834  
     
(1)  
See Note 3 of the Notes to the Consolidated Financial Statements
See Notes to the Consolidated Financial Statements

13


Table of Contents

BLACK BOX CORPORATION
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Note 1: Basis of Presentation
The accompanying unaudited interim consolidated financial statements of Black Box Corporation (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The Company believes that these consolidated financial statements reflect all normal, recurring adjustments needed to present fairly the Company’s results for the interim periods presented. The results for interim periods may not be indicative of the results of operations for any other interim period or for the full year. As previously disclosed, the financial statements and notes thereto included in the Company’s most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission (“SEC”) for the fiscal year ended March 31, 2006 (“Form 10-K”) will need to be restated and, therefore, should not be relied upon. See Note 3 of the Notes to the Consolidated Financial Statements.
The Company’s fiscal year ends on March 31. The fiscal quarters consist of 13 weeks and end on the Saturday nearest each calendar quarter end. The actual ending dates for the periods presented in these Notes to the Consolidated Financial Statements as of December 31, 2006 and 2005 were December 30, 2006 and December 31, 2005. References to “Fiscal Year” or “Fiscal” mean the Company’s fiscal year ended March 31 for the year referenced. All references to dollar amounts herein are presented in thousands, except per share amounts.
Principles of Consolidation
The consolidated financial statements include the accounts of the parent company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowances for doubtful accounts receivable, sales returns, net realizable value of inventories, loss contingencies, warranty reserves, intangible assets and goodwill. Actual results could differ from those estimates. Management believes the estimates made are reasonable.
Reclassification
Certain reclassifications have been made to the financial statements for prior periods in order to conform to the presentation for the three (3) and nine (9) months ended December 30, 2006.
Note 2: Significant Accounting Policies / Recent Accounting Pronouncements
Significant Accounting Policies
The significant accounting policies used in the preparation of the Company’s Consolidated Financial Statements are disclosed Note 1 within the Notes to the Consolidated Financial Statements for the year ended March 31, 2006 contained in Form 10-K. Additional significant accounting policies adopted during Fiscal 2007 are disclosed below.
Stock-Based Compensation
On April 1, 2006, the Company adopted Statement of Financial Accounting Standards (“SFAS”) No. 123 (revised 2004), “Share-Based Payment” (“SFAS 123(R)”) which requires companies to estimate the fair value of share-based payment awards and recognize compensation expense over the requisite service period for the portion of the award that is ultimately expected to vest. Prior to the adoption of SFAS 123(R), the Company accounted for share-based awards to employees and directors using the intrinsic value method in accordance with Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB 25”) as allowed under SFAS No. 123, “Accounting for Stock-Based Compensation” (“SFAS 123”). Under the intrinsic value method, no stock-based compensation expense related to stock options was required to be recognized if the exercise price of the Company’s stock options granted to employees and directors was equal to or greater than the fair market value of the underlying stock on the measurement date.
The Company adopted SFAS 123(R) using the modified prospective transition method which requires compensation cost to be recognized for all share-based payments granted after the date of adoption and for all unvested awards existing on the date of adoption. In accordance with the modified prospective transition method, the Company’s Consolidated Financial Statements for prior periods have not been retroactively adjusted to reflect, and do not include, the impact of SFAS 123(R). However, the modified prospective transition

14


Table of Contents

method does require the Company to provide pro-forma disclosure of specific income statement line items for periods prior to the adoption of SFAS 123(R) as if the fair-value-based method had been applied to all awards. See Note 14 of the Notes to the Consolidated Financial Statements.
SFAS 123(R) requires companies to estimate the fair value of share-based payment awards on the grant-date using an option-pricing model. Upon adoption of SFAS 123(R), the Company began using the Black-Scholes option pricing model as the method of valuation for the Company’s stock options. The model requires the use of various assumptions. The key assumptions are summarized as follows:
Expected volatility: The Company estimates the volatility of the common stock at the date of grant based on the historical volatility of its common stock.
Dividend yield: The Company estimates the dividend yield assumption based on the Company’s historical and projected dividend payouts.
Risk-free interest rate: The Company bases risk-free interest rate on the observed interest rates appropriate for the term of the Company’s employee stock options.
Annual forfeiture rate and expected holding period: The Company estimates the annual forfeiture rate and expected holding period based on historical experience.
Amortization period: The Company recognizes the fair value of awards into expense over the requisite service periods associated with the award.
Recent Accounting Pronouncements
Fair Value Option for Financial Assets and Financial Liabilities
In February 2007, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities—Including an Amendment of FASB Statement No. 115” (“SFAS 159”). SFAS 159 permits an entity to elect to measure eligible items at fair value (“fair value option”) including many financial instruments. The provisions of SFAS 159 are effective for the Company as of April 1, 2008. If the fair value option is elected, the Company will report unrealized gains and losses on items for which the fair value option has been elected in earnings at each subsequent reporting date. Upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. The fair value option may be applied for a single eligible item without electing it for other identical items, with certain exceptions, and must be applied to the entire eligible item and not to a portion of the eligible item. The Company is currently evaluating the irrevocable election of the fair value option pursuant to SFAS 159.
Prior Year Misstatements on Current Year Financial Statements
In September 2006, the SEC issued Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements” (“SAB 108”). SAB 108 provides interpretive guidance on how the effects of prior year uncorrected misstatements should be considered when quantifying misstatements in current year financial statements for the purpose of a materiality assessment. The SEC staff believes that registrants should quantify errors using both a balance sheet and an income statement approach and evaluate whether either approach results in quantifying a misstatement that, when all relevant quantitative and qualitative factors are considered, is material. SAB 108 is effective as of the Company’s fiscal year end March 31, 2007. The Company adopted SAB 108 as of March 31, 2007. The adoption of SAB 108 did not have a material impact on its consolidated financial statements.
Fair Value Measurements
In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”), which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. SFAS 157 is effective for the Company beginning on April 1, 2008. The requirements of SFAS 157 will be applied prospectively except for certain derivative instruments that would be adjusted through the opening balance of retained earnings in the period of adoption. The Company is evaluating the impact of the adoption of SFAS 157 on the Company’s consolidated financial statements.
Defined Benefit Pension and Other Postretirement Plans
In September 2006, the FASB issued SFAS No 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans” (“SFAS 158”) that would amend SFAS No. 87, “Employers’ Accounting for Pensions,” SFAS No. 88, “Employers’ Accounting for Settlements and Curtailments of Defined Benefit Pension Plans and for Termination Benefits,” SFAS No. 106, “Employers’

15


Table of Contents

Accounting for Postretirement Benefits Other Than Pensions” and SFAS No. 132 (Revised 2003), “Employers’ Disclosures about Pensions and Other Postretirement Benefits.” This standard requires, among other things, companies to recognize on the balance sheet the funded or unfunded status of pension and other postretirement benefit plans and to recognize the change in funded status in the period the change occurs through comprehensive income. The provisions of SFAS 158 are effective as of the Company’s fiscal year end March 31, 2007. The Company adopted SFAS 158 as of March 31, 2007. The adoption of SFAS 158 had no impact on the Company’s Statement of Operations on the date of adoption. However, the Company did record a gain into other comprehensive income of approximately $2.7 million (1.7 million, net of tax.)
Uncertainty in Income Taxes
In July 2006, the FASB issued FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes” (“FIN 48”). This Interpretation requires that realization of an uncertain income tax position must be “more likely than not” (i.e., greater than 50% likelihood of receiving a benefit) before it can be recognized in the financial statements. Further, FIN 48 prescribes the benefit to be recorded in the financial statements as the amount most likely to be realized assuming a review by tax authorities having all relevant information and applying current conventions. The Interpretation also clarifies the financial statement classification of tax-related penalties and interest and sets forth new disclosures regarding unrecognized tax benefits. FIN 48 is effective for the next fiscal year beginning after December 15, 2006. The Company plans to adopt the Interpretation as of April 1, 2007 as required. The Interpretation is currently being evaluated by the Company for its full impact and, at this time, the Company believes it has properly and adequately provided for all income tax positions and therefore expects minimal impact from adopting the Interpretation.
Definition of Settlement in FIN 48
In May 2007, the FASB issued staff position No. FIN 48-1, “Definition of Settlement in FASB Interpretation No. 48” (“FSP FIN 48-1”) which amended FIN 48 to provide guidance about how an enterprise should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits. Under FSP FIN 48-1, a tax position could be effectively settled on completion of an examination by a taxing authority. The Company plans to adopt FSP FIN 48-1 in conjunction with adoption of FIN 48 as of April 1, 2007. This staff position is currently being evaluated by the Company for its full impact and, at this time, the Company believes it has properly and adequately provided for all income tax positions and therefore expects minimal impact from adoption.
Stock-Based Compensation
In December 2004, the FASB issued SFAS 123(R). SFAS 123(R) is a revision of SFAS No. 123, supersedes APB 25 and amends SFAS No. 95, “Statement of Cash Flows.” SFAS 123(R) requires that companies recognize all share-based payments to employees, including grants of employee stock options, in the financial statements. The recognized cost is based on the fair value of the equity or liability instruments issued. Pro-forma disclosure of this cost is no longer an alternative under SFAS 123(R). This Statement was effective for public companies at the beginning of the first annual reporting period beginning after June 15, 2005.
As permitted by SFAS 123, the Company accounted for its stock-based compensation plans under APB 25’s intrinsic value method and, as such, recognized stock-based compensation expense if the exercise price of the Company’s stock options granted to employees and directors was equal to or greater than the fair market value of the underlying stock on the measurement date. The adoption of SFAS 123(R)’s fair value method has had no impact on the Company’s overall financial position or cash flows. Based on SFAS 123(R), the Company transitioned to the new requirements by using the modified prospective transition method. This transition method requires compensation cost to be recognized for all share-based payments granted after the date of adoption and for all unvested awards existing on the date of adoption.
SFAS 123(R) also requires the benefits of tax deductions in excess of recognized compensation cost be reported as a financing cash flow, rather than as an operating cash flow as required under past standards. This requirement will reduce net operating cash flows and increase net financing cash flows in periods after adoption when the benefits of tax deductions are in excess of recognized compensation cost.
The Company adopted the provisions of SFAS 123(R) as of April 1, 2006. For the three and nine month periods ended December 31, 2006, the Company recognized compensation expense of $1,840 ($1,196 net of tax) or $0.07 per diluted share and $7,476 ($4,860 net of tax) or $0.27 per diluted share, respectively on the Company’s Consolidated Statements of Income. See Significant Accounting Policies (within this Note 2 of the Notes to the Consolidated Financial Statements) and Note 14 of the Notes to the Consolidated Financial Statements for further reference to the disclosures required by SFAS 123(R).
Tax Effects of Share-Based Payment Awards
On November 10, 2005, the FASB issued Staff Position No. SFAS 123(R)-3, “Transition Election Related to Accounting for Tax Effects of Share-Based Payment Awards” (“SFAS 123(R)-3”). The alternative transition method includes simplified methods to establish the beginning balance of the additional paid-in capital pool (“APIC pool”) related to the tax effects of employee share-based compensation, and to determine the subsequent impact on the APIC pool and Consolidated Statements of Cash Flows of the tax effects of employee share-based compensation awards that are outstanding upon adoption of SFAS 123(R). The company has elected this transition method for calculating tax effects of share-based payment awards.

16


Table of Contents

Note 3: Restatement of Consolidated Financial Statements
Restatement through March 31, 2006
Background
On November 13, 2006, Black Box received a letter of informal inquiry from the Enforcement Division of the SEC relating to the Company’s stock option practices from January 1, 1997 to present. As a result, the Audit Committee, with the assistance of outside legal counsel, commenced an independent review of the Company’s historical stock option grant practices and related accounting for stock option grants during the period from 1992 to the present (the “Review Period”).
On February 1, 2007, the Company announced that, while the review of option grant practices was continuing, it believed that it would need to record additional non-cash charges for stock-based compensation expense relating to certain stock option grants and, accordingly, cautioned investors about relying on its historical financial statements until the Company could determine with certainty whether a restatement would be required and, if so, the extent of any such restatement and the periods affected.
On March 19, 2007, although the Audit Committee had not yet completed its review, the Audit Committee concluded that the exercise price of certain stock option grants differed from the fair market value of the underlying shares on the appropriate measurement date. At that time, the Company and the Audit Committee announced that it was currently expected that the Company’s additional non-cash, pre-tax charges for stock-based compensation expense relating to certain stock option grants would approximate $63 million for the Review Period. In addition, the Company and the Audit Committee concluded that the Company would need to restate its previously-issued financial statements contained in reports previously filed by the Company with the SEC. Accordingly, on March 19, 2007, the Company and the Audit Committee concluded that the Company’s previously-issued financial statements and other historical financial information and related disclosures for the Review Period, including applicable reports of its current or former independent registered public accounting firms and related press releases, should not be relied upon.
On May 25, 2007, the Company was advised by the Enforcement Division of the SEC that a Formal Order of Private Investigation arising out of the Company’s stock option practices had been entered and on May 29, 2007 the Company received a subpoena that was issued by the SEC.
On May 31, 2007, the Company announced that, as a result of the ongoing review of stock option practices, Company management and the Audit Committee expected that the Company’s additional non-cash, pre-tax charges for stock-based compensation expense relating to certain stock option grants would approximate $70 million for the Review Period.
Findings of the Audit Committee
During the Review Period, the Company granted stock options pursuant to an employee stock option plan and a director stock option plan to acquire approximately 10.9 million shares of the Company’s common stock, par value $.001 per share (the “common stock”). Such plans at all relevant times provided for option grants to be approved by a designated committee of non-employee directors or, in the case of the director stock option plan, by the Company’s Board of Directors (“the Board”). Approximately 2,000 stock option grants were awarded during the Review Period with 69 recorded grant dates. No stock options have been granted since September, 2006. The Audit Committee reviewed all stock options granted during the Review Period, including option grants to the Company’s directors, officers and rank and file employees (including grants to new employees, grants awarded in connection with Company acquisitions and grants made as individual or group performance awards). The Audit Committee’s review of the Company’s stock option granting practices included a comprehensive examination of reasonably available relevant physical and electronic documents as well as interviews with current and former directors, officers and Company personnel.
The Audit Committee’s review was initially focused on determining whether the Company’s prior stock option granting practices were in compliance with the plans’ granting provisions and applicable law or called into question its accounting for such options. Once it became evident that such issues and accounting implications existed, the inquiry focused on those matters necessary: to determine whether any accounting charges were material and whether a restatement of the Company’s previously-issued financial statements would be required; to establish a basis for effecting any required restatement; to assure that, on as timely a basis as possible, the Company could file any required curative disclosures with the SEC and assure its continued eligibility for listing on The NASDAQ Stock Market; and to provide an informed basis for the Company’s response to the identified issues, including appropriate corrective and remedial actions.
The following information summarizes certain of the findings of the Audit Committee. The findings identified approximately $71.5 million of unrecorded expense at the time of grant (i.e., the difference between the fair market value of the common stock on the

17


Table of Contents

appropriate measurement date and the stated exercise price), net of forfeitures, during the Review Period, of which $70.0 million was recorded in the Company’s Consolidated Financial Statements through March 31, 2006 and $1.5 million of unrecorded expense at the time of grant will be included, beginning at April 1, 2006, in the Company’s computation of compensation expense in accordance with SFAS 123(R). The following summarizes the unrecorded expense at the time of grant by time period and category of recipient:
   
$4.2 million for the period from Fiscal 1993 through Fiscal 1997 ($0.2 million for directors, $2.5 million for officers and $1.5 million for rank and file employees)
 
   
$45.6 million for the period from Fiscal 1998 through August 2002 ($1.1 million for directors, $25.7 million for officers and $18.7 million for rank and file employees)
 
   
$21.8 million for the period from August 2002 to the present ($0.04 million for directors, $0.6 million for officers and $21.1 million for rank and file employees)
The Audit Committee’s additional key findings are summarized below:
Lack of Adequate Documentation: For a majority of grants issued by the Company during the Review Period, there is either no or inadequate documentation of approval actions that satisfies the requisites for establishing a measurement date under APB 25. Of the 69 recorded grant dates, there are documented approval actions by the Board or the Option or Compensation Committee of the Board (the “Compensation Committee”) with respect to particular grants for 12 dates. In the period December 1992 to May 1996, neither the minutes of the Compensation Committee nor of the Board reflect any action to approve specific grants. In some instances, evidence of single director (the chairman of the Compensation Committee) approval actions exists. This absence of non-employee director level documentation also applies to a majority of grants with a recorded grant date after 1996. In some cases, Compensation Committee minutes contain a reference to reports on the status of the option pool but do not document any action to approve specific grants. Approval documentation for certain grants has internal inconsistencies or conflicts with other documents thereby rendering this documentation unreliable as a basis for establishing a measurement date. In some cases, the only existing documentation is the executed option agreement and/or the entry of the option grant into the option database. Notwithstanding these approval documentation inadequacies, the Company entered into option agreements with grantees and has honored such grants.
Grant Approvals: During the Review Period, relatively few option grants were approved in complete compliance with the Company’s stock option plans. Available documentation reflects that the Company approved option grants in a variety of ways. With respect to the employee stock option plan, grants were approved by the Compensation Committee as contemplated by the plan at various times, by the full Board in 1998 and 1999, by a single director (the chairman of the Compensation Committee) on nine recorded grant dates during the period 1994 through 2001 and by the Company’s Chief Executive Officer (“CEO”) at various times. With respect to the director stock option plan, grants were generally approved by the designated Board committee and, in a few cases, by the chairman of the Compensation Committee. In one instance in 2000, there is no conclusive documentary evidence of the approval of director grants other than the signed director option agreements.
The delegation of authority by the Compensation Committee to the CEO with respect to grants to rank and file employees was not fully documented. However, there was an understood and accepted practice between the CEO and the Compensation Committee whereby the CEO made certain awards to individual employees. In some instances, this involved the allocation among rank and file employees of blocks of shares approved by the Compensation Committee; in three (3) such instances, the number of shares ultimately awarded pursuant to this process exceeded the approved size of the block, which was contrary to the understanding of the Compensation Committee members. Further, contrary to the understanding of Committee members, the award and/or documentation of those individual grants often significantly lagged the approval of the block grant. In August 2005, the Compensation Committee specifically acknowledged a prior grant of delegated authority to the CEO to make option grants to rank and file employees and ratified all prior awards by the CEO. In some cases, documentation of approval action is either inconclusive or missing, and the Company therefore has been unable to determine what entity or person actually approved specific grants.
Option Pricing: The recorded grant dates for a majority of grants do not match the applicable measurement dates as determined under APB 25. The grants of options with exercise prices lower than the fair market values of the stock on the actual measurement dates did not satisfy the fair market pricing requirement in the Company’s plans, as amended in 1998, and were not consistent with the Company’s disclosures in SEC filings stating that the exercise price of options was equal to the fair market value of the stock on the date of the grant.
The relationship between the stated exercise price of options and the fair market value of the Company’s stock on the date of the identifiable approval actions varied from grant to grant. In some cases, the exercise price of grants reflected the fair market value of the underlying shares on the date of any documented approval action. In other cases, the exercise prices reflected the fair market value of the underlying shares on a date either prior or subsequent to any such documented approval action and the exercise price was lower than the fair market value on the date of any such action. In several such cases before August 2002, the use of such grant dates and lower exercise prices (together with other available evidence) supports a finding that the recorded grant dates and corresponding exercise prices were

18


Table of Contents

selected with the benefit of hindsight. For certain grants where the mismatch between the recorded grant date and the approval action was only a matter of days, however, the mismatch appears to have been attributable to inaccurate recording or administrative delays. In some cases, the apparent approval action did not identify all grantees; for example, there are cases where a block grant was approved subject to a later determination of individual grant recipients and grants were recorded with a grant date, and corresponding exercise price, that matched the date of the apparent approval of the block grant and the fair market value of the common stock on that date although individual grant recipients may have been identified some time after approval of the block grant. Finally, in some cases, the approval action for specific grants is not adequately documented. Where the recorded grant date did not satisfy the requisites for a measurement date under APB 25, the Company relied on default methodologies to determine an appropriate measurement date.
Internal Controls: As outlined above, the Company’s historical administration of its options program lacked discipline as it relates to proper adherence to the plan requirements, corporate recordkeeping and documentation. Since November 2003, however, the Company has properly administered the stock option program as it relates to awards to directors and officers. During the investigation, the Company identified control gaps related to grants made throughout the Review Period. As of March 31, 2007, the Company implemented additional procedures to its process that are focused on formalized documentation of appropriate approvals and determination of grant terms to employees.
Procedural and Remedial Actions
The Audit Committee and other relevant Board committees are committed to a continued review and implementation of procedural enhancements and remedial actions in light of the foregoing findings. Consistent with its obligation to act in the best interests of the Company taking into account all relevant facts and circumstances, the Audit Committee is continuing to assess the appropriateness of a broad range of possible procedural enhancements and potential remedial measures in light of the findings of its investigation. While the Audit Committee has not completed its consideration of all such steps, procedural enhancements may include recommendations regarding improved stock option administration procedures and controls, training and monitoring compliance with those procedures, corporate recordkeeping, corporate risk assessment, evaluation of the internal compliance environment and other remedial steps that may be appropriate. The Audit Committee is also expected to address issues of individual conduct or responsibility, including those of the Board, CEOs and Chief Financial Officers (“CFOs”) serving during the Review Period. Potential remedial measures may include an evaluation of the role of and possible claims or other remedial actions against current and former Company personnel who may be found to have been responsible for identified problems during the Review Period. The Audit Committee expects to recommend to the Board and/or its appropriate committees procedural enhancements and remedial measures that appropriately address the issues raised by its findings. In advance of action by the Audit Committee, as noted above, the Company has implemented additional procedures to its process for approving stock option grants that are focused on formalized documentation of appropriate approvals and determination of grant terms to employees.
Restatement Methodologies
As of April 1, 2006, the Company adopted SFAS 123(R) using the modified prospective transition method. Under this transition method, compensation expense is to be recognized for all share-based compensation awards granted after the date of adoption and for all unvested awards existing on the date of adoption. Prior to April 1, 2006, the Company accounted for stock-based compensation awards to directors, officers and rank and file employees using the intrinsic value method in accordance with APB 25 as allowed under SFAS 123. Under the intrinsic value method, no share-based compensation expense related to stock options was required to be recognized if the exercise price of the stock option was at least equal to the fair market value of the common stock on the “measurement date.” APB 25 defines the measurement date as the first date on which are known both (1) the number of shares that an individual grant recipient is entitled to receive and (2) the option or purchase price, if any.
In light of the Audit Committee’s review of the Company’s stock option granting practices during the Review Period and as to those cases in which the Company previously used a recorded grant date as the measurement date that the Company determined could no longer be relied upon, the Company has developed and applied the following methodologies to remeasure those stock option grants and record the relevant charges in accordance with APB 25 by considering the following sources of information: (i) meeting minutes of the Board and of committees thereof and related materials, (ii) Unanimous Written Consents of the Board and of committees thereof, (iii) the dates on which stock option grants were entered into the Company’s stock option database (“create date”), (iv) relevant email correspondence reflecting stock option grant approval actions, (v) individual stock option agreements and related materials, (vi) employee and Board offer letters, (vii) documents relating to acquisitions, (viii) reports on Form 4 filed with the SEC and (ix) guidance of the Office of the Chief Accountant of the SEC on stock option matters as set forth in its letter dated September 19, 2006.
Grants with Appropriate Committee Approval. With respect to grants of approximately 1.0 million shares, or approximately 9% of the total grants in the Review Period, the Company has evidence to support the approval of the grant under the stock option plans by the relevant committee of the Board, and such evidence includes the number of options each individual was entitled to receive and the option price. However, the relationship between these documented approval actions and the originally-recorded grant dates and exercise prices

19


Table of Contents

for the options so approved varied during the Review Period. In some cases, grants were recorded with a grant date and a corresponding exercise price that matched the date of the approval action or were otherwise consistent with the terms of the approval actions. In other cases, however, the recorded grant dates and corresponding exercise prices of the grants reflected the fair market value of the common stock on a date prior to the committee’s documented approval actions. The Company has restated the compensation expense for stock option grants relating to approximately 0.4 million shares of common stock by using the date of the documented approval action as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $1.8 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.07 million relates to director options, $1.3 million relates to officer options and $0.4 million relates to rank and file employee options.
Grants with Other Approvals. With respect to grants of approximately 1.9 million shares, or approximately 18% of the total grants in the Review Period, the Company has evidence to support the approval of the grant by the Board, an outside director or the Company’s CEO and the identification of the number of options each individual was entitled to receive together with the option price. These grants are distinguished from the grants described in the prior paragraph in that the nature of the approval was not fully consistent with the terms of the relevant stock option plan. As with the grants discussed in the preceding paragraph, the relationship between these documented approval actions and the originally-recorded grant dates and exercise prices for the options so approved varied during the Review Period. In some cases, grants were recorded with a grant date and a corresponding exercise price that matched the date of the approval action or were otherwise consistent with the terms of the approval action. In other cases, however, the recorded grant dates and corresponding exercise prices of the grants reflected the fair market value of the Company’s stock on a date prior to the approval action. The Company has restated the compensation expense for stock option grants relating to approximately 1.6 million shares of common stock by using the date of the documented approval action as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $7.6 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.5 million relates to director options, $2.6 million relates to officer options and $4.5 million relates to rank and file employee options.
Grants Lacking Adequate Documentation. With respect to grants of approximately 7.9 million shares (5.0 million shares to rank and file employees), or 73.0% of the total grants in the Review Period, the Company has been unable to locate adequate documentation of approval actions that would satisfy the requisites for a measurement date under APB 25. For these grants, management considered all available relevant information to form a reasonable conclusion as to the most reasonable measurement date. For all grants in this category, the Company has established default methodologies for determining the most appropriate measurement date under APB 25.
With respect to grants entered into the Company’s stock option database after September 9, 1999, when the database began to reflect a “create date” which is the date on which a grant was entered into the system, the Company has determined to use the individual “create date” for each grant as the APB 25 measurement date, which was in most cases different from the originally-recorded grant date. The Company believes that this “create date” is the most appropriate methodology in the absence of sufficient evidence of approvals for these grants as it represents the earliest point in time at which the evidence shows that all requisites for the establishment of the measurement date had been satisfied. Such “create dates” preceded, often by a significant amount of time, the execution of stock option agreements, which, generally, were manually signed by the Company’s CEO and manually signed and dated by the grantee. In addition, in almost all cases, a grant entered into the database, which established the “create date,” ultimately resulted in the creation of a stock option agreement reflecting such grant. Accordingly, while execution of the stock option agreements constituted a clear acknowledgement by the grantee and the Company of the grantee’s legal entitlement to the grant the Company believes the “create date” more accurately reflects the date of approval than does the signed option agreement. The Company has restated the compensation expense for stock option grants relating to approximately 4.2 million shares of common stock by using the “create date” as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $49.8 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.5 million relates to director options, $17.2 million relates to officer options and $32.2 million relates to rank and file employee options. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to such create dates included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the create date for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted for which the “create date” methodology was utilized to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.09 million to $73.8 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $49.8 million, net of forfeitures, included in the Restatement.
For options entered into the Company’s option database before September 9, 1999, the Company determined the measurement date generally by reference to signed option agreements (or the deemed signature date for certain options as discussed below). The executed option agreements (hereinafter “signed option agreements”), manually signed by the Company’s CEO and manually signed and dated by the grantee, constituted an acknowledgement by the grantee and the Company of the grantee’s legal entitlement to the grant and, in the absence of authoritative information as to when all the requisites for the establishment of the measurement date had been satisfied, provides a measurement date framework based on entitlement. The Company has restated the compensation expense for stock option

20


Table of Contents

grants relating to approximately 1.4 million shares of common stock by using the signed option agreements as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $6.4 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.3 million relates to director options, $3.6 million relates to officer options and $2.5 million relates to rank and file employee options. The Company believes this methodology was the most appropriate in the absence of sufficient evidence of approvals for these grants as it represents the earliest point in time at which the evidence shows that all requisites for the establishment of the measurement date had been satisfied for these grants. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to the dating of signed option agreements included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the date of the grantee’s signature on the stock option agreement for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted for which the signed option agreements methodology was utilized to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.03 million to $9.6 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $6.4 million, net of forfeitures, included in the Restatement.
In those cases where no reliably-dated signed option agreement could be located and where no post-September 9, 1999 “create date” exists (stock option grants totaling approximately 0.9 million shares), the Company used the average period between recorded grant date and date of the signatures on all other grantee signed option agreements with the same grant date as the measurement date. For example, if there were four stock option grants with a grant date of January 1, 1996, the Company had the signed option agreements for three of these stock option grants and the average number of days between the grant date and the signature dates of these three signed option agreements was 20 days, January 21, 1996 was used as the measurement date for the grant for which no signed option agreement could be located. The Company has restated the compensation expense for stock option grants relating to approximately 0.7 million shares of common stock using this “average days to sign agreement” method. The total additional non-cash, pre-tax charge for these grants is approximately $4.4 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.06 million relates to director options, $4.2 million relates to officer options and $0.2 million relates to rank and file employee options. The Company believes this methodology was the most appropriate in the absence of sufficient evidence of approvals for these grants because it gives a reasonable approximation of the measurement date related to these options in light of the available evidence. The Company conducted a sensitivity analysis by comparing the Company’s current default methodology (i.e., “average days to sign agreement”) with another default methodology. For this analysis, the Company identified the range of potential grant dates defined by the earliest signed option agreement and the latest signed option agreement. The Company then identified the low and high closing prices of the common stock over the range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $2.6 million to $5.9 million, net of forfeitures. The Company’s analyses indicate that stock-based compensation expense computed using other identified alternative default methodologies would not materially differ from stock-based compensation expense computed using the “average days to sign agreement” methodology. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to the average days to sign agreements also included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the average days to sign agreement for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.03 million to $6.1 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $4.4 million, net of forfeitures, included in the Restatement.
Given the volatility of the common stock during much of the Review Period, the use of methodologies and measurement dates different from those described above could have resulted in a higher or lower cumulative compensation expense which would have caused net income or loss to be different from the amounts reported in the restated consolidated financial statements. The Company’s procedures for evaluating the appropriateness of measurement dates fixed using the default methodologies described above also included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the appropriate measurement date for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $9.3 million to $99.3 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $70.0 million, net of forfeitures, included in the Restatement.

21


Table of Contents

Other adjustments through March 31, 2006
From 1994 through 1998, the Company did not properly account for stock options for one officer that were modified after the grant date pursuant to a separation agreement. Some of these modifications were not identified in the Company’s financial reporting processes and were therefore not properly reflected in its financial statements. As a result, the Company has recorded a non-cash charge for stock-based compensation of $1.0 million during Fiscal 1999.
Summary
In summary, the Company recorded cumulative non-cash charges for stock-based compensation of $70.9 million through March 31, 2006, offset in part by a cumulative income tax benefit of $27.7 million, for a total after-tax charge of $43.2 million. These charges had no impact on net sales or cash and cash equivalents as previously reported in the Company’s financial statements; as a result, no changes to these items are reflected in the Restatement. Non-cash charges for stock-based compensation expense have been recorded as adjustments to “Selling, General, and Administrative Expenses” within the Company’s Consolidated Statements of Income.
1Q07 and 2Q07 Restatement
Stock-based compensation expense
In addition to the Restatement noted above through March 31, 2006, the Company has recorded a non-cash charge for stock-based compensation of $0.8 million and $2.4 million for the three (3) and six (6) month periods ended September 30, 2006, offset in part by income tax benefits of $0.3 million and $1.0 million, or total after-tax charges of $0.5 million and $1.4 million. This charge was recorded to reflect additional non-cash, stock-based compensation expense recognized under the fair value method (SFAS 123(R)) because the exercise price for certain stock option grants prior to, but not vested as of March 31, 2006, differed from the fair market value of the underlying shares on the appropriate measurement date, some of which occurred during Fiscal 2007.
Accounting for derivatives
On July 26, 2006, the Company entered into an interest rate swap to reduce its exposure from fluctuating interest rates. SFAS No.133 “Accounting for Derivative Instruments and Hedging Activities” (“SFAS 133”) requires that all derivative instruments be recorded on the balance sheet as either an asset or liability measured at their fair value, and that changes in the derivatives’ fair value be recognized currently in earnings unless specific hedge accounting criteria are met. From inception of the hedge, the Company had applied a method of cash flow hedge accounting under SFAS 133 to account for the interest rate swap that allowed the Company to assume no ineffectiveness in such agreements, called the “short-cut” method.
Subsequently, the Company analyzed its eligibility for the short-cut method in light of certain clarifications delivered by the Office of the Chief Accountant of the SEC, and determined that its interest rate swap did not qualify for the short-cut method under SFAS 133 because certain prepayment features relating to the underlying actual debt were not identical to those contained in the interest rate swap. Because the Company’s documentation at hedge inception reflected the short-cut method rather than the long haul method for determining hedge ineffectiveness, the derivative did not meet the requirements for a cash flow hedge. Documentation for the long haul method of accounting at hedge inception cannot be retrospectively applied under SFAS 133. Therefore, fluctuations in the interest rate swap’s fair value should have been recorded through the Company’s Consolidated Statement of Income instead of through “Other Comprehensive Income (Loss)”, which is a component of stockholders’ equity. The adjustment for 2Q07 will decrease reported net income and increase “Other Comprehensive Income” by approximately $1.4 million. This change in accounting for this derivative instrument could result in significant volatility in the Company’s reported net income and earnings per share due to increases and decreases in the fair value of the interest rate swap. However, the derivative instrument remains highly effective and the change in accounting for this derivative instrument does not impact operating cash flows or total stockholders equity.
The table below reflects the impact of the additional non-cash charges for stock-based compensation expense and the non-cash charge related to the interest rate swap on the Company’s Consolidated Statements of Income, including the cumulative adjustment to Retained Earnings as of March 31, 2006 and September 30, 2006 on the Company’s Consolidated Balance Sheet. All dollar amounts are presented in thousands except per share amounts. Per share amounts may not total due to rounding.

22


Table of Contents

                                                                 
                                            (As                
    (As                     Adjust-             previously             (As  
    previously     Adjust-     Income     ment,             reported)             Restated)  
    reported)     ment,     Tax     Net of     (As Restated)     Diluted     Adjust-     Diluted  
    Net Income     Pre-Tax     Benefit     Tax     Net Income     EPS     ment     EPS  
 
 
                                                               
FY 94
   $  13,370      $ 43     $ (19 )    $  24      $ 13,346      $ 0.83      $ --      $ 0.83  
FY 95
    14,515       461       (144 )     317       14,198       0.89       (0.02 )     0.87  
FY 96
    18,278       406       (151 )     255       18,023       1.10       (0.01 )     1.09  
FY 97
    24,792       1,172       (456 )     716       24,076       1.40       (0.04 )     1.36  
FY 98
    32,404       3,595       (1,393 )     2,202       30,202       1.79       (0.12 )     1.67  
FY 99
    38,145       4,506       (1,732 )     2,774       35,371       2.09       (0.15 )     1.94  
FY 00
    48,852       5,778       (2,209 )     3,569       45,283       2.60       (0.19 )     2.41  
FY 01
    64,190       10,290       (3,953 )     6,337       57,853       3.22       (0.32 )     2.90  
FY 02
    62,042       11,333       (4,381 )     6,952       55,090       2.97       (0.33 )     2.64  
FY 03
    48,685       8,927       (2,328 )     6,599       42,086       2.39       (0.32 )     2.07  
FY 04
    47,243       8,197       (4,156 )     4,041       43,202       2.52       (0.22 )     2.30  
FY 05
    29,912       5,178       (2,312 )     2,866       27,046       1.68       (0.16 )     1.52  
                                 
 
                                                               
Cumulative
03/31/05
   $  442,428      $  59,886     (23,234 )    $  36,652      $ 405,776      $ 23.48     $ (1.89 )    $ 21.59  
 
                                                               
1Q06
    7,394       1,120       (442 )     678       6,716       0.43       (0.04 )     0.39  
2Q06
    12,797       1,126       (444 )     682       12,115       0.74       (0.04 )     0.70  
3Q06
    12,511       2,431       (959 )     1,472       11,039       0.70       (0.08 )     0.62  
4Q06
    4,656       6,368       (2,612 )     3,756       900       0.26       (0.21 )     0.05  
                                 
 
                                                               
FY 06
   $  37,358      $  11,045     (4,457 )    $  6,588      $ 30,770      $ 2.13     $ (0.37 )    $ 1.76  
 
                                                               
Cumulative
03/31/06
   $  479,786      $  70,931     (27,691 )    $  43,240      $ 436,546      $ 25.61     $ (2.26 )    $ 23.35  
 
                                                               
1Q07
    7,807       1,629       (635 )     994       6,813       0.43       (0.06 )     0.37  
2Q07
    13,079       2,210       (806 )     1,404       11,675       0.74       (0.08 )     0.66  
                                 
2QYTD07
   $ 20,886      $  3,839     (1,441 )    $  2,398      $ 18,488      $ 1.18     $ (0.14 )    $ 1.04  
                                 
 
                                                               
Cumulative
09/30/06
   $  500,672      $  74,770     (29,132 )    $  45,638      $ 455,034      $ 26.78     $ (2.39 )    $ 24.39  
 
Income Tax Considerations
In the course of the investigation, the Company determined that a number of officers may have exercised options for which the application of Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), may apply. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes because the Company incorrectly applied the measurement date as defined in APB 25. If such options are deemed to be granted at less than fair market value, pursuant to Section 162(m) of the Code (“Section 162(m)”), any compensation to officers, including proceeds from options exercised in any given tax year, in excess of $1.0 million will be disallowed as a deduction for tax purposes. The Company estimates that the potential tax effected liability for any such disallowed Section 162(m) deduction would approximate $3.6 million. The Company may also incur interest and penalties if it were to incur any such tax liability, which could be material.
In addition, the Company is considering the application of Section 409A of the Code (“Section 409A”) to those options for which it incorrectly applied the measurement date as defined in APB 25. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes and thus subject to Section 409A. Accordingly, the Company may adopt measures to address the application of Section 409A. The Company does not currently know what impact Section 409A will have, or any such measures, if adopted, would have on its results of operations, financial position or cash flows, although such impact could be material.
Expenses Incurred by the Company
The Company has incurred expenses for legal fees and external audit firm fees, in the aggregate amount of approximately $0.6 million, in the fiscal year ended March 31, 2007, in relation to (i) the Audit Committee’s review of the Company’s historical stock option practices and related accounting for stock option grants, (ii) the informal inquiry and formal order of investigation by the Securities and Exchange Commission regarding its past stock option practices, (iii) the derivative action relating to the Company’s historical stock option practices filed against the Company as a nominal defendant and certain of the Company’s current and former directors and officers as to whom it may have indemnification obligations and (iv) related matters. Further, the Company expects to incur significant additional expense related to the foregoing matters in the fiscal year ending March 31, 2008. It is anticipated that certain of those expenses will be reimbursed under the Company’s directors’ & officers’ indemnification insurance.

23


Table of Contents

Restatement Impact on the Consolidated Statements of Income
The following tables reconcile the Company’s Consolidated Statements of Income from the previously reported results to the restated results for the three (3) and nine (9) month periods ended December 31, 2005. All dollar amounts are in thousands, except per share amounts. Per share amounts may not total due to rounding.
                         
    Three Month Period Ended December 31, 2005 (Unaudited)  
    As Previously              
    Reported     Adjustment     As Restated  
 
Revenues:
                       
Hotline products
   $ 52,771      $ --      $ 52,771  
On-Site services
    129,364       --       129,364  
             
Total
    182,135       --       182,135  
 
                       
Cost of sales:
                       
Hotline products
    26,308       --       26,308  
On-Site services
    82,425       --       82,425  
             
Total
    108,733       --       108,733  
 
                       
Gross profit
    73,402       --       73,402  
 
                       
Selling, general & administrative expenses
    50,441       2,431       52,872  
Restructuring and other charges
    --       --       --  
Intangibles amortization
    1,349       --       1,349  
             
 
                       
Operating income
    21,612       (2,431 )     19,181  
 
                       
Interest expense (income), net
    2,397       --       2,397  
Other expenses (income), net
    114       --       114  
             
 
                       
Income before provision for income taxes
    19,101       (2,431 )     16,670  
 
                       
Provision for income taxes
    6,590       (959 )     5,631  
             
 
                       
Net income
   $ 12,511      $ (1,472 )    $ 11,039  
             
 
                       
Earnings per common share:
                       
Basic
   $ 0.72      $ (0.08 )    $ 0.64  
             
Diluted
   $ 0.70      $ (0.08 )    $ 0.62  
             
 
                       
Weighted average common shares outstanding
                       
Basic
    17,286       --       17,286  
             
Diluted
    17,786       --       17,786  
             
 
                       
Dividends per share
   $ 0.06      $ --      $ 0.06  
 

24


Table of Contents

                         
    Nine Month Period Ended December 31, 2005 (Unaudited)  
    As Previously              
    Reported     Adjustment     As Restated  
 
Revenues:
                       
Hotline products
   $ 160,279      $ --      $ 160,279  
On-Site services
    386,188       --       386,188  
             
Total
    546,467       --       546,467  
 
                       
Cost of sales:
                       
Hotline products
    79,011       --       79,011  
On-Site services
    249,232       --       249,232  
             
Total
    328,243       --       328,243  
 
                       
Gross profit
    218,224       --       218,224  
 
                       
Selling, general & administrative expenses
    152,008       4,677       156,685  
Restructuring and other charges
    5,290       --       5,290  
Intangibles amortization
    4,235       --       4,235  
             
 
                       
Operating income
    56,691       (4,677 )     52,014  
 
                       
Interest expense (income), net
    6,686       --       6,686  
Other expenses (income), net
    79       --       79  
             
 
                       
Income before provision for income taxes
    49,926       (4,677 )     45,249  
 
                       
Provision for income taxes
    17,224       (1,845 )     15,379  
             
 
                       
Net income
   $ 32,702      $ (2,832 )    $ 29,870  
             
 
                       
Earnings per common share:
                       
Basic
   $ 1.92      $ (0.17 )    $ 1.75  
             
Diluted
   $ 1.88      $ (0.16 )    $ 1.72  
             
 
                       
Weighted average common shares outstanding
                       
Basic
    17,050       --       17,050  
             
Diluted
    17,362       --       17,362  
             
 
                       
Dividends per share
   $ 0.18      $ --      $ 0.18  
 

25


Table of Contents

Restatement Impact on the Consolidated Balance Sheets
The following tables reconcile the Company’s Consolidated Balance Sheets from the previously reported results to the restated results as of March 31, 2006. All dollar amounts are in thousands.
                         
    March 31, 2006 (Unaudited)  
    As Previously              
    Reported     Adjustment     As Restated  
 
Assets
                       
Cash and cash equivalents
   $ 11,207      $ --      $ 11,207  
Accounts receivable, net
    116,713       --       116,713  
Inventories, net
    53,926       --       53,926  
Costs / estimated earnings in excess of billings on uncompleted contracts
    23,803       --       23,803  
Deferred tax asset
    8,973       --       8,973  
Prepaid and other current assets
    16,502       --       16,502  
             
Total current assets
    231,124       --       231,124  
 
                       
Property, plant and equipment, net
    35,124       --       35,124  
Goodwill, net
    468,724       --       468,724  
Intangibles:
                       
Customer relationships, net
    24,657       --       24,657  
Other intangibles, net
    30,783       --       30,783  
Deferred tax asset
    4,231       15,678       19,909  
Other assets
    5,091       --       5,091  
             
Total assets
   $ 799,734      $ 15,678      $ 815,412  
             
 
                       
Liabilities
                       
Accounts payable
   $ 44,943      $ --      $ 44,943  
Accrued compensation and benefits
    13,954       --       13,954  
Deferred revenue
    22,211       --       22,211  
Restructuring reserve
    3,292       --       3,292  
Billings in excess of costs / estimated earnings on uncompleted contracts
    8,648       --       8,648  
Current maturities of long-term debt
    1,049       --       1,049  
Other liabilities
    33,771       3,587       37,358  
             
Total current liabilities
    127,868       3,587       131,455  
 
                       
Long-term debt
    122,673       --       122,673  
Other liabilities
    8,293       --       8,293  
             
Total liabilities
    258,834       3,587       262,421  
 
                       
Stockholders’ Equity
                       
Preferred Stock
    --       --       --  
Common Stock
    25       --       25  
Additional paid-in capital
    362,810       55,331       418,141  
Treasury stock
    (296,824)       --       (296,824)  
Accumulated other comprehensive income
    13,036       --       13,036  
Retained earnings
    461,853       (43,240)       418,613  
             
Total stockholders’ equity
    540,900       12,091       552,991  
             
 
                       
Total liabilities and stockholders’ equity
   $ 799,734      $ 15,678      $ 815,412  
             
 
   
 

26


Table of Contents

Restatement Impact on the Consolidated Statement of Cash Flows
The following tables reconcile the Company’s Consolidated Statements of Cash Flows from the previously reported results to the restated results for the nine (9) month period ended December 31, 2005. All dollar amounts are in thousands.
                         
    Nine Month Period Ended December 31, 2005 (Unaudited)  
    As Previously              
    Reported     Adjustment     As Restated  
 
Operating Activities
                       
Net income
   $ 32,702     $ (2,832)      $ 29,870  
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
                       
Intangibles amortization and depreciation
    11,013       --       11,013  
Deferred taxes
    (2,083)       2,570       487  
Stock compensation expense
    --       4,677       4,677  
Tax benefit from exercised stock options
    (3,347)       2,279       (1,068)  
Changes in operating assets and liabilities:
                       
Accounts receivable, net
    73       --       73  
Inventories, net
    5,673       --       5,673  
All other current assets excluding deferred tax asset
    3,016       (6,694)       (3,678)  
Liabilities exclusive of long term debt
    (8,135)       --       (8,135)  
             
Net cash provided by (used for) operating activities
   $ 38,912      $ --      $ 38,912  
 
                       
Investing Activities
                       
Capital expenditures
   $ (3,151)      $ --      $ (3,151)  
Capital disposals
    1,232       --       1,232  
Acquisition of businesses (payments)/recoveries
    (40,682)       --       (40,682)  
Prior merger-related (payments)/recoveries
    (378)       --       (378)  
             
Net cash provided by (used for) investing activities
   $ (42,979)      $ --      $ (42,979)  
 
                       
Financing Activities
                       
Proceeds from borrowings
   $ 157,280      $ --      $ 157,280  
Repayment of borrowings
    (164,698)       --       (164,698  
Repayment on discounted lease rentals
    (847)       --       (847)  
Proceeds from exercise of options
    16,344)       --       16,344  
Payment of dividends
    (3,049)       --       (3,049)  
Purchase of treasury stock
    (14)       --       (14)  
             
Net cash provided by (used for) financing activities
   $ 5,016      $ --      $ 5,016  
Foreign currency exchange impact on cash
   $ (398)      $ --      $ (398)  
             
Increase / (decrease) in cash and cash equivalents
   $ 551      $ --      $ 551  
Cash and cash equivalents at beginning of period
   $ 11,592      $ --      $ 11,592  
             
Cash and cash equivalents at end of period
   $ 12,143      $ --      $ 12,143  
             
 
                       
Supplemental Cash Flow:
                       
Cash paid for interest
   $ 5,817      $ --      $ 5,817  
Cash paid for income taxes
    13,539       --       13,539  
Non-cash financing activities:
                       
Dividends payable
    1,044       --       1,044  
Capital leases
    834       --       834  
 

27


Table of Contents

Note 4: Inventories
The Company’s inventories consist of the following:
                 
    December 31, 2006     March 31, 2006  
 
Raw materials
   $ 1,743      $ 1,426  
Finished goods
    97,415       66,787  
         
Subtotal
    99,158       68,213  
Excess and obsolete inventory reserves
    (25,081)       (14,287)  
         
Inventory, net
   $ 74,077      $ 53,926  
         
 
Note 5: Goodwill and Other Intangible Assets
As required by SFAS No. 142 “Goodwill and Other Intangible Assets,” goodwill and intangible assets with indefinite useful lives are not amortized. The Company is required to perform an impairment test annually, or as often as impairment indicators are present. The Company’s policy is to evaluate its non-amortizable intangible assets for impairment during the third quarter of each fiscal year. The Company performed the most recent test during the third quarter of Fiscal 2007, and concluded that no impairment existed. The Company’s intangibles, as identified in SFAS No. 141 “Business Combinations” (“SFAS 141”), other than goodwill, are its trademarks, non-compete agreements, customer relationships and acquired backlog.
The following table summarizes changes to goodwill at the Company’s reporting units during the period:
                                 
    North                    
    America     Europe     All Other     Total  
 
Balance as of March 31, 2006
  400,998     65,684     $ 2,042     $ 468,724  
Currency translation
    7       7,010       46       7,063  
Current period acquisitions (Note 10)
    119,535       --       --       119,535  
Prior period acquisitions
    (6,785)       --       --       (6,785)
Earn-out payments
    --       --       --       --  
Other
    19       --       --       19  
                 
Balance as of December 31, 2006
  513,774     72,694      $ 2,088     588,556  
 
At December 31, 2006, certain merger agreements provided for contingent payments (earn-out) of up to $4,588. If future operating performance goals of acquired companies are met, goodwill will be adjusted for the amount of the contingent payments.
The following table summarizes the gross carrying amount, accumulated amortization and net carrying amount by major intangible asset class:
                                                 
    December 31, 2006     March 31, 2006  
    Gross             Net     Gross             Net  
    Carrying     Accum.     Carrying     Carrying     Accum.     Carrying  
    Amount     Amort.     Amount     Amount     Amort.     Amount  
 
Definite-lived
                                               
Non-compete agreements
   $  8,017      $ 3,053      $ 4,964      $ 4,894      $ 1,851      $ 3,043  
Customer relationships
    59,137       3,175       55,962       25,654       997       24,657  
Acquired backlog
    10,593       6,803       3,790       3,935       3,934       1  
         
Total
   $  77,747      $  13,031      $ 64,716      $  34,483      $ 6,782      $  27,701  
 
                                               
Indefinite-lived
                                               
Trademarks
    35,992       8,253       27,739       35,992       8,253       27,739  
         
 
                                               
Total
   $  113,739      $  21,284      $ 92,455      $  70,475      $  15,035      $  55,440  
 
The Company’s indefinite lived intangible assets not subject to amortization consist solely of the Company’s trademark portfolio obtained through business acquisitions. The Company’s definite-lived intangible assets subject to amortization are comprised of employee non-compete contracts, backlog and customer relationships also obtained through business acquisitions. Intangible asset amortization is computed using the straight-line method based upon the estimated useful lives of the respective assets, which range from one to 20 years.

28


Table of Contents

The following table summarizes the changes to carrying amounts of intangible assets during the period.
                                 
            Non-Competes     Customer        
    Trademarks     and Backlog     Relationships     Total  
 
Balance at March 31, 2006
   $ 27,739      $ 3,044      $ 24,657      $  55,440  
Amortization expense
    --       (3,936 )     (2,178 )     (6,114 )
Currency translation
    --       52       --       52  
Current period acquisitions (Note 10)
    --       8,839       27,079       35,918  
Prior period acquisitions
    --       755       6,404       7,159  
                 
Balance at December 31, 2006
   $ 27,739      $ 8,754      $ 55,962      $  92,455  
 
Intangible asset amortization expense was $2,677 and $6,114 for the three and nine months ended December 31, 2006, respectively. Intangible asset amortization expense was $1,349 and $4,235 for the three and nine months ended December 31, 2005, respectively. The Company acquired definite-lived intangibles from the completion of three (3) acquisitions during the nine-month period ended December 31, 2006 (see Note 10 of the Notes to the Consolidated Financial Statements). The estimated definite-lived intangibles recorded of $35,918 were based on a preliminary allocation pending completion of third party valuation. The Company recorded amortization expense of $1,933 and $4,043 for the three and nine month periods ended December 31, 2006 for these newly acquired definite-lived assets.
The following table details estimated future intangible amortization expense. These estimates are based on the carrying amounts of intangible assets as of December 31, 2006 that are subject to change pending the outcome of purchase accounting related to our current acquisitions:
         
Years Ending March 31,  
 
2007 (4Q07 only)
   $  3,964  
2008
    5,433  
2009
    4,330  
2010
    4,196  
2011
    3,620  
2012
    3,113  
Thereafter
    40,060  
       
Total
   $  64,716  
 
Note 6: Indebtedness
The Company’s long-term debt consists of the following:
                      
    December 31, 2006     March 31, 2006  
 
Revolving credit agreement
   $ 251,410      $ 121,303  
Interest rate swap fair value (see Note 7)
    1,308       --  
Capital lease obligations
    1,671       1,891  
Other
    136       528  
         
Total debt
   $ 254,525      $ 123,722  
Less: current portion
    (587 )     (1,049 )
         
Long-term debt
   $ 253,938      $ 122,673  
 
Revolving credit agreement:
On March 28, 2006, the Company entered into a Second Amendment to the Second Amended and Restated Credit Agreement dated January 24, 2005, as amended February 17, 2005 (collectively, the “Credit Agreement”) with Citizens Bank of Pennsylvania, as agent, and a group of lenders. The Credit Agreement expires on March 28, 2011. Borrowings under the Credit Agreement are permitted up to a maximum amount of $310,000, which includes up to $15,000 of swing line loans and $25,000 of letters of credit. The Credit Agreement may be increased by the Company up to an additional $90,000 with the approval of the lenders and may be unilaterally and permanently reduced by the Company to not less than the then outstanding amount of all borrowings. Interest on outstanding indebtedness under the Credit Agreement accrues, at the Company’s option, at a rate based on either: (a) the greater of (i) the prime rate per annum of the agent then in effect and (ii) 0.50% plus the rate per annum announced by the Federal Reserve Bank of New York as being the weighted average of the rates on overnight Federal funds transactions arranged by Federal funds brokers on the previous trading day or (b) a rate per annum equal to the LIBOR rate plus 0.75% to 1.25% (determined by a leverage ratio based on the Company’s EBITDA). The Credit Agreement requires the Company to maintain compliance with certain non-financial and financial covenants such as minimum net worth, leverage and fixed charge coverage ratios. As of December 31, 2006, the Company was in compliance with all required covenants under the Credit Agreement.
During the nine month period ended December 31, 2006, the Company increased net borrowings under the Credit Agreement by

29


Table of Contents

approximately $130,107. The Company primarily utilized the proceeds from net borrowings to fund the acquisitions of the USA Commercial and Government and Canadian operations of NextiraOne, LLC (“NextiraOne”), Nu-Vision Technologies, Inc. and Nu-Vision Technologies, LLC (collectively referred to as “NUVT”) during the first quarter Fiscal 2007 and Nortech Telecommunications, Inc. (“NTI”) during the third quarter Fiscal 2007 (see Note 10 of the Notes to the Consolidated Financial Statements) and to repurchase common stock during the second and third quarters Fiscal 2007.
During the three month period ended December 31, 2006, the maximum amount and weighted average balance outstanding under the Credit Agreement were $276,985 and $266,763, respectively. The weighted average interest rate on all outstanding debt was approximately 6.25% and 5.59% for the three month periods ended December 31, 2006 and 2005, respectively. During the nine month period ended December 31, 2006, the maximum amount and weighted average balance outstanding under the Credit Agreement were $284,470 and $251,153, respectively. The weighted average interest rate on all outstanding debt was approximately 6.20% and 4.86% for the nine month periods ended December 31, 2006 and 2005, respectively.
Capital Lease Obligations:
The capital lease obligations are primarily for facilities and equipment. The lease agreements have remaining terms ranging from less than one year to four years with interest rates ranging from 3.83% to 10.83%.
Other:
Other debt is comprised of various bank and third party loans secured by specific pieces of equipment and real property. The loans have remaining terms of less than one year to five years with interest rates ranging from 0.0% to 7.1%.
Unused Available Borrowings:
As of December 31, 2006, the Company had $4,009 outstanding in letters of credit and $54,581 available under the Credit Agreement.
Note 7: Derivative Instruments and Hedging Activities
Foreign Currency Forward Contracts:
The Company enters into foreign currency forward contracts to hedge exposure to variability in expected fluctuations in foreign currencies. As of December 31, 2006, the Company had open contracts in Australian and Canadian dollar, Danish krone, Euro, Japanese yen, Norwegian kroner, Pound sterling, Swedish krona and Swiss franc, which have been designated as cash flow hedges. These contracts had a notional amount of approximately $63,994 and a fair value of $63,692 and mature within the next twenty seven months.
As of December 31, 2006, an unrecognized gain of $896 on all open foreign currency forward contracts is included in the Company’s Consolidated Balance Sheets as a component of Other Comprehensive Income (loss) (“OCI”). This unrecognized gain is expected to be credited to earnings over the life of the maturing contracts as the hedged forecasted transaction occurs and it is expected that the gain will be offset by currency losses on the items being hedged.
The Company recognized gains of $17 and $309 into earnings on matured contracts for the three and nine month periods ending December 31, 2006, respectively. There was no hedge ineffectiveness during the nine month period ending December 31, 2006.
Interest Rate Swap:
To mitigate the risk of interest-rate fluctuations associated with the Company’s variable rate long term debt, the Company has implemented an interest-rate risk management strategy that incorporates the use of derivative instruments to minimize significant unplanned fluctuations in earnings caused by interest rate volatility. The Company’s goal is to manage interest-rate sensitivity by modifying the re-pricing characteristics of certain balance sheet liabilities so that the net-interest margin is not, on a material basis, adversely affected by the movements in interest rates.
On July 26, 2006, the Company entered into an interest rate swap which has been used to effectively convert a portion of the Company’s variable rate debt to fixed rate. The interest rate swap has a notional value of $100,000 reducing to $50,000 after three years and does not qualify for hedge accounting. For the three and nine month periods ended December 31, 2006, the Company recognized an $87 gain and a $1,308 loss, respectively, related to the change in fair value of the interest rate swap included in “Interest Expense (Income)” in the Company’s Consolidated Statements of Income. The loss is recorded as a component of “Long Term Debt” in the Company’s Consolidated Balance Sheet.

30


Table of Contents

Note 8: Earnings Per Share
The following table details the computation of basic and diluted earnings per common share from continuing operations:
                                 
    Three month period ended     Nine month period ended  
    December 31,     December 31,  
            (As Restated)             (As Restated)  
    2006     2005     2006     2005  
 
Net income, as reported
  10,493     $ 11,039     28,981     29,870  
 
                               
Weighted average common shares outstanding (basic)
    17,398       17,286       17,451       17,050  
Effect of dilutive securities from employee stock options
    382       500       358       312  
         
Weighted average common shares outstanding (diluted)
    17,780       17,786       17,809       17,362  
 
                               
Basic earnings per common share
  0.60     $ 0.64     1.66     $ 1.75  
Dilutive earnings per common share
  0.59     $ 0.62     1.63     $ 1.72  
 
The Weighted Average Common Shares Outstanding (diluted) computation is not impacted during any period where the exercise price of a stock option is greater than the average market price. There were 824,240 and 563,406 non-dilutive stock options outstanding during the three month periods ended December 31, 2006 and 2005, respectively, that are not included in the corresponding period Weighted Average Common Shares Outstanding (diluted) computation. There were 825,240 and 2,494,091 non-dilutive stock options outstanding during the nine month periods ended December 31, 2006 and 2005, respectively that are not included in the corresponding period Weighted Average Common Shares Outstanding (diluted) computation.
Note 9: Comprehensive Income and Stockholders’ Equity
The following table details the computation of comprehensive income:
                                 
    Three month period ended     Nine month period ended  
    December 31,     December 31,  
            (As Restated)             (As Restated)  
    2006     2005     2006     2005  
         
Net income
  $ 10,493     $ 11,039     $ 28,981     $ 29,870  
 
                               
Foreign currency translation adjustment
    5,191       (2,246)       11,235       (11,292)  
 
                               
Unrealized gains/(losses) on derivatives designated and qualified as cash flow hedges, net of reclassification of unrealized gains/(losses) on expired derivatives
    (307)       (358)       (246)       (125)  
         
 
Comprehensive income (loss)
  15,377     $ 8,435     $ 39,970     $ 18,453  
 
The components of Accumulated Other Comprehensive Income consisted of the following:
                 
    December 31, 2006     March 31, 2006  
 
Foreign currency translation adjustment
  $ 23,129     $ 11,894  
Unrealized gains/(losses) on derivatives designated and qualified as cash flow hedges, net of reclassification of unrealized gains/(losses) on expired derivatives
    896       1,142  
 
           
Total accumulated other comprehensive income
  $ 24,025     $ 13,036  
 
Note 10: Acquisitions
During third quarter Fiscal 2007, the Company acquired NTI, a privately-held company based out of Chicago, IL. In connection with the NTI acquisition, the Company has made a preliminary allocation to goodwill and definite-lived intangible assets, respectively. The definite-lived intangible assets recorded represent the estimated fair market value of customer relationships and non-compete agreements. The Company estimates that the definite-lived intangibles are to be amortized over a period of five to 20 years.
During the first quarter Fiscal 2007, the Company acquired NextiraOne. The following table summarizes the preliminary fair value of the NextiraOne assets acquired and liabilities assumed at the date of acquisition.

31


Table of Contents

         
    At April 30, 2006  
 
Current assets, primarily consisting of accounts receivable and inventories
  $ 88,477  
Property, plant and equipment
    10,030  
Other non-current assets
    1,386  
Intangible assets
    21,962  
Goodwill
    93,914  
 
     
Total assets acquired
  $ 215,769  
 
       
Current liabilities, primarily consisting of deferred revenue, restructuring reserve and accrued expenses
  $ 105,981  
Other non-current liabilities, primarily consisting of restructuring reserve
    22,319  
 
     
Total liabilities acquired
  $ 128,300  
 
     
Net assets acquired
  $ 87,469  
 
The following table details the amounts recorded to each major intangible asset class:
         
    At April 30, 2006  
 
Backlog
  $ 6,662  
Customer relationships and contracts
    15,300  
 
     
Total intangible assets*
  $ 21,962  
 
*  
The estimated weighted average amortization period for these definite-lived assets is 14.2 years.
The transaction resulted in $93,914 of goodwill. The Company paid this premium for NextiraOne in order to further expand its operational footprint in the voice and data technology markets. In addition, the purchase increased the Company’s solutions offerings, providing for a stronger worldwide technical services partner for its collective clients.
The Company paid a cash total of $97,305 for the outstanding interests in NextiraOne which included an estimate for the equity book value (total assets less total liabilities, as adjusted by the parties for certain items) as of the closing date. The actual equity book value adjustment is expected to be confirmed during the fourth quarter, at which time the final purchase price will be determined.
As of December 31, 2006, the equity book value adjustment resulted in a $10,535 receivable from the seller. This receivable is recorded in Other Current Assets and is considered fully collectible. The costs of the acquisitions were funded with borrowings under the Credit Agreement described in Note 6 of the Notes to the Consolidated Financial Statements.
Included in the total cash paid at closing was $42,143 that was allocated to escrow accounts, including a general escrow, and an escrow for certain specified items regarding litigation, accounts receivable, deposits and credits, equipment leases, accounts payable, worker’s compensation and real estate leases. The amounts in escrow have been and will continue to be released to NextiraOne’s seller or to the Company in accordance with the terms of the agreements.
After consummation of the acquisition, the Company began to integrate NextiraOne products, employees and facilities with its own. In so doing, the Company incurred $15,726 of costs related to facility consolidations and $8,857 of severance costs for the separation of approximately 250 employees. In accordance with SFAS 141, these costs were properly included in the purchase price allocation for NextiraOne. The majority of the severance costs will be paid in Fiscal 2007 with certain facility costs extending through Fiscal 2014.
In connection with the NextiraOne acquisition, the Company obtained various contractual obligations in the form of operating leases for facilities and vehicles of approximately $35,120 at the acquisition date. The following table summarizes the payments due by period related to those contractual obligations as of December 30, 2006:
         
Payments Due by Period
 
Less than 1 year
  13,745  
1-3 years
    13,327  
 
       
Total
  27,072  
 
Also, during first quarter Fiscal 2007, the Company acquired NUVT. In connection with the NUVT acquisition, the Company has made a preliminary allocation of $24,113 and $12,673 to goodwill and definite-lived intangible assets, respectively. The definite-lived intangible assets recorded represent the estimated fair market value of acquired backlog, customer relationships and non-compete agreements. The Company estimates that the definite-lived intangibles are to be amortized over a period of one to 20 years.
The allocation of the purchase price for these Fiscal 2007 acquisitions is based on preliminary estimates of the fair values of certain assets acquired and liabilities assumed as of the date of the acquisition. Management, with the assistance of independent valuation specialists, is currently assessing the fair values of the tangible and intangible assets acquired and liabilities assumed. The preliminary allocations of

32


Table of Contents

purchase price are dependant upon certain estimates and assumptions, which are preliminary and may vary from the amounts reported herein.
NextiraOne and NUVT contributed on-site services revenues of $82,734 and $231,024 during the three and nine month periods ended December 31, 2006, respectively.
The following unaudited pro-forma summary presents the Company’s results of operations as if the acquisitions of NextiraOne and NUVT had occurred on April 1, 2005 and does not purport to represent what the Company’s results of operations would have been had the acquisitions occurred on such date or at the beginning of the period indicated, or to project the Company’s results of operations for any future date or period, or to be a fair reflection of the assets purchased at the date of acquisition. The pro-forma results of operations exclude the impact of nonrecurring or extraordinary adjustments, together with related income tax effects. These pro-forma results of operations do not include the effects of cost synergies and one-time nonrecurring transactions associated with the acquisition.
                                     
    For the three months ended     For the nine months ended  
    December 31,     December 31,  
            (As Restated)             (As Restated)  
    2006     2005     2006     2005  
 
Revenue (Pro-forma)
  264,806     $ 293,696     797,172     $ 940,134  
Net Income from continuing operations (Pro-forma), net of tax
  10,491     $ 9,544     27,181     $ 32,400  
Earnings per common share (Pro-forma)
                               
Basic
  0.60     $ 0.55     1.56     $ 1.90  
Diluted
  0.59     $ 0.54     1.53     $ 1.87  
 
Purchase Price Allocation Update (prior year acquisitions):
During first quarter Fiscal 2006, the Company acquired 100% of the issued and outstanding equity interests of Telecommunication Systems Management, Inc. (“TSM”), GTC Technology Group, Inc. and Technology Supply, Inc. (collectively referred to as “GTC”) and Business Communications, Inc., Bainbridge Communication, Inc., BCI of Tampa, LLC and Networx, L.L.C. (collectively referred to as “BCI”). These companies primarily provide full-service voice communication solutions and services in the Florida and Virginia markets. In connection with the acquisitions, the Company has allocated $8,385 and $5,846 to goodwill and definite-lived intangible assets, respectively. The definite-lived intangible assets recorded represent the fair market value of acquired customer relationships and non-compete agreements. The definite-lived intangibles are being amortized over a period of five to 20 years.
During second quarter Fiscal 2006, the Company acquired substantially all of the assets and certain liabilities of Universal Solutions of North America, L.L.C. and related entities (“Universal”). Universal primarily provides planning, installation and maintenance services for voice and data network systems in 14 states. In connection with the acquisition, the Company has allocated $9,430 and $8,000 to goodwill and definite-lived intangible assets, respectively. The definite-lived intangible assets recorded represent the estimated fair market value of acquired customer relationships and non-compete agreements. The definite-lived intangibles are being amortized over a period of five to 20 years.
During third quarter Fiscal 2006, the Company purchased 100% of the issued and outstanding equity interests of Communication is World InterActive Networking, Inc. (“C=WIN”) and Converged Solutions Group, LLC (“CSG”). C=WIN has an active customer base which includes commercial and various government agency accounts. CSG has an active customer base which includes commercial, education, health care and various government agency accounts. The C=WIN and CSG acquisitions primarily provide planning, installation and maintenance services for voice and data network systems in 15 states. In connection with the acquisitions, the Company has allocated $6,074 and $9,620 to goodwill and definite-lived intangible assets, respectively. The definite-lived intangible assets recorded represent the estimated fair market value of acquired customer relationships and non-compete agreements. The Company estimates that the definite-lived intangibles are to be amortized over a period of four to 20 years.
The results of operations of TSM, GTC, BCI, Universal, C=WIN and CSG are included in the Company’s Consolidated Statements of Income beginning on their respective acquisition dates. The acquisitions taken individually did not have a material impact on the Company’s results of operations.
The following acquired companies will collectively be referred to as “Acquired Companies”: TSM, GTC, BCI, Universal, C=WIN, CSG, NextiraOne, NUVT, and NTI.

33


Table of Contents

Note 11: Commitments and Contingencies
Regulatory Matters
As previously disclosed, on November 13, 2006, the Company received a letter of informal inquiry from the Enforcement Division of the SEC relating to the Company’s stock option practices from January 1, 1997 to present. On May 24, 2007, the SEC issued a formal order of investigation in connection with this matter, and, on May 29, 2007, the Company received a document subpoena from the SEC acting pursuant to such order. The Company has cooperated with the SEC in this matter and intends to continue to do so.
As previously disclosed, the Audit Committee, with the assistance of outside legal counsel, is conducting an independent review of the Company’s historical stock option grant practices and related accounting for stock option grants. See the “Explanatory Note” preceding Part I, Item 1 of this Form 10-Q for more information regarding this and related matters.
On September 20, 2006, the Company received formal notice from the Internal Revenue Service (“IRS”) regarding its intent to begin an audit of the Company’s tax years 2004 and 2005. In connection with this normal recurring audit, the IRS has requested certain documentation with respect to stock options for the Company’s 2004 and 2005 tax years. The Company has produced various documents requested by the IRS and is currently in the process of responding to additional documentation requests.
At the conclusion of these regulatory matters, the Company could be subject to additional taxes, fines or penalties which could be material.
Litigation Matters
In November 2006, two stockholder derivative lawsuits were filed against the Company itself, as a nominal defendant, and several of the Company’s current and former officers and directors in the United States District Court for the Western District of Pennsylvania. The two substantially identical stockholder derivative complaints allege that the individual defendants improperly backdated grants of stock options to several officers and directors in violation of the Company’s stockholder-approved stock option plans during the period 1996-2002, improperly recorded and accounted for backdated stock options in violation of generally accepted accounting principles, improperly took tax deductions based on backdated stock options in violation of the Internal Revenue Code of 1986, as amended, produced and disseminated false financial statements and SEC filings to the Company’s stockholders and to the market that improperly recorded and accounted for the backdated option grants, concealed the alleged improper backdating of stock options and obtained substantial benefits from sales of Company stock while in the possession of material inside information. The complaints seek damages on behalf of the Company against certain current and former officers and directors and allege breach of fiduciary duty, unjust enrichment, securities law violations and other claims. The two lawsuits have been consolidated into a single action as In re Black Box Corporation Derivative Litigation, Master File No. 2:06-CV-1531-TMH, and plaintiffs filed a consolidated amended complaint on January 29, 2007. The parties have stipulated that responses by the defendants, including the Company, are due on or before August 1, 2007. The Company may have indemnification obligations arising out of this matter to its current and former directors and officers named in this litigation. The Company has made a claim for such costs under an insurance policy.
The Company is, as a normal part of its business operations, a party to legal proceedings in addition to those described in current and previous filings.
As previously disclosed, the Company received a subpoena, dated December 8, 2004, from the United States General Services Administration (“GSA”), Office of Inspector General. The subpoena requires production of documents and information. The Company understands that the materials are being sought in connection with an investigation regarding potential violations of the terms of a GSA Multiple Award Schedule contract. The Company has not received any communication on this matter from the GSA since June 2005.
Based on the facts currently available to the Company, management believes the matters described under this caption “Litigation Matters” are adequately provided for, covered by insurance, without merit or not probable that an unfavorable outcome will result.
Product Warranties
Estimated future warranty costs related to certain products are charged to operations in the period the related revenue is recognized. The product warranty liability reflects the Company’s best estimate of probable liability under those warranties. As of December 31, 2006 and March 31, 2006, the Company has recorded a warranty reserve of $4,570 and $1,383, respectively.
There has been no significant or unusual activity during the three and nine month periods ended December 31, 2006 other than the acquisitions as discussed in Note 10 of the Notes to the Consolidated Financial Statements.
Note 12: Pension Plan Costs
On April 30, 2006, the Company acquired NextiraOne who is a sponsor of a non-contributory defined benefit plan (the “CWA Plan”) for the Communication Workers of America Local 1109 (“CWA 1109”). Benefits from the CWA Plan are based upon years of service and

34


Table of Contents

rates negotiated by the Company and CWA 1109. Pension costs are funded to satisfy minimum requirements prescribed by the Employee Retirement Income Security Act of 1974.
The following table summarizes the components of net periodic benefit cost for the three and nine month periods ended December 31, 2006. Nine month results include the net periodic benefit cost from May 1, 2006 (date following acquisition) through December 31, 2006:
                 
    For the three months     For the nine months  
    ended December 31,     ended December 31,  
    2006     2006  
 
Service cost
  $ 131     $ 350  
Interest cost
    349       930  
Expected return on plan assets
    (373)       (995)  
Amortization of prior service cost
    --       --  
Amortization of unrealized gains and losses
    --       --  
 
           
Net periodic benefit cost
  $ 107     $ 285  
 
As of April 30, 2006, the projected benefit obligation, accumulated benefit obligation and fair value of plan assets were $25,400, $25,400 and $18,697, respectively. A liability of $6,703 representing the unfunded portion of the CWA Plan is included in Other Liabilities within the Consolidated Balance Sheets.
The following are the weighted-average assumptions utilized for this plan:
         
    April 30, 2006  
 
Discount rate
    5.50%  
Rate of compensation increase
    N/A  
Expected long-term rate of return
    8.00%  
 
Note 13: Restructuring and Other Charges
The Company incurred $15,726 of costs related to facility consolidations and $8,857 of severance costs for the separation of approximately 250 employees. In accordance with SFAS 141, these costs were properly included in the purchase price allocation for NextiraOne. The majority of the severance costs will be paid in Fiscal 2007 with certain facility costs extending through Fiscal 2014. The Company paid $4,578 and $11,710 during the three and nine month periods ended December 31, 2006, respectively, relating to such obligations.
The following table summarizes the changes to the restructuring reserve during the period:
                         
    Employee     Facility        
    Severance     Closures     Total  
 
Balance at March 31, 2006
  260     10,438     10,698  
Acquisition adjustments (see Note 10)
    8,857       15,843       24,700  
Cash expenditures
    (6,636)       (7,831)       (14,467)  
 
                 
Balance at December 31, 2006
  2,481     18,450     20,931  
 
Note 14: Stock-based Compensation
The Company has two stock option plans, the 1992 Stock Option Plan, as amended (the “Employee Plan”), and the 1992 Director Stock Option Plan, as amended (the “Director Plan”). As of December 31, 2006, the Employee Plan is authorized to issue stock options and stock appreciation rights (“SARs”) for up to 9,200,000 shares of common stock. The Employee Plan provides that options are to be granted by a committee appointed by the Company’s Board to key employees of the Company; such stock options generally become exercisable in equal amounts over a three-year period. As of December 31, 2006, the Director Plan is authorized to issue stock options and SARs for up to 270,000 shares of common stock. The Director Plan provides that options are to be granted by the Board or a committee appointed by the Board; such options generally become exercisable in equal amounts over a three-year period. No SARs have been issued under either plan.
Stock-based compensation expense includes (i) compensation expense for share-based awards granted prior to, but not yet vested as of March 31, 2006, based on the grant-date fair value estimated in accordance with the pro-forma provisions of SFAS 123 and (ii) compensation expense for the share-based payment awards granted subsequent to March 31, 2006 based on the grant-date fair value estimated in accordance with the provisions of SFAS 123(R). For the three and nine month periods ended December 31, 2006, the Company recognized compensation expense of $1,840 ($1,196 net of tax) or $0.07 per diluted share and $7,476 ($4,860 net of tax) or $0.27 per diluted share, respectively which is recorded to Selling, General and Administrative expense on the Company’s Consolidated Statements of Income.

35


Table of Contents

As a result of the Restatement, the Company has restated its stock-based compensation expense recognized under the intrinsic value method (APB 25) for the three (3) and nine (9) month periods ended December 31, 2005. The following table reconciles the Company’s stock-based compensation expense from the previously reported results to the restated results for the three (3) and nine (9) month periods ended December 31, 2005.
                         
    Stock-Based Compensation Expense, Pre-Tax  
    (As Previously              
    Reported)     Adjustment     (As Restated)  
 
Three Months Ended December 31, 2005
  $ --     $ 2,431     $ 2,431  
Nine Months Ended December 31, 2005
    --       4,677       4,677  
 
As noted above, the restated stock-based compensation expense for the three (3) and nine (9) months ended December 31, 2005 was $2,431 ($1,580 net of tax), or approximately $0.09 per diluted share and $4,677 ($3,040 net of tax), or approximately $0.18 per diluted share, respectively.
The following table summarizes the changes in the Company’s outstanding stock options as of and for the period ending December 31, 2006.
             
    Nine month period ended December 31, 2006  
        Weighted-Average Exercise  
    Shares   Price (per share)  
Outstanding at March 31, 2006
  5,055   $ 38.29  
Granted
  70     39.12  
Exercised
  (356)     34.13  
Forfeited or expired
  (58)     38.62  
 
       
Outstanding at December 31, 2006
  4,711   $ 38.61  
Exercisable at December 31, 2006
  4,219   $ 39.06  
Weighted average fair value of options granted during the period using Black-Scholes option pricing model
      $ 17.88  
 
The weighted average fair value of stock options granted during the period and the stock-based compensation expense recognized during the three (3) and nine (9) month periods ended December 31, 2006 were based on the Black-Scholes option pricing model using the following weighted average assumptions.
     
    3Q07
 
Expected life (in years)
  5.7
Risk free interest rate
  4.18%
Annual forfeiture rate
  1.53%
Volatility
  45.47%
Dividend yield
  0.60%
 
The following table summarizes certain information regarding the Company’s outstanding stock options at December 31, 2006:
                                                         
    Options Outstanding   Options Exercisable
            Weighted                        
            Average   Weighted   Average           Weighted   Average
    Shares   Remaining   Average   Intrinsic   Shares   Average   Intrinsic
Range of Exercise   Outstanding   Contractual   Exercise   Value   Exercisable   Exercise   Value
          Prices   (000’s)   Life (Years)   Price   (000’s)   (000’s)   Price   (000’s)
 
$19.95 -26.60
    257       1.5     $ 21.85     $ 5,329       257     $ 21.85     $ 5,329  
$26.60 -33.25
    330       2.2       30.14       4,104       330       30.14       4,104  
$33.25 -39.90
    1,826       8.4       37.14       9,904       1,333       38.02       6,050  
$39.90 -46.55
    2,140       5.0       42.38       392       2,140       42.38       392  
$46.55 -53.20
    154       2.8       49.39       --       154       49.39     --
$53.20 -59.85
    2       3.0       55.88       --       2       55.88     --
$59.85 -66.50
    2       3.0       63.22       --       2       63.22     --
         
$19.95 -$66.50
    4,711       5.8     $ 38.61     $ 19,729       4,219     $ 39.06       15,875  
 
The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value, based on the Company’s average stock price on December 31, 2006 of $42.56, which would have been received by the option holders had all option holders exercised their options as of that date. As of December 31, 2006, there was approximately $6,223 of total unrecognized pre-tax compensation expense related to non-vested stock options granted under the plans which is expected to be recognized over a period of 2.7 years.

36


Table of Contents

Pro-forma Information
The Company adopted SFAS 123(R) using the modified prospective transition method. The modified prospective transition method requires the Company to provide pro-forma disclosure of specific income statement line items for periods prior to the adoption of SFAS 123(R) as if the fair-value-based method had been applied to all awards. The following table illustrates the pro-forma effect on net income (loss) and net income (loss) per share prior to the adoption of SFAS 123(R). This table only shows pro-forma amounts for the three (3) and nine (9) month period ending December 31, 2005 since the Company adopted the fair value recognition provisions of SFAS 123(R) on April 1, 2006 and, therefore, compensation expenses are recognized in the consolidated income statement for all share-based payments granted prior to, but not yet vested as of March 31, 2006. Per share amounts may not total due to rounding.
                         
    Three months ended December 31, 2005  
    As              
    previously              
    reported     Adjustment     As Restated  
 
Net income (Loss) - As reported
   $  12,511     (1,472)      $  11,039  
Plus: Stock-based compensation expense included in reported net income, net of related tax
    --       2,431       2,431  
Less: Stock-based compensation expense determined by the fair value method for all awards, net of related tax
    (17,703)       (12,723)       (30,426)  
 
                 
Net Income (Loss) - Pro-forma
  (5,192)     (11,764)     (16,956)  
 
                       
Earnings per common share
                       
Basic – as reported
   $  0.72     (0.08)      $  0.64  
Basic – pro-forma
  (0.30)     (0.68)     (0.98)  
 
                       
Diluted – as reported
   $  0.70     (0.08)      $  0.62  
Diluted – pro-forma
  (0.29)     (0.66)     (0.95)  
 
                         
    Nine months ended December 31, 2005  
    As              
    previously              
    reported     Adjustment     As Restated  
 
Net income (Loss) - As reported
   $  32,702     (2,832)      $  29,870  
Plus: Stock-based compensation expense included in reported net income, net of related tax
    --       4,677       4,677  
Less: Stock-based compensation expense determined by the fair value method for all awards, net of related tax
    (22,925)       (18,666)       (41,591)  
 
                 
Net Income (Loss) - Pro-forma
   $  9,777     (16,821)     (7,044)  
 
                       
Earnings per common share
                       
Basic – as reported
   $  1.92     (0.17)      $  1.75  
Basic – pro-forma
   $  0.57     (0.98)     (0.41)  
 
                       
Diluted – as reported
   $  1.88     (0.16)      $  1.72  
Diluted – pro-forma
   $  0.56     (0.96)     (0.40)  
 
The pro-forma impacts computed above were based on the Black-Scholes option pricing model using the following weighted average assumptions.
     
    3Q06
 
Expected life (in years)
  5.6
Risk free interest rate
  4.17%
Volatility
  49.0%
Dividend yield
  0.60%
 
On October 31, 2005, in response to the issuance of SFAS No. 123(R), the Compensation Committee of the Board of Directors of the Company authorized the acceleration of the vesting of all of the Company’s outstanding out-of-the-money unvested stock options held by current employees, including officers, and directors. Approximately 405,224 options that would otherwise have vested from time to time over the next three years became immediately exercisable. Such stock options had an exercise price greater than $39.77, the approximate

37


Table of Contents

fair market value of the common stock on October 31, 2005. The accelerated vesting of these options increased the pro-forma compensation expense for the three months ended December 31, 2005 by approximately $4,217, net of tax.
On October 31, 2005, the Company issued options to purchase approximately 989,700 shares of common stock which were granted fully vested, the effect of which increased the pro-forma compensation expense for the three months ended December 31, 2005 by approximately $14,656, net of tax.
Note 15: Segment Reporting
Management reviews financial information for the consolidated Company accompanied by disaggregated information on net revenues, operating income and assets by geographic region for the purpose of making operational decisions and assessing financial performance. Additionally, Management is presented with and reviews net revenues and gross profit by service type. The accounting policies of the individual operating segments are the same as those of the Company.
The following table presents financial information about the Company’s reportable segments by geographic region:
                                 
    Three months ended     Nine months ended  
    December 31,     December 31,  
            (As Restated)             (As Restated)  
    2006     2005     2006     2005  
 
North America
                               
Revenues
  220,391     143,173     644,260     426,788  
Operating income
    13,685       13,309       41,204       39,459  
Depreciation
    3,047       2,093       8,788       6,110  
Amortization
    2,644       1,272       6,012       3,747  
Segment assets (as of December 31)
    1,033,503       776,746       1,033,503       776,746  
Europe
                               
Revenues
  34,610     29,950     94,799     92,899  
Operating income
    4,502       4,101       11,134       7,161  
Depreciation
    133       155       364       517  
Amortization
    23       70       74       463  
Segment assets (as of December 31)
    133,554       122,829       133,554       122,829  
All Other
                               
Revenues
  9,805     9,012     27,467     26,780  
Operating income
    1,881       1,771       5,372       5,394  
Depreciation
    23       36       67       151  
Amortization
    10       7       28       25  
Segment assets (as of December 31)
    17,065       16,258       17,065       16,258  
 
The sum of segment revenues, operating income, depreciation and amortization equals the consolidated revenues, operating income, depreciation and amortization. The following reconciles segment assets to total consolidated assets:
               
            (As Restated)  
    December 31, 2006     March 31, 2006  
 
Segment assets for North America, Europe and All Other
  1,184,122     894,557  
Corporate eliminations
    (72,204)       (79,145)  
 
           
Total consolidated assets
  1,111,918     815,412  
 
The following table presents financial information about the Company by service type:
                                 
    Three months ended     Nine months ended  
    December 31,     December 31,  
    2006     2005     2006     2005  
         
Data Services
                               
Revenues
  46,350     47,083     137,328     152,568  
Gross Profit
    14,236       14,794       41,460       45,800  
Voice Services
                               
Revenues
  160,686     82,281     464,140     233,620  
Gross Profit
    54,566       32,145       158,242       91,156  
Hotline Services
                               
Revenues
  57,770     52,771     165,058     160,279  
Gross Profit
    27,883       26,463       81,863       81,268  
 
The sum of service type revenues and gross profit equals consolidated revenues and gross profit.

38


Table of Contents

Note 16: Subsequent Events
On February 2, 2007, the Company announced the acquisition of ADS Telecom, Inc. (“ADS”), a privately-held company based out of Orlando, FL. ADS has an active customer base which includes commercial, financial, healthcare and various government agency accounts. Annual historical revenues of ADS are approximately $14 million.

39


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The discussion and analysis for the three (3) and nine (9) month periods ended December 31, 2005 as set forth below in this Item 2 has been amended to reflect the Restatement as described in the Explanatory Note and in Note 3 of the Notes to the Consolidated Financial Statements. For this reason, the data set forth in this section may not be comparable to discussions and data in the Company’s previously filed Quarterly Reports on Form 10-Q. All dollar amounts are presented in thousands unless otherwise noted.
Restatement through March 31, 2006
Background
On November 13, 2006, Black Box received a letter of informal inquiry from the Enforcement Division of the SEC relating to the Company’s stock option practices from January 1, 1997 to present. As a result, the Audit Committee, with the assistance of outside legal counsel, commenced an independent review of the Company’s historical stock option grant practices and related accounting for stock option grants during the Review Period.
On February 1, 2007, the Company announced that, while the review of option grant practices was continuing, it believed that it would need to record additional non-cash charges for stock-based compensation expense relating to certain stock option grants and, accordingly, cautioned investors about relying on its historical financial statements until the Company could determine with certainty whether a restatement would be required and, if so, the extent of any such restatement and the periods affected.
On March 19, 2007, although the Audit Committee had not yet completed its review, the Audit Committee concluded that the exercise price of certain stock option grants differed from the fair market value of the underlying shares on the appropriate measurement date. At that time, the Company and the Audit Committee announced that it was currently expected that the Company’s additional non-cash, pre-tax charges for stock-based compensation expense relating to certain stock option grants would approximate $63 million for the Review Period. In addition, the Company and the Audit Committee concluded that the Company would need to restate its previously-issued financial statements contained in reports previously filed by the Company with the SEC. Accordingly, on March 19, 2007, the Company and the Audit Committee concluded that the Company’s previously-issued financial statements and other historical financial information and related disclosures for the Review Period, including applicable reports of its current or former independent registered public accounting firms and related press releases, should not be relied upon.
On May 25, 2007, the Company was advised by the Enforcement Division of the SEC that a Formal Order of Private Investigation arising out of the Company’s stock option practices had been entered and on May 29, 2007 the Company received a subpoena that was issued by the SEC.
On May 31, 2007, the Company announced that, as a result of the ongoing review of stock option practices, Company management and the Audit Committee expected that the Company’s additional non-cash, pre-tax charges for stock-based compensation expense relating to certain stock option grants would approximate $70 million for the Review Period.
Findings of the Audit Committee
During the Review Period, the Company granted stock options pursuant to an employee stock option plan and a director stock option plan to acquire approximately 10.9 million shares of common stock. Such plans at all relevant times provided for option grants to be approved by a designated committee of non-employee directors or, in the case of the director stock option plan, by the Board. Approximately 2,000 stock option grants were awarded during the Review Period with 69 recorded grant dates. No stock options have been granted since September, 2006. The Audit Committee reviewed all stock options granted during the Review Period, including option grants to the Company’s directors, officers and rank and file employees (including grants to new employees, grants awarded in connection with Company acquisitions and grants made as individual or group performance awards). The Audit Committee’s review of the Company’s stock option granting practices included a comprehensive examination of reasonably available relevant physical and electronic documents as well as interviews with current and former directors, officers and Company personnel.
The Audit Committee’s review was initially focused on determining whether the Company’s prior stock option granting practices were in compliance with the plans’ granting provisions and applicable law or called into question its accounting for such options. Once it became evident that such issues and accounting implications existed, the inquiry focused on those matters necessary: to determine whether any accounting charges were material and whether a restatement of the Company’s previously-issued financial statements would be required; to establish a basis for effecting any required restatement; to assure that, on as timely a basis as possible, the Company could file any

40


Table of Contents

required curative disclosures with the SEC and assure its continued eligibility for listing on NASDAQ; and to provide an informed basis for the Company’s response to the identified issues, including appropriate corrective and remedial actions.
The following information summarizes certain of the findings of the Audit Committee. The findings identified approximately $71.5 million of unrecorded expense at the time of grant (i.e., the difference between the fair market value of the common stock on the appropriate measurement date and the stated exercise price), net of forfeitures, during the Review Period, of which $70.0 million was recorded in the Company’s Consolidated Financial Statements through March 31, 2006 and $1.5 million of unrecorded expense at the time of grant will be included, beginning at April 1, 2006, in the Company’s computation of compensation expense in accordance with SFAS 123(R). The following summarizes the unrecorded expense at the time of grant by time period and category of recipient:
   
$4.2 million for the period from Fiscal 1993 through Fiscal 1997 ($0.2 million for directors, $2.5 million for officers and $1.5 million for rank and file employees)
 
   
$45.6 million for the period from Fiscal 1998 through August 2002 ($1.1 million for directors, $25.7 million for officers and $18.7 million for rank and file employees)
 
   
$21.8 million for the period from August 2002 to the present ($0.04 million for directors, $0.6 million for officers and $21.1 million for rank and file employees)
The Audit Committee’s additional key findings are summarized below:
Lack of Adequate Documentation: For a majority of grants issued by the Company during the Review Period, there is either no or inadequate documentation of approval actions that satisfies the requisites for establishing a measurement date under APB 25. Of the 69 recorded grant dates, there are documented approval actions by the Board or the Option or Compensation Committee with respect to particular grants for 12 dates. In the period December 1992 to May 1996, neither the minutes of the Compensation Committee nor of the Board reflect any action to approve specific grants. In some instances, evidence of single director (the chairman of the Compensation Committee) approval actions exists. This absence of non-employee director level documentation also applies to a majority of grants with a recorded grant date after 1996. In some cases, Compensation Committee minutes contain a reference to reports on the status of the option pool but do not document any action to approve specific grants. Approval documentation for certain grants has internal inconsistencies or conflicts with other documents thereby rendering this documentation unreliable as a basis for establishing a measurement date. In some cases, the only existing documentation is the executed option agreement and/or the entry of the option grant into the option database. Notwithstanding these approval documentation inadequacies, the Company entered into option agreements with grantees and has honored such grants.
Grant Approvals: During the Review Period, relatively few option grants were approved in complete compliance with the Company’s stock option plans. Available documentation reflects that the Company approved option grants in a variety of ways. With respect to the employee stock option plan, grants were approved by the Compensation Committee as contemplated by the plan at various times, by the full Board in 1998 and 1999, by a single director (the chairman of the Compensation Committee) on nine recorded grant dates during the period 1994 through 2001 and by the Company’s CEO at various times. With respect to the director stock option plan, grants were generally approved by the designated Board committee and, in a few cases, by the chairman of the Compensation Committee. In one instance in 2000, there is no conclusive documentary evidence of the approval of director grants other than the signed director option agreements.
The delegation of authority by the Compensation Committee to the CEO with respect to grants to rank and file employees was not fully documented. However, there was an understood and accepted practice between the CEO and the Compensation Committee whereby the CEO made certain awards to individual employees. In some instances, this involved the allocation among rank and file employees of blocks of shares approved by the Compensation Committee; in three (3) such instances, the number of shares ultimately awarded pursuant to this process exceeded the approved size of the block, which was contrary to the understanding of the Compensation Committee members. Further, contrary to the understanding of Committee members, the award and/or documentation of those individual grants often significantly lagged the approval of the block grant. In August 2005, the Compensation Committee specifically acknowledged a prior grant of delegated authority to the CEO to make option grants to rank and file employees and ratified all prior awards by the CEO. In some cases, documentation of approval action is either inconclusive or missing, and the Company therefore has been unable to determine what entity or person actually approved specific grants.
Option Pricing: The recorded grant dates for a majority of grants do not match the applicable measurement dates as determined under APB 25. The grants of options with exercise prices lower than the fair market values of the stock on the actual measurement dates did not satisfy the fair market pricing requirement in the Company’s plans, as amended in 1998, and were not consistent with the Company’s disclosures in SEC filings stating that the exercise price of options was equal to the fair market value of the stock on the date of the grant.
The relationship between the stated exercise price of options and the fair market value of the Company’s stock on the date of the

41


Table of Contents

identifiable approval actions varied from grant to grant. In some cases, the exercise price of grants reflected the fair market value of the underlying shares on the date of any documented approval action. In other cases, the exercise prices reflected the fair market value of the underlying shares on a date either prior or subsequent to any such documented approval action and the exercise price was lower than the fair market value on the date of any such action. In several such cases before August 2002, the use of such grant dates and lower exercise prices (together with other available evidence) supports a finding that the recorded grant dates and corresponding exercise prices were selected with the benefit of hindsight. For certain grants where the mismatch between the recorded grant date and the approval action was only a matter of days, however, the mismatch appears to have been attributable to inaccurate recording or administrative delays. In some cases, the apparent approval action did not identify all grantees; for example, there are cases where a block grant was approved subject to a later determination of individual grant recipients and grants were recorded with a grant date, and corresponding exercise price, that matched the date of the apparent approval of the block grant and the fair market value of the common stock on that date although individual grant recipients may have been identified some time after approval of the block grant. Finally, in some cases, the approval action for specific grants is not adequately documented. Where the recorded grant date did not satisfy the requisites for a measurement date under APB 25, the Company relied on default methodologies to determine an appropriate measurement date.
Internal Controls: As outlined above, the Company’s historical administration of its options program lacked discipline as it relates to proper adherence to the plan requirements, corporate recordkeeping and documentation. Since November 2003, however, the Company has properly administered the stock option program as it relates to awards to directors and officers. During the investigation, the Company identified control gaps related to grants made throughout the Review Period. As of March 31, 2007, the Company implemented additional procedures to its process that are focused on formalized documentation of appropriate approvals and determination of grant terms to employees.
Procedural and Remedial Actions
The Audit Committee and other relevant Board committees are committed to a continued review and implementation of procedural enhancements and remedial actions in light of the foregoing findings. Consistent with its obligation to act in the best interests of the Company taking into account all relevant facts and circumstances, the Audit Committee is continuing to assess the appropriateness of a broad range of possible procedural enhancements and potential remedial measures in light of the findings of its investigation. While the Audit Committee has not completed its consideration of all such steps, procedural enhancements may include recommendations regarding improved stock option administration procedures and controls, training and monitoring compliance with those procedures, corporate recordkeeping, corporate risk assessment, evaluation of the internal compliance environment and other remedial steps that may be appropriate. The Audit Committee is also expected to address issues of individual conduct or responsibility, including those of the Board, CEOs and CFOs serving during the Review Period. Potential remedial measures may include an evaluation of the role of and possible claims or other remedial actions against current and former Company personnel who may be found to have been responsible for identified problems during the Review Period. The Audit Committee expects to recommend to the Board and/or its appropriate committees procedural enhancements and remedial measures that appropriately address the issues raised by its findings. In advance of action by the Audit Committee, as noted above, the Company has implemented additional procedures to its process for approving stock option grants that are focused on formalized documentation of appropriate approvals and determination of grant terms to employees.
Restatement Methodologies
As of April 1, 2006, the Company adopted SFAS 123(R) using the modified prospective transition method. Under this transition method, compensation expense is to be recognized for all share-based compensation awards granted after the date of adoption and for all unvested awards existing on the date of adoption. Prior to April 1, 2006, the Company accounted for stock-based compensation awards to directors, officers and rank and file employees using the intrinsic value method in accordance with APB 25 as allowed under SFAS 123. Under the intrinsic value method, no share-based compensation expense related to stock options was required to be recognized if the exercise price of the stock option was at least equal to the fair market value of the common stock on the “measurement date.” APB 25 defines the measurement date as the first date on which are known both (1) the number of shares that an individual grant recipient is entitled to receive and (2) the option or purchase price, if any.
In light of the Audit Committee’s review of the Company’s stock option granting practices during the Review Period and as to those cases in which the Company previously used a recorded grant date as the measurement date that the Company determined could no longer be relied upon, the Company has developed and applied the following methodologies to remeasure those stock option grants and record the relevant charges in accordance with APB 25 by considering the following sources of information: (i) meeting minutes of the Board and of committees thereof and related materials, (ii) Unanimous Written Consents of the Board and of committees thereof, (iii) create date, (iv) relevant email correspondence reflecting stock option grant approval actions, (v) individual stock option agreements and related materials, (vi) employee and Board offer letters, (vii) documents relating to acquisitions, (viii) reports on Form 4 filed with the SEC and (ix) guidance of the Office of the Chief Accountant of the SEC on stock option matters as set forth in its letter dated September 19, 2006.

42


Table of Contents

Grants with Appropriate Committee Approval. With respect to grants of approximately 1.0 million shares, or approximately 9% of the total grants in the Review Period, the Company has evidence to support the approval of the grant under the stock option plans by the relevant committee of the Board, and such evidence includes the number of options each individual was entitled to receive and the option price. However, the relationship between these documented approval actions and the originally-recorded grant dates and exercise prices for the options so approved varied during the Review Period. In some cases, grants were recorded with a grant date and a corresponding exercise price that matched the date of the approval action or were otherwise consistent with the terms of the approval actions. In other cases, however, the recorded grant dates and corresponding exercise prices of the grants reflected the fair market value of the common stock on a date prior to the committee’s documented approval actions. The Company has restated the compensation expense for stock option grants relating to approximately 0.4 million shares of common stock by using the date of the documented approval action as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $1.8 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.07 million relates to director options, $1.3 million relates to officer options and $0.4 million relates to rank and file employee options.
Grants with Other Approvals. With respect to grants of approximately 1.9 million shares, or approximately 18% of the total grants in the Review Period, the Company has evidence to support the approval of the grant by the Board, an outside director or the Company’s CEO and the identification of the number of options each individual was entitled to receive together with the option price. These grants are distinguished from the grants described in the prior paragraph in that the nature of the approval was not fully consistent with the terms of the relevant stock option plan. As with the grants discussed in the preceding paragraph, the relationship between these documented approval actions and the originally-recorded grant dates and exercise prices for the options so approved varied during the Review Period. In some cases, grants were recorded with a grant date and a corresponding exercise price that matched the date of the approval action or were otherwise consistent with the terms of the approval action. In other cases, however, the recorded grant dates and corresponding exercise prices of the grants reflected the fair market value of the Company’s stock on a date prior to the approval action. The Company has restated the compensation expense for stock option grants relating to approximately 1.6 million shares of common stock by using the date of the documented approval action as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $7.6 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.5 million relates to director options, $2.6 million relates to officer options and $4.5 million relates to rank and file employee options.
Grants Lacking Adequate Documentation. With respect to grants of approximately 7.9 million shares (5.0 million shares to rank and file employees), or 73.0% of the total grants in the Review Period, the Company has been unable to locate adequate documentation of approval actions that would satisfy the requisites for a measurement date under APB 25. For these grants, management considered all available relevant information to form a reasonable conclusion as to the most reasonable measurement date. For all grants in this category, the Company has established default methodologies for determining the most appropriate measurement date under APB 25.
With respect to grants entered into the Company’s stock option database after September 9, 1999, when the database began to reflect a “create date” which is the date on which a grant was entered into the system, the Company has determined to use the individual “create date” for each grant as the APB 25 measurement date, which was in most cases different from the originally-recorded grant date. The Company believes that this “create date” is the most appropriate methodology in the absence of sufficient evidence of approvals for these grants as it represents the earliest point in time at which the evidence shows that all requisites for the establishment of the measurement date had been satisfied. Such “create dates” preceded, often by a significant amount of time, the execution of stock option agreements, which, generally, were manually signed by the Company’s CEO and manually signed and dated by the grantee. In addition, in almost all cases, a grant entered into the database, which established the “create date,” ultimately resulted in the creation of a stock option agreement reflecting such grant. Accordingly, while execution of the stock option agreements constituted a clear acknowledgement by the grantee and the Company of the grantee’s legal entitlement to the grant the Company believes the “create date” more accurately reflects the date of approval than does the signed option agreement. The Company has restated the compensation expense for stock option grants relating to approximately 4.2 million shares of common stock by using the “create date” as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $49.8 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.5 million relates to director options, $17.2 million relates to officer options and $32.2 million relates to rank and file employee options. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to such create dates included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the create date for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted for which the “create date” methodology was utilized to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.09 million to $73.8 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $49.8 million, net of forfeitures, included in the Restatement.
For options entered into the Company’s option database before September 9, 1999, the Company determined the measurement date

43


Table of Contents

generally by reference to signed option agreements (or the deemed signature date for certain options as discussed below). The executed option agreements (hereinafter “signed option agreements”), manually signed by the Company’s CEO and manually signed and dated by the grantee, constituted an acknowledgement by the grantee and the Company of the grantee’s legal entitlement to the grant and, in the absence of authoritative information as to when all the requisites for the establishment of the measurement date had been satisfied, provides a measurement date framework based on entitlement. The Company has restated the compensation expense for stock option grants relating to approximately 1.4 million shares of common stock by using the signed option agreements as the measurement date. The total additional non-cash, pre-tax charge for these grants is approximately $6.4 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.3 million relates to director options, $3.6 million relates to officer options and $2.5 million relates to rank and file employee options. The Company believes this methodology was the most appropriate in the absence of sufficient evidence of approvals for these grants as it represents the earliest point in time at which the evidence shows that all requisites for the establishment of the measurement date had been satisfied for these grants. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to the dating of signed option agreements included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the date of the grantee’s signature on the stock option agreement for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted for which the signed option agreements methodology was utilized to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.03 million to $9.6 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $6.4 million, net of forfeitures, included in the Restatement.
In those cases where no reliably-dated signed option agreement could be located and where no post-September 9, 1999 “create date” exists (stock option grants totaling approximately 0.9 million shares), the Company used the average period between recorded grant date and date of the signatures on all other grantee signed option agreements with the same grant date as the measurement date. For example, if there were four stock option grants with a grant date of January 1, 1996, the Company had the signed option agreements for three of these stock option grants and the average number of days between the grant date and the signature dates of these three signed option agreements was 20 days, January 21, 1996 was used as the measurement date for the grant for which no signed option agreement could be located. The Company has restated the compensation expense for stock option grants relating to approximately 0.7 million shares of common stock using this “average days to sign agreement” method. The total additional non-cash, pre-tax charge for these grants is approximately $4.4 million, net of forfeitures, amortized over the appropriate vesting period through March 31, 2006, of which $0.06 million relates to director options, $4.2 million relates to officer options and $0.2 million relates to rank and file employee options. The Company believes this methodology was the most appropriate in the absence of sufficient evidence of approvals for these grants because it gives a reasonable approximation of the measurement date related to these options in light of the available evidence. The Company conducted a sensitivity analysis by comparing the Company’s current default methodology (i.e., “average days to sign agreement”) with another default methodology. For this analysis, the Company identified the range of potential grant dates defined by the earliest signed option agreement and the latest signed option agreement. The Company then identified the low and high closing prices of the common stock over the range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $2.6 million to $5.9 million, net of forfeitures. The Company’s analyses indicate that stock-based compensation expense computed using other identified alternative default methodologies would not materially differ from stock-based compensation expense computed using the “average days to sign agreement” methodology. The Company’s procedures for evaluating the appropriateness of measurement dates fixed with reference to the average days to sign agreements also included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the average days to sign agreement for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-based compensation expense for these grants, which was $0.03 million to $6.1 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $4.4 million, net of forfeitures, included in the Restatement.
Given the volatility of the common stock during much of the Review Period, the use of methodologies and measurement dates different from those described above could have resulted in a higher or lower cumulative compensation expense which would have caused net income or loss to be different from the amounts reported in the restated consolidated financial statements. The Company’s procedures for evaluating the appropriateness of measurement dates fixed using the default methodologies described above also included a sensitivity analysis which provided an understanding of the differences between the additional recorded charge for stock-based compensation expense and the charges that would result from using other identified alternative methods for determining measurement dates. The Company’s sensitivity analysis included identifying the range of potential grant dates defined by the recorded grant date and the appropriate measurement date for each grant. The Company then identified the low and high closing prices of the common stock within that range of potential grant dates and applied both the low and high closing prices of the common stock to the number of shares granted to determine the range of potential adjustments to stock-

44


Table of Contents

based compensation expense for these grants, which was $9.3 million to $99.3 million, net of forfeitures, as compared to the additional non-cash, pre-tax charge for these grants of approximately $70.0 million, net of forfeitures, included in the Restatement.
Other adjustments through March 31, 2006
From 1994 through 1998, the Company did not properly account for stock options for one officer that were modified after the grant date pursuant to a separation agreement. Some of these modifications were not identified in the Company’s financial reporting processes and were therefore not properly reflected in its financial statements. As a result, the Company has recorded a non-cash charge for stock-based compensation of $1.0 million during Fiscal 1999.
Summary
In summary, the Company recorded cumulative non-cash charges for stock-based compensation of $70.9 million through March 31, 2006, offset in part by a cumulative income tax benefit of $27.7 million, for a total after-tax charge of $43.2 million. These charges had no impact on net sales or cash and cash equivalents as previously reported in the Company’s financial statements; as a result, no changes to these items are reflected in the Restatement. Non-cash charges for stock-based compensation expense have been recorded as adjustments to “Selling, General, and Administrative Expenses” within the Company’s Consolidated Statements of Income.
1Q07 and 2Q07 Restatement
Stock-based compensation expense
In addition to the Restatement noted above through March 31, 2006, the Company has recorded a non-cash charge for stock-based compensation of $0.8 million and $2.4 million for the three (3) and six (6) month periods ended September 30, 2006, offset in part by income tax benefits of $0.3 million and $1.0 million, or total after-tax charges of $0.5 million and $1.4 million. This charge was recorded to reflect additional non-cash, stock-based compensation expense recognized under the fair value method (SFAS 123(R)) because the exercise price for certain stock option grants prior to, but not vested as of March 31, 2006, differed from the fair market value of the underlying shares on the appropriate measurement date, some of which occurred during Fiscal 2007.
Accounting for derivatives
On July 26, 2006, the Company entered into an interest rate swap to reduce its exposure from fluctuating interest rates. SFAS 133 requires that all derivative instruments be recorded on the balance sheet as either an asset or liability measured at their fair value, and that changes in the derivatives’ fair value be recognized currently in earnings unless specific hedge accounting criteria are met. From inception of the hedge, the Company had applied a method of cash flow hedge accounting under SFAS 133 to account for the interest rate swap that allowed the Company to assume no ineffectiveness in such agreements, called the “short-cut” method.
Subsequently, the Company analyzed its eligibility for the short-cut method in light of certain clarifications delivered by the Office of the Chief Accountant of the SEC, and determined that its interest rate swap did not qualify for the short-cut method under SFAS 133 because certain prepayment features relating to the underlying actual debt were not identical to those contained in the interest rate swap. Because the Company’s documentation at hedge inception reflected the short-cut method rather than the long haul method for determining hedge ineffectiveness, the derivative did not meet the requirements for a cash flow hedge. Documentation for the long haul method of accounting at hedge inception cannot be retrospectively applied under SFAS 133. Therefore, fluctuations in the interest rate swap’s fair value should have been recorded through the Company’s Consolidated Statement of Income instead of through “Other Comprehensive Income (Loss)”, which is a component of stockholders’ equity. The adjustment for 2Q07 will decrease reported net income and increase “Other Comprehensive Income” by approximately $1.4 million. This change in accounting for this derivative instrument could result in significant volatility in the Company’s reported net income and earnings per share due to increases and decreases in the fair value of the interest rate swap. However, the derivative instrument remains highly effective and the change in accounting for this derivative instrument does not impact operating cash flows or total stockholders’ equity.
The table below reflects the impact of the additional non-cash charges for stock-based compensation expense and the non-cash charge related to the interest rate swap on the Company’s Consolidated Statements of Income, including the cumulative adjustment to Retained Earnings as of March 31, 2006 and September 30, 2006 on the Company’s Consolidated Balance Sheet. See Note 3 of the Notes to Consolidated Financial Statements for reference to footnote disclosure that reconciles the previously filed annual financial information to the restated annual financial information. All dollar amounts are presented in thousands except per share amounts. Per share amounts may not total due to rounding.

45


Table of Contents

                                                                 
    (As                     Adjust-             (As             (As  
    previously     Adjust-     Income     ment,     (As     previously             Restated)  
    reported)     ment,     Tax     Net of     Restated)     reported)     Adjust-     Diluted  
    Net Income     Pre-Tax     Benefit     Tax     Net Income     Diluted EPS     ment     EPS  
 
 
                                                               
FY 94
  $ 13,370     $ 43     $ (19 )   $ 24     $ 13,346     $ 0.83     $ --     $ 0.83  
FY 95
    14,515       461       (144 )     317       14,198       0.89       (0.02 )     0.87  
FY 96
    18,278       406       (151 )     255       18,023       1.10       (0.01 )     1.09  
FY 97
    24,792       1,172       (456 )     716       24,076       1.40       (0.04 )     1.36  
FY 98
    32,404       3,595       (1,393 )     2,202       30,202       1.79       (0.12 )     1.67  
FY 99
    38,145       4,506       (1,732 )     2,774       35,371       2.09       (0.15 )     1.94  
FY 00
    48,852       5,778       (2,209 )     3,569       45,283       2.60       (0.19 )     2.41  
FY 01
    64,190       10,290       (3,953 )     6,337       57,853       3.22       (0.32 )     2.90  
FY 02
    62,042       11,333       (4,381 )     6,952       55,090       2.97       (0.33 )     2.64  
FY 03
    48,685       8,927       (2,328 )     6,599       42,086       2.39       (0.32 )     2.07  
FY 04
    47,243       8,197       (4,156 )     4,041       43,202       2.52       (0.22 )     2.30  
FY 05
    29,912       5,178       (2,312 )     2,866       27,046       1.68       (0.16 )     1.52  
 
                                 
 
                                                               
Cumulative
                                                               
03/31/05
  $ 442,428     $ 59,886     $ (23,234 )   $ 36,652     $ 405,776     $ 23.48     $ (1.89 )   $ 21.59  
 
                                                               
1Q06
    7,394       1,120       (442 )     678       6,716       0.43       (0.04 )     0.39  
2Q06
    12,797       1,126       (444 )     682       12,115       0.74       (0.04 )     0.70  
3Q06
    12,511       2,431       (959 )     1,472       11,039       0.70       (0.08 )     0.62  
4Q06
    4,656       6,368       (2,612 )     3,756       900       0.26       (0.21 )     0.05  
 
                                 
 
                                                               
FY 06
  $ 37,358     $ 11,045     $ (4,457 )   $ 6,588     $ 30,770     $ 2.13     $ (0.37 )   $ 1.76  
 
                                                               
Cumulative
                                                               
03/31/06
  $ 479,786     $ 70,931     $ (27,691 )   $ 43,240     $ 436,546     $ 25.61     $ (2.26 )   $ 23.35  
 
                                                               
1Q07
    7,807       1,629       (635 )     994       6,813       0.43       (0.06 )     0.37  
2Q07
    13,079       2,210       (806 )     1,404       11,675       0.74       (0.08 )     0.66  
 
                                 
2QYTD07
  $ 20,886     $ 3,839     $ (1,441 )   $ 2,398     $ 18,488     $ 1.18     $ (0.14 )   $ 1.04  
 
                                 
Cumulative
                                                               
09/30/06
  $ 500,672     $ 74,770     $ (29,132 )   $ 45,638     $ 455,034     $ 26.78     $ (2.39 )   $ 24.39  
 
Income Tax Considerations
In the course of the investigation, the Company determined that a number of officers may have exercised options for which the application of Section 162(m) of the Code, may apply. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes because the Company incorrectly applied the measurement date as defined in APB 25. If such options are deemed to be granted at less than fair market value, pursuant to Section 162(m), any compensation to officers, including proceeds from options exercised in any given tax year, in excess of $1.0 million will be disallowed as a deduction for tax purposes. The Company estimates that the potential tax effected liability for any such disallowed Section 162(m) deduction would approximate $3.6 million. The Company may also incur interest and penalties if it were to incur any such tax liability, which could be material.
In addition, the Company is considering the application of Section 409A to those options for which it incorrectly applied the measurement date as defined in APB 25. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes and thus subject to Section 409A. Accordingly, the Company may adopt measures to address the application of Section 409A. The Company does not currently know what impact Section 409A will have, or any such measures, if adopted, would have, on its results of operations, financial position or cash flows, although such impact could be material.
Expenses Incurred by the Company
The Company has incurred expenses for legal fees and external audit firm fees, in the aggregate amount of approximately $0.6 million, in the fiscal year ended March 31, 2007, in relation to (i) the Audit Committee’s review of the Company’s historical stock option practices and related accounting for stock option grants, (ii) the informal inquiry and formal order of investigation by the Securities and Exchange Commission regarding its past stock option practices, (iii) the derivative action relating to the Company’s historical stock option practices filed against the Company as a nominal defendant and certain of the Company’s current and former directors and officers as to whom it may have indemnification obligations and (iv) related matters. Further, the Company expects to incur significant additional expense related to the foregoing matters in the fiscal year ending March 31, 2008. It is anticipated that certain of those expenses will be reimbursed under the Company’s directors’ & officers’ indemnification insurance.

46


Table of Contents

The Company
The Company offers one-source network infrastructure services for: data networks (Data Services), including structured cabling for wired and wireless systems; voice systems (Voice Services), including new and upgraded telephony systems; and 24/7/365 hotline technical support (Hotline Services) for more than 118,000 network infrastructure products that it sells through its catalog, Internet Web site and on-site services offices.
Management is presented with and reviews revenues and operating income by geographical segment. In addition, revenues and gross profit information by service type are provided below for further analysis.
The Company has completed several acquisitions previously defined as “the Acquired Companies” from the first quarter of Fiscal 2006 through the third quarter of Fiscal 2007 that have a significant impact on the Company’s consolidated financial statements and, more specifically, North America Voice Services for the periods under review. See Note 10 of the Notes to the Consolidated Financial Statements for reference to the “Acquired Companies.” In connection with certain acquisitions, the Company incurs expenses that it excludes when evaluating the continuing operations of the Company. The following table is included to provide a schedule of the current and an estimate of future acquisition related expenses based on the acquisition activity through December 31, 2006.
                                                         
    1Q07     2Q07     3Q07     4Q07     FY07     FY08     Thereafter  
 
SGA
                                                       
Asset write-up
                                                       
depreciation expense
  $ --     $ 1,197     $ 713     $ 652     $ 2,562     $ 1,635     $ 1,655  
on acquisitions
                                                       
 
                                                       
Amortization
                                                       
Amortization of
                                                       
intangible assets on
    1,440       1,892       2,621       3,918       9,871       5,257       55,031  
acquisitions
                                                       
 
                         
Total
  $ 1,440     $ 3,089     $ 3,334     $ 4,570     $ 12,433     $ 6,892     $ 56,686  
 

47


Table of Contents

Information on revenues and operating income by reportable geographic segment (North America, Europe and All Other) is presented below. The tables below should be read in conjunction with the following discussion. The additional non-cash charges for stock-based compensation expense for the three (3) and nine (9) month periods ended December 31, 2005 was recorded in Selling, General and Administrative expense which is included in the Company’s measure of Operating Income. See Note 3 of the Notes to the Consolidated Financial Statements.
                                                                 
          Three months ended December 30 and 31,     Nine months ended December 30 and 31,  
                    (As Restated)                 (As Restated)
    2006 2005 2006 2005
            % of total         % of total         % of total         % of total
    $   revenue $   revenue $   revenue $   revenue
 
Revenues:
                                                               
North America
  220,391       83.2%     143,173       78.6%     644,260       84.0%     426,788       78.1%  
Europe
    34,610       13.1%       29,950       16.4%       94,799       12.4%       92,899       17.0%  
All Other
    9,805       3.7%       9,012       4.9%       27,467       3.6%       26,780       4.9%  
         
Total
  264,806       100%     182,135       100%     766,526       100%     546,467       100%  
 
                                                               
Operating Income:
                                                               
North America
  13,685             13,309             41,204             39,459          
% of North America
                                                               
revenues
    6.2%               9.3%               6.4%               9.2%          
Europe
  4,502             4,101             11,134             7,161          
% of Europe
                                                               
revenues
    13.0%               13.7%               11.7%               7.7%          
All Other
  1,881             1,771             5,372             5,394          
% of All Other
                                                               
revenues
    19.2%               19.7%               19.6%               20.1%          
 
                                               
 
                                                               
Total
  20,068       7.6%     19,181       10.5%     57,710       7.5%     52,014       9.5%  
 
                                                               
Reconciling items:
                                                               
North America
  5,174             3,676             16,443             11,575          
Europe
    --               --               --               3,742          
All Other
    --               --               --               --          
 
                                               
Total
  5,174       2.0%     3,676       2.0%     16,443       2.1%     15,317       2.8%  
 

48


Table of Contents

Information on revenues and gross profit by service type (Data Services, Voice Services and Hotline Services) is presented below. The additional non-cash charges for stock-based compensation expense were recorded in Selling, General and Administrative expense which is not included in the Company’s measure of Gross Profit and therefore does not impact the following table or the corresponding discussions.
                                                                 
    Three months ended December 30 and 31, Nine months ended December 30 and 31,
    2006 2005 2006 2005
            % of total         % of total         % of total         % of total
    $   revenue $   revenue $   revenue $   revenue
Revenues:
                                                               
Data Services(1)
  $ 46,350       17.5%     $ 47,083       25.8%     $ 137,328       17.9%     $ 152,568       27.9%  
Voice Services(1)
    160,686       60.7%       82,281       45.2%       464,140       60.6%       233,620       42.8%  
Hotline Services
    57,770       21.8%       52,771       29.0%       165,058       21.5%       160,279       29.3%  
         
Total
  $ 264,806       100%     $ 182,135       100%     $ 766,526       100%     $ 546,467       100%  
 
                                                               
Gross Profit
                                                               
Data Services
  $ 14,236             $ 14,794             $ 41,460             $ 45,800          
% of Data
                                                               
Services revenues
    30.7%               31.4%               30.2%               30.0%          
Voice Services
  $ 54,566             $ 32,145             $ 158,242             $ 91,156          
% of Voice
                                                               
Services revenues
    34.0%               39.1%               34.1%               39.0%          
Hotline Services
  $ 27,883             $ 26,463             $ 81,863             $ 81,268          
% of Hotline
                                                               
Services revenues
    48.3%               50.1%               49.6%               50.7%          
 
                                               
 
                                                               
Total
  $ 96,685       36.5%     $ 73,402       40.3%     $ 281,565       36.7%     $ 218,224       39.9%  
 
(1) Data Services and Voice Services may also be collectively referred to as “On-Site Services.”
Third Quarter Fiscal 2007 (3Q07) Compared to Third Quarter Fiscal 2006 (3Q06):
Total Revenues
Total revenues for 3Q07 were $264,806, an increase of 45% compared to revenues for 3Q06 of $182,135. The increase was primarily due to the incremental revenue from the Acquired Companies, which added revenues of $98,054 and $14,952 to 3Q07 and 3Q06, respectively. Excluding the effects of the acquisitions and the positive impact of exchange rates of $3,014 relative to the U.S. dollar, total revenues would have decreased 2% from $167,183 to $163,738 for the reasons discussed below.
Revenues by Geography
North America Revenues
Revenues in North America for 3Q07 were $220,391, an increase of 54% compared to revenues for 3Q06 of $143,173. The increase was primarily due to the incremental revenue from the Acquired Companies, which added $98,054 and $14,952 for 3Q07 and 3Q06, respectively. Excluding the effects of these acquisitions and the positive impact of exchange rates of $187 relative to the U.S. dollar, North America revenues would have decreased 5% from $128,221 to $122,150. The Company believes the overall decrease is due to the completion of several nonrecurring projects, offset in part by success in the Company’s Data, Voice and Hotline Services (“DVH”) cross-selling initiatives.
Europe Revenues
Revenues in Europe for 3Q07 were $34,610, an increase of 16% compared to revenues for 3Q06 of $29,950. Excluding the positive impact of exchange rates of $2,745 relative to the U.S. dollar, Europe revenues would have increased 6% from $29,950 to $31,865. The Company believes the overall increase is due to the success in the Company’s DVH cross-selling initiatives.

49


Table of Contents

All Other Revenues
Revenues for All Other for 3Q07 were $9,805, an increase of 9% compared to revenues for 3Q06 of $9,012. Excluding the positive impact of exchange rates of $82 relative to the U.S. dollar, All Other revenues would have increased 8% from $9,012 to $9,723.
Revenue by Service Type
Data Services
Revenues from Data Services for 3Q07 were $46,350, a decrease of 2% compared to revenues for 3Q06 of $47,083. Excluding the positive impact of exchange rates of $1,176 relative to the U.S. dollar for its International Data Services, Data Services revenues would have decreased 4% from $47,083 to $45,174 for 3Q07. The Company believes the overall decrease in Data Services revenue was due to the completion of several nonrecurring projects.
Voice Services
Revenues from Voice Services for 3Q07 were $160,686, an increase of 95% compared to revenues for 3Q06 of $82,281. The increase was primarily due to the incremental revenue from the Acquired Companies, which added $98,054 and $14,952 for 3Q07 and 3Q06, respectively. Excluding the effects of these acquisitions, Voice Services revenues would have decreased 7% from $67,329 to $62,632. The Company believes that this overall decrease in Voice Services revenue is primarily due to the completion of nonrecurring projects.
Hotline Services
Revenues from Hotline Services for 3Q07 were $57,770, an increase of 9% compared to revenues for 3Q06 of $52,771. Excluding the positive impact of exchange rates of $1,831 relative to the U.S. dollar, Hotline Services revenues would have increased 6% from $52,771 to $55,939. The Company believes the overall increase in Hotline Services revenues was driven by the success in the Company’s DVH cross-selling initiatives.
Gross Profit
Gross profit dollars for 3Q07 were $96,685, an increase of 32% compared to gross profit dollars for 3Q06 of $73,402. The Company believes the increase in gross profit dollars was due to the increase in revenues from the Acquired Companies. Gross profit as a percent of revenues for 3Q07 was 36.5%, a decrease of 3.8% compared to gross profit as a percentage of revenues for 3Q06 of 40.3%. The decrease in gross profit percentage was due primarily to the impact of lower gross profit in its Voice Services segment driven by the acquisition of NextiraOne and the impact of lower gross profit in its Hotline Services segment driven by increased product costs and product mix.
Gross profit dollars for Data Services for 3Q07 were $14,236, or 30.7% of revenues, compared to gross profit dollars for 3Q06 of $14,794, or 31.4% of revenues. Gross profit dollars for Voice Services for 3Q07 were $54,566, or 34.0% of revenues, compared to gross profit dollars for 3Q06 of $32,145, or 39.1% of revenues. Gross profit dollars for Hotline Services for 3Q07 were $27,883, or 48.3% of revenues, compared to gross profit dollars for 3Q06 of $26,463, or 50.1% of revenues.
SG&A Expenses
Selling, general and administrative (“SG&A”) expenses for 3Q07 were $73,940, an increase of $21,068 compared to SG&A expenses for 3Q06 of $52,872. The increase in SG&A expense dollars over the prior year was due primarily to the Acquired Companies. SG&A expenses as a percent of revenue for 3Q07 were 27.9% compared to 29.0% for 3Q06. The decrease in SG&A as a percent of revenue was due primarily to lower SG&A as a percent of revenues related to the Acquired Companies, a $700 benefit for the write-off of previously accrued vacation payables due to a change in the Company’s vacation policy in some of the Acquired Companies, and a decrease to non-cash stock-based compensation expense of $591.
Intangibles Amortization
Intangibles amortization for 3Q07 was $2,677, an increase of $1,328 compared to intangibles amortization for 3Q06 of $1,349. The increase was primarily attributable to the amortization of intangible assets acquired through the purchase of the Acquired Companies. See Note 10 of the Notes to the Consolidated Financial Statements for further details related to the Acquired Companies.

50


Table of Contents

Operating Income
Operating income for 3Q07 was $20,068, or 7.6% of revenues, an increase of $887 compared to operating income for 3Q06 of $19,181, or 10.5% of revenues.
Interest Expense, Net
Net interest expense for 3Q07 was $4,061, an increase of $1,664 compared to net interest expense for 3Q06 of $2,397 due to an increase in the weighted average outstanding debt from $266,763 for 3Q07 compared to approximately $149,737 for 3Q06. The increase in debt relates primarily to the acquisitions of NextiraOne and NUVT during the first quarter Fiscal 2007. In addition, the weighted average interest rate outstanding for 3Q07 was 6.25%, an increase of 0.66% compared to the 3Q06 rate of 5.59%.
Provision for Income Taxes
The tax provision for 3Q07 was $5,636, an effective tax rate of 34.9%. This compares to the tax provision for 3Q06 of $5,631, an effective tax rate of 33.8%. The tax rate for 3Q07 was higher than 3Q06 due to the impact of book stock option expense and the associated tax asset and changes in the overall mix of taxable income among worldwide offices.
Net Income
As a result of the foregoing, net income for 3Q07 was $10,493, or 4.0% of revenues, compared to $11,039, or 6.1% of revenues, for 3Q06.
Nine Months Fiscal 2007 (3QYTD07) Compared to Nine Months Fiscal 2006 (3QYTD06):
Total Revenues
Total revenues for 3QYTD07 were $766,526, an increase of 40% compared to revenues for 3QYTD06 of $546,467. The increase was primarily due to the incremental revenue from the Acquired Companies, which added $280,221 and $34,345 of revenues to 3QYTD07 and 3QYTD06, respectively. Excluding the effects of the acquisitions and the positive impact of exchange rates of $4,905 relative to the U.S. dollar, total revenues would have decreased 6% from $512,122 to $481,400 for the reasons discussed below.
Revenues by Geography
North America Revenues
Revenues in North America for 3QYTD07 were $644,260, an increase of 51% compared to revenues for 3QYTD06 of $426,788. The increase was primarily due to the incremental revenue from the Acquired Companies, which added $280,221 and $34,345 for 3QYTD07 and 3QYTD06, respectively. Excluding the effects of these acquisitions and the positive impact of exchange rates of $1,094 relative to the U.S. dollar, North America revenues would have decreased 8% from $392,443 to $362,945. The Company believes the overall decrease is due to the completion of several nonrecurring projects, offset in part by success in the Company’s DVH cross-selling initiatives.
Europe Revenues
Revenues in Europe for 3QYTD07 were $94,799, an increase of 2% compared to revenues for 3QYTD06 of $92,899. Excluding the positive impact of exchange rates of $3,991 relative to the U.S. dollar, Europe revenues would have decreased 2% from $92,899 to $90,808. The Company believes the overall decrease is due to the completion of nonrecurring projects offset in part by the success in the Company’s DVH cross-selling initiatives.

51


Table of Contents

All Other Revenues
Revenues for All Other for 3QYTD07 were $27,467, an increase of 3% compared to revenues for 3QYTD06 of $26,780. Excluding the negative impact of exchange rates of $180 relative to the U.S. dollar, All Other revenues would have increased 3% from $26,780 to $27,647.
Revenue by Service Type
Data Services
Revenues from Data Services for 3QYTD07 were $137,328, a decrease of 10% compared to revenues for 3QYTD06 of $152,568. Excluding the positive impact of exchange rates of $2,320 relative to the U.S. dollar for its International Data Services, Data Services revenues would have decreased 12% from $152,568 to $135,008. The Company believes the overall decrease in Data Services revenue was due to the completion of several nonrecurring projects.
Voice Services
Revenues from Voice Services for 3QYTD07 were $464,140, an increase of 99% compared to revenues for 3QYTD06 of $233,620. The increase was primarily due to the incremental revenue from the Acquired Companies, which added $280,221 and $34,345 for 3QYTD07 and 3QYTD06, respectively. Excluding the effects of these acquisitions, Voice Services revenues would have decreased 8% from $199,275 to $183,919 between periods. The Company believes that this overall decrease in Voice Services revenue is primarily due to the completion of several nonrecurring projects and planned post-merger client attrition from the acquisition of Norstan, Inc. in 4Q05.
Hotline Services
Revenues from Hotline Services for 3QYTD07 were $165,058, an increase of 3% compared to revenues for 3QYTD06 of $160,279. Excluding the positive impact of exchange rates of $2,570 relative to the U.S. dollar, Hotline Services revenues would have increased 1% from $160,279 to $162,488. The Company believes the stabilization is due in part to the success in the Company’s DVH cross-selling initiatives.
Gross Profit
Gross profit dollars for 3QYTD07 were $281,565, an increase of 29% compared to gross profit dollars for 3QYTD06 of $218,224. The Company believes the increase in gross profit dollars over the prior year was due to the increase in revenues from the Acquired Companies. Gross profit as a percent of revenues for 3QYTD07 was 36.7%, a decrease of 3.2% compared to gross profit as a percentage of revenues for 3QYTD06 of 39.9%. The decrease in gross profit percentage was due primarily to the impact of lower gross profit in its Voice Services segment driven by the acquisition of NextiraOne.
Gross profit dollars for Data Services for 3QYTD07 were $41,460, or 30.2% of revenues, compared to gross profit dollars for 3QYTD06 of $45,800, or 30.0% of revenues. Gross profit dollars for Voice Services for 3QYTD07 were $158,242, or 34.1% of revenues, compared to gross profit dollars for 3QYTD06 of $91,156, or 39.0% of revenues. Gross profit dollars for Hotline Services for 3QYTD07 were $81,863, or 49.6% of revenues, compared to gross profit dollars for 3QYTD06 of $81,268, or 50.7% of revenues.
SG&A Expenses
SG&A expenses for 3QYTD07 were $217,741, an increase of $61,056 compared to SG&A expenses for 3QTYD06 of $156,685. The increase in SG&A expense dollars over the prior year was due primarily to the Acquired Companies. SG&A expenses as a percent of revenues for 3QYTD07 were 28.4% compared to 28.7% for 3QYTD06. The decrease in SG&A as a percent of revenue was due primarily to lower SG&A as a percent of revenues related to the Acquired Companies offset in part by an increase in non-cash stock-based compensation expense of $2,799.

52


Table of Contents

Restructuring Charges
The Company did not record any restructuring charges during 3QYTD07. During 1Q06, the Company recorded a restructuring charge of $5,290. This charge was comprised of $3,473 for staffing level adjustments and $1,817 for real estate consolidations in Europe and North America. Of this charge, $3,742 and $1,548 related to Europe and North America, respectively.
Intangibles Amortization
Intangibles amortization for 3QYTD07 was $6,114, an increase of $1,879 compared to intangible amortization for 3QYTD06 of $4,235. The increase was primarily attributable to the amortization of intangible assets acquired through the purchase of the Acquired Companies. See Note 10 of the Notes to the Consolidated Financial Statements for further details related to the Acquired Companies.
Operating Income
Operating income for 3QYTD07 was $57,710, or 7.5% of revenues, an increase of $5,696 compared to operating income for 3QYTD06 of $52,014, or 9.5% of revenues.
Interest Expense, Net
Net interest expense for 3QYTD07 was $13,222, an increase of $6,536 compared to net interest expense for 3QYTD06 of $6,686. The increase in interest expense is due to an increase in the weighted average outstanding debt and weighted average interest rate from approximately $159,476 and 4.86% for 3QYTD06, respectively, to approximately $251,153 and 6.2% for 3QYTD07, respectively. The increase in debt relates primarily to the acquisitions of NextiraOne and NUVT during the first quarter Fiscal 2007. Also included in interest expense for 3QYTD07 is $1,308 related to the change in fair value of the Company’s interest rate swap.
Provision for Income Taxes
The tax provision for 3QYTD07 was $15,442, an effective tax rate of 34.8%. This compares to the tax provision for 3QYTD06 of $15,379, an effective tax rate of 34.0%. The tax rate for 3QYTD07 was higher than 3QYTD06 primarily due to changes in the overall mix of taxable income among worldwide offices.
Net Income
As a result of the foregoing, net income for 3QYTD07 was $28,981, or 3.8% of revenues, compared to $29,870, or 5.5% of revenues, for 3QYTD06.
Liquidity and Capital Resources
Cash Flows from Operating Activities
Net cash provided by operating activities during 3QYTD07 was $24,596. Significant factors contributing to the source of cash were: net income of $28,981 inclusive of non-cash charges of $15,333 and $7,476 for amortization / depreciation expense and stock compensation expense, respectively and an increase in billings in excess of costs and uncompleted contracts of $5,700. Significant factors contributing to a use of cash were: increase in net inventory of $6,629, an increase in costs in excess of billings of $10,161, a decrease in restructuring reserve of $13,992 and a decrease in deferred revenue of $5,559. Changes in the above accounts are based on average Fiscal 2007 exchange rates.
Net cash provided by operating activities during 3QYTD06 was $38,912. Significant factors contributing to a source of cash were: net income of $29,870 inclusive of non-cash charges of $11,013 and $4,677 for amortization / depreciation expense and stock compensation expense, respectively, and a decrease in net inventory of $5,673. Significant factor contributing to a use of cash was a decrease of accounts payable of $7,204, a decrease of deferred revenue of 3,017 and a decrease of restructuring reserve of $2,148. Changes in the above accounts are based on average Fiscal 2006 exchange rates.
As of December 31, 2006 and 2005, the Company had cash and cash equivalents of $15,362 and $12,143, respectively, working capital of $126,879 and $105,420, respectively, and a current ratio of 1.52 and 1.73, respectively.

53


Table of Contents

The Company believes that its cash provided by operating activities and availability under its credit facility will be sufficient to fund the Company’s working capital requirements, capital expenditures, dividend program, potential stock repurchases, potential future acquisitions or strategic investments and other cash needs for the next 12 months.
Cash Flows from Investing Activities
Net cash used by investing activities during 3QYTD07 was $137,241. Significant factors contributing to a use of cash were: $3,475 for gross capital expenditures and $132,878 to acquire NextiraOne, NUVT and NTI. See Note 10 of the Notes to the Consolidated Financial Statements for additional details regarding the acquisitions of NextiraOne, NUVT and NTI.
Net cash used by investing activities during 3QYTD06 was $42,979. Significant factors contributing to a use of cash were: $3,151 for gross capital expenditures and $40,682 to acquire TSM, GTC, BCI, Universal, CWIN, and CSG.
Cash Flows from Financing Activities
Net cash provided by financing activities during 3QYTD07 was $117,826. Significant factors contributing to the cash inflow were $129,075 of net borrowings on long term debt and $12,141 of proceeds from the exercise of stock options. Significant uses of cash were $20,206 for the repurchase of common stock and $3,157 for the payment of dividends.
Net cash provided by financing activities during 3QYTD06 was $5,016. Significant factors contributing to the cash inflow were $16,344 of proceeds from the exercise of stock options. Significant uses of cash were $7,418 in long term debt payments and $3,049 for the payment of dividends.
Total Debt
On March 28, 2006, the Company entered into a Second Amendment to the Second Amended and Restated Credit Agreement dated January 24, 2005, as amended February 17, 2005 (collectively, and previously defined as the “Credit Agreement”) with Citizens Bank of Pennsylvania, as agent, and a group of lenders. The Credit Agreement expires on March 28, 2011. Borrowings under the Credit Agreement are permitted up to a maximum amount of $310,000, which includes up to $15,000 of swing line loans and $25,000 of letters of credit. The Credit Agreement may be increased by the Company up to an additional $90,000 with the approval of the lenders and may be unilaterally and permanently reduced by the Company to not less than the then outstanding amount of all borrowings. Interest on outstanding indebtedness under the Credit Agreement accrues, at the Company’s option, at a rate based on either: (a) the greater of (i) the prime rate per annum of the agent then in effect and (ii) 0.50% plus the rate per annum announced by the Federal Reserve Bank of New York as being the weighted average of the rates on overnight Federal funds transactions arranged by Federal funds brokers on the previous trading day or (b) a rate per annum equal to the LIBOR rate plus 0.75% to 1.25% (determined by a leverage ratio based on the Company’s EBITDA). The Credit Agreement requires the Company to maintain compliance with certain non-financial and financial covenants such as minimum net worth, leverage and fixed charge coverage ratios. As of December 31, 2006, the Company was in compliance with all required covenants under the Credit Agreement.
As of December 31, 2006, the Company had total debt outstanding of $254,525. Total debt was comprised of $251,410 outstanding under the credit agreement, $1,308 for the fair value of the interest rate swap, $1,671 of obligations under capital leases and $136 of various other third-party, non-employee loans. The weighted average interest rate on all indebtedness of the Company during 3Q07 and 3QYTD07 was approximately 6.25% and 6.20% respectively. The weighted average interest rate on all indebtedness of the Company during 3Q06 and 3QYTD06 was approximately 5.59% and 4.86%, respectively.
Dividends
During 1Q07, the Board declared a cash dividend of $0.06 per share on all outstanding shares of common stock. The dividend totaled $1,061 and was paid on July 14, 2006 to stockholders of record at the close of business on June 30, 2006. During 2Q07, the Board declared a cash dividend of $0.06 per share on all outstanding shares of common stock. The dividend totaled $1,041 and was paid on October 13, 2006 to stockholders of record at the close of business on September 29, 2006. During 3Q07, the Board declared a cash dividend of $0.06 per share on all outstanding shares of common stock. The dividend totaled $1,047 and was paid on January 15, 2007 to stockholders of record at the close of business on December 29, 2006. In aggregate, the Company has declared cash dividends of $3,149 or $0.18 per share during the nine (9) month period ended December 31, 2006. While the Company expects to continue to declare dividends for the foreseeable future, there can be no assurance as to the timing or amount of such dividends.

54


Table of Contents

Repurchase of Common Stock
During 2Q07, the Company repurchased approximately 441,000 shares of common stock for $17,587. During 3Q07, the Company repurchased approximately 60,000 shares of common stock for $2,620. Since inception of the repurchase program in April 1999 through December 31, 2006, the Company has repurchased in aggregate approximately 7,436,000 shares of common stock for approximately $317,030. Funding for the stock repurchases came primarily from existing cash flow from operations. Additional repurchases of stock may occur from time to time depending upon factors such as the Company’s cash flows and general market conditions. While the Company expects to continue to repurchase shares of common stock for the foreseeable future, there can be no assurance as to the timing or amount of such repurchases.
Significant Accounting Policies
The significant accounting policies used in the preparation of the Company’s consolidated financial statements are disclosed in Note 1 within the Notes to the Consolidated Financial Statements for the year ended March 31, 2006 contained in Form 10-K. Additional significant accounting policies adopted during Fiscal 2007 are disclosed below.
Stock-Based Compensation
On April 1, 2006, the Company adopted SFAS 123(R) which requires companies to estimate the fair value of share-based payment awards and recognize compensation expense over the requisite service period for the portion of the award that is ultimately expected to vest. Prior to the adoption of SFAS 123(R), the Company accounted for share-based awards to employees and directors using the intrinsic value method in accordance with APB 25 as allowed under SFAS 123. Under the intrinsic value method, no stock-based compensation expense related to stock options was required to be recognized if the exercise price of the Company’s stock options granted to employees and directors was equal to or greater than the fair market value of the underlying stock on the measurement date.
The Company adopted SFAS 123(R) using the modified prospective transition method which requires compensation cost to be recognized for all share-based payments granted after the date of adoption and for all unvested awards existing on the date of adoption. In accordance with the modified prospective transition method, the Company’s Consolidated Financial Statements for prior periods have not been retroactively adjusted to reflect, and do not include, the impact of SFAS 123(R). However, the modified prospective transition method does require the Company to provide pro-forma disclosure of specific income statement line items for periods prior to the adoption of SFAS 123(R) as if the fair-value-based method had been applied to all awards. See Note 14 of the Notes to the Consolidated Financial Statements.
SFAS 123(R) requires companies to estimate the fair value of share-based payment awards on the grant-date using an option-pricing model. Upon adoption of SFAS 123(R), the Company began using the Black-Scholes option pricing model as the method of valuation for the Company’s stock options. The model requires the use of various assumptions. The key assumptions are summarized as follows:
Expected Volatility: The Company estimates the volatility of the common stock at the date of grant based on the historical volatility of its common stock.
Dividend Yield: The Company estimates the dividend yield assumption based on the Company’s historical and projected dividend payouts.
Risk-free interest rate: The Company bases risk-free interest rate on the observed interest rates appropriate for the term of the Company’s employee stock options.
Annual forfeiture rate and expected holding period: The Company estimates the annual forfeiture rate and expected holding period based on historical experience.
Amortization period: The Company recognizes the fair value of awards into expense over the requisite service periods associated with the award.
Impact of Recently Issued Accounting Pronouncements
Fair Value Option for Financial Assets and Financial Liabilities
In February 2007, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities—Including an Amendment of FASB Statement No. 115” (“SFAS 159”). SFAS 159 permits an entity to elect to measure eligible items at fair value (“fair value option”) including many financial instruments. The provisions of SFAS 159 are

55


Table of Contents

effective for the Company as of April 1, 2008. If the fair value option is elected, the Company will report unrealized gains and losses on items for which the fair value option has been elected in earnings at each subsequent reporting date. Upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. The fair value option may be applied for a single eligible item without electing it for other identical items, with certain exceptions, and must be applied to the entire eligible item and not to a portion of the eligible item. The Company is currently evaluating the irrevocable election of the fair value option pursuant to SFAS 159.
Prior Year Misstatements on Current Year Financial Statements
In September 2006, the SEC issued Staff Accounting Bulletin No. 108 (“SAB 108”), “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”. SAB 108 provides interpretive guidance on how the effects of prior year uncorrected misstatements should be considered when quantifying misstatements in current year financial statements for the purpose of a materiality assessment. SAB 108 is effective as of the Company’s fiscal year end March 31, 2007. The Company adopted SAB 108 as of March 31, 2007. The adoption of SAB 108 did not have a material impact on its consolidated financial statements.
Fair Value Measurements
In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” (“SFAS 157”), which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. SFAS 157 is effective for the Company beginning on April 1, 2008. The Company is evaluating the impact of the adoption of SFAS 157 on the Company’s consolidated financial statements.
Defined Benefit Pension and Other Postretirement Plans
In September 2006, the FASB issued SFAS No 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans” (“SFAS 158”). This standard requires, among other things, companies to recognize on the balance sheet the funded or unfunded status of pension and other postretirement benefit plans and to recognize the change in funded status in the period the change occurs through comprehensive income. The provisions of SFAS 158 are effective as of the Company’s fiscal year end March 31, 2007. The Company adopted SFAS 158 as of March 31, 2007. The adoption of SFAS 158 had no impact on the Company’s Statement of Operations on the date of adoption. However, the Company did record a gain into other comprehensive income of approximately $2.7 million (1.7 million, net of tax.)
Uncertainty in Income Taxes
In July 2006, the FASB issued FASB Interpretation No. 48 (“FIN 48”), “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in tax positions. The Company plans to adopt the Interpretation as of April 1, 2007. The Interpretation is currently being evaluated by the Company for its full impact and, at this time, the Company believes it has properly and adequately provided for all income tax positions and therefore expects minimal impact from adopting the Interpretation.
Definition of Settlement in FIN 48
In May 2007, the FASB issued staff position No. FIN 48-1 (“FSP FIN 48-1”), “Definition of Settlement in FASB Interpretation No. 48” which amended FIN 48 to provide guidance about how an enterprise should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits. The Company plans to adopt FSP FIN 48-1 in conjunction with adoption of FIN 48 as of April 1, 2007. This staff position is currently being evaluated by the Company for its full impact and, at this time, the Company believes it has properly and adequately provided for all income tax positions and therefore expects minimal impact from adoption.
Stock-Based Compensation
On April 1, 2006, the Company adopted the provisions of SFAS 123(R). For the three and nine month periods ended December 31, 2006, the Company recognized compensation expense of $1,840 ($1,196 net of tax) or $0.07 per diluted share and $7,476 ($4,860 net of tax) or $0.27 per diluted share, respectively on the Company’s Consolidated Statements of Income. See Note 2 and Note 14 of the Notes to the Consolidated Financial Statements for reference.
Tax Effects of Share-Based Payment Awards
On November 10, 2005, the FASB issued Staff Position No. SFAS 123(R)-3, “Transition Election Related to Accounting for Tax Effects of Share-Based Payment Awards” (“SFAS 123(R)-3”). The alternative transition method includes simplified methods to establish the beginning balance of the additional paid-in capital pool (“APIC pool”) related to the tax effects of employee share-based compensation, and to determine the subsequent impact on the APIC pool and Consolidated Statements of Cash Flows of the tax effects of employee share-based compensation awards that are outstanding upon adoption of SFAS 123(R). The company has elected this transition method for calculating tax effects of share-based payment awards.

56


Table of Contents

Inflation
The overall effects of inflation on the Company have been nominal. Although long-term inflation rates are difficult to predict, the Company continues to strive to minimize the effects of inflation through improved productivity and cost reduction programs as well as price adjustments within the constraints of market competition.
Cautionary Forward Looking Statements
When included in this Quarterly Report on Form 10-Q or in documents incorporated herein by reference, the words “expects,” “intends,” “anticipates,” “believes,” “estimates” and analogous expressions are intended to identify forward-looking statements. Such statements are inherently subject to a variety of risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, among others, the timing and final outcome of the ongoing review of the Company’s stock option practices, including the related SEC investigation, shareholder derivative lawsuit, NASDAQ process regarding listing of the common stock and tax matters, and the impact of any actions that may be required or taken as a result of such review, SEC investigation, shareholder derivative lawsuit, NASDAQ process or tax matters, levels of business activity and operating expenses, expenses relating to corporate compliance requirements, cash flows, global economic and business conditions, successful integration of acquisitions, including the NextiraOne business, the timing and costs of restructuring programs, successful marketing of DVH (Data, Voice, and Hotline) Services, successful implementation of our M&A program, including identifying appropriate targets, consummating transactions and successfully integrating the businesses, competition, changes in foreign, political and economic conditions, fluctuating foreign currencies compared to the U.S. dollar, rapid changes in technologies, client preferences, the ability of the Company to identify, acquire and operate additional technical services companies and various other matters, many of which are beyond the Company’s control. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and speak only as of the date of this Quarterly Report on Form 10-Q. The Company expressly disclaims any obligation or undertaking to release publicly any updates or any changes in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based.

57


Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk.
The Company is exposed to market risks in the ordinary course of business that include interest rate volatility and foreign currency exchange rates volatility. Market risk is measured as the potential negative impact on earnings, cash flows or fair values resulting from a hypothetical change in interest rates or foreign currency exchange rates over the next year.
Interest Rate Risk
The Company’s primary interest rate risk relates to its long-term debt obligations. As of December 31, 2006, the Company had total long-term obligations of $254,525, including the current portion of those obligations of $587. Of the outstanding debt, $1,810 was in fixed rate obligations, $100,000 was in variable rate debt that was effectively converted to a fixed rate through an interest rate swap agreement and $151,410 was in variable rate obligations. As of December 31, 2006, an instantaneous 100 basis point increase in the interest rate of the variable rate debt would reduce the Company’s net income in the subsequent quarter by $384 assuming the Company employed no intervention strategies.
To mitigate the risk of interest-rate fluctuations associated with the Company’s variable rate long-term debt, the Company has implemented an interest-rate risk management strategy that incorporates the use of derivative instruments to minimize significant unplanned fluctuations in earnings caused by interest-rate volatility. The Company’s goal is to manage interest-rate sensitivity by modifying the re-pricing characteristics of certain balance sheet liabilities so that the net-interest margin is not, on a material basis, adversely affected by the movements in interest rates.
On July 26, 2006, the Company entered into an interest rate swap which has been used to effectively convert a portion of the Company’s variable rate debt to fixed rate. The interest rate swap has a notional value of $100,000 reducing to $50,000 after three years and does not qualify for hedge accounting. Changes in the fair market value of the interest rate swap are recorded as an asset or liability in the Company’s Consolidated Balance Sheet and Interest Expense (Income) in the Company’s Consolidated Statements of Income.
Foreign Exchange Rate Risk
The Company has operations, clients and suppliers worldwide, thereby exposing the Company’s financial results to foreign currency fluctuations. In an effort to reduce this risk of foreign currency fluctuations, the Company generally sells and purchases inventory based on prices denominated in U.S. dollars. Intercompany sales to subsidiaries are generally denominated in the subsidiaries’ local currency. The Company has entered and will continue in the future, on a selective basis, to enter into foreign currency forward contracts to reduce the foreign currency exposure related to certain intercompany transactions, primarily trade receivables and loans. All of the foreign currency forward contracts have been designated and qualify as cash flow hedges. The effective portion of any changes in the fair value of the derivative instruments is recorded in OCI until the hedged forecasted transaction occurs or the recognized currency transaction affects earnings. Once the forecasted transaction occurs or the recognized currency transaction affects earnings, the effective portion of any related gains or losses on the cash flow hedge is reclassified from OCI to other expense (income) in the Company’s Consolidated Statement of Income. In the event it becomes probable that the hedged forecasted transaction will not occur, the ineffective portion of any gain or loss on the related cash flow hedge would be reclassified from OCI to other expense (income).
As of December 31, 2006, the Company had open foreign exchange contracts in Australian and Canadian dollars, Danish krone, Euro, Japanese yen, Norwegian kroner, Pound sterling, Swedish krona and Swiss franc. The open contracts have contract rates ranging from 1.2658 to 1.3407 Australian dollar, 1.1141 to 1.1472 Canadian dollar, 5.6222 to 5.8136 Danish krone, 0.7482 to 0.8185 Euro, 105.47 to 110.10 Japanese yen, 6.0294 to 6.4315 Norwegian kroner, 0.5069 to 0.5435 Pound sterling, 6.7675 to 7.1925 Swedish krona and 1.1827 to 1.2133 Swiss franc, all per U.S. dollar. The total open contracts had a notional amount of approximately $63,994, have a fair value of $63,692 and will expire within twenty-seven months. The Company does not hold or issue any other financial derivative instruments nor does it engage in speculative trading of financial derivatives.

58


Table of Contents

Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
As disclosed in the Explanatory Note and in Note 3 of the Notes to Consolidated Financial Statements in this Form 10-Q, and as previously disclosed, the Audit Committee, with the assistance of outside legal counsel, commenced an independent review of the Company’s historical stock option grant practices and related accounting for stock option grants for the Review Period. On March 19, 2007, the Audit Committee concluded that the exercise price of certain stock option grants differed from the fair market value of the underlying shares on the appropriate measurement date. At that time, the Company and the Audit Committee announced that it was currently expected that the Company’s additional non-cash, pre-tax charges for stock-based compensation expense relating to certain stock option grants would approximate $63 million (subsequently adjusted as set forth elsewhere in this Form 10-Q) for the Review Period. In addition, the Company and the Audit Committee concluded that the Company would need to restate its previously-issued financial statements contained in reports previously filed by the Company with the SEC. Accordingly, on March 19, 2007, the Company and the Audit Committee concluded that the Company’s previously-issued financial statements and other historical financial information and related disclosures for the Review Period, including applicable reports of its current or former independent registered public accounting firms and related press releases, should not be relied upon.
In connection with the preparation of this Form 10-Q, an evaluation was performed, under the supervision and with the participation of Company management, including the CEO and the CFO, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of December 30, 2006. Based on that evaluation and the foregoing, management, including the CEO and the CFO, has concluded that, as of December 30, 2006, the Company had a material weakness in internal control over financial reporting with respect to the Company’s stock option grant practices and related accounting for stock option grants and that, as a result of this material weakness in internal control over financial reporting, its disclosure controls and procedures were not effective as of December 30, 2006.
There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including cost limitations, judgments used in decision making, assumptions regarding the likelihood of future events, soundness of internal controls, fraud, the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can provide only reasonable, and not absolute, assurance of achieving their control objectives.
Changes in Internal Control Over Financial Reporting
During the three (3) and nine (9) month periods ended December 30, 2006, there had been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
As of the date of filing of this Form 10-Q, management has made significant revisions to the Company’s internal control structure surrounding the Company’s stock option grant practices, including the formalization of documentation with respect to appropriate approvals for stock option grants and additional levels of review with respect to stock option grant terms, which management believes should facilitate the prevention and/or detection of material errors in future periods. Also, as of the date of filing of this Form 10-Q, the Audit Committee has completed its review of the Company’s stock option grant practices and continues to analyze the facts discovered in its review in order to make additional recommendations for appropriate remedial actions regarding the Company’s stock option grant practices and related accounting for stock option grants. It is anticipated that the Company will adopt and implement any such additional recommendations. Pending the Audit Committee’s consideration of and the Company’s implementation of these recommendations, the Company has not made and does not intend to make any stock option grants. The Company also took action to suspend the exercise of outstanding stock options. It is anticipated that the Company will permit stock option exercises following the filing of this Form 10-Q and the FY07 Form 10-K.
The scope of management’s assessment of the effectiveness of internal controls over financial reporting includes all of the Company’s material businesses except for NextiraOne, a material business acquired on April 30, 2006. The NextiraOne portion of the business will be included in the current year assessment to be completed as of March 31, 2007.

59


Table of Contents

PART II – OTHER INFORMATION
Item 1. Legal Proceedings.
Regulatory Matters
As previously disclosed, on November 13, 2006, the Company received a letter of informal inquiry from the Enforcement Division of the SEC relating to the Company’s stock option practices from January 1, 1997 to present. On May 24, 2007, the SEC issued a formal order of investigation in connection with this matter, and, on May 29, 2007, the Company received a document subpoena from the SEC acting pursuant to such order. The Company has cooperated with the SEC in this matter and intends to continue to do so.
As previously announced, the Audit Committee of the Board of Directors of the Company, with the assistance of outside legal counsel, is conducting an independent review of the Company’s historical stock option grant practices and related accounting for stock option grants. See the “Explanatory Note” preceding Part I, Item 1 of this Form 10-Q for more information regarding this and related matters.
On September 20, 2006, the Company received formal notice from the Internal Revenue Service (“IRS”) regarding its intent to begin an audit of the Company’s tax years 2004 and 2005. In connection with this normal recurring audit, the IRS has requested certain documentation with respect to stock options for the Company’s 2004 and 2005 tax years. The Company has produced various documents requested by the IRS and is currently in the process of responding to additional documentation requests.
At the conclusion of these regulatory matters, the Company could be subject to additional taxes, fines or penalties which could be material.
Litigation Matters
In November 2006, two stockholder derivative lawsuits were filed against the Company itself, as a nominal defendant, and several of the Company’s current and former officers and directors in the United States District Court for the Western District of Pennsylvania. The two substantially identical stockholder derivative complaints allege that the individual defendants improperly backdated grants of stock options to several officers and directors in violation of the Company’s stockholder-approved stock option plans during the period 1996-2002, improperly recorded and accounted for backdated stock options in violation of generally accepted accounting principles, improperly took tax deductions based on backdated stock options in violation of the Code produced and disseminated false financial statements and SEC filings to the Company’s stockholders and to the market that improperly recorded and accounted for the backdated option grants, concealed the alleged improper backdating of stock options and obtained substantial benefits from sales of Company stock while in the possession of material inside information. The complaints seek damages on behalf of the Company against certain current and former officers and directors and allege breach of fiduciary duty, unjust enrichment, securities law violations and other claims. The two lawsuits have been consolidated into a single action as In re Black Box Corporation Derivative Litigation, Master File No. 2:06-CV-1531-TMH, and plaintiffs filed a consolidated amended complaint on January 29, 2007. The parties have stipulated that responses by the defendants, including the Company, are due on or before August 1, 2007. The Company may have indemnification obligations arising out of this matter to its current and former directors and officers named in this litigation. The Company has made a claim for such costs under an insurance policy.
The Company is involved in, or has pending, various legal proceedings, claims, suits and complaints arising out of the normal course of business.
As previously disclosed, the Company received a subpoena, dated December 8, 2004, from the United States General Services Administration (“GSA”), Office of Inspector General. The subpoena requires production of documents and information. The Company understands that the materials are being sought in connection with an investigation regarding potential violations of the terms of a GSA Multiple Award Schedule contract. The Company has not received any communication on this matter from the GSA since June 2005.
Based on the facts currently available to the Company, management believes the matters described under this caption “Litigation Matters” are adequately provided for, covered by insurance, without merit or not probable that an unfavorable outcome will result.
Item 1A. Risk Factors.
In addition to the Risk Factors set forth in the Company’s Form 10-K for the fiscal year ended March 31, 2006, you should carefully consider the following risk factor, as well as the other information contained in this document, when evaluating your investment in our securities.

60


Table of Contents

Stock options matters – As previously disclosed, on November 13, 2006, we received a letter of informal inquiry from the Enforcement Division of the SEC relating to the Company’s stock option practices from January 1, 1997 to present. Our Audit Committee, with the assistance of outside legal counsel, is conducting an independent review of the Company’s historical stock option grant practices and related accounting for stock option grants. On May 24, 2007, the SEC issued a formal order of investigation in connection with this matter, and, on May 29, 2007, we received a document subpoena from the SEC acting pursuant to such order. We have cooperated with the SEC in this matter and intend to continue to do so. See the “Explanatory Note” preceding Part I, Item 1 of this Form 10-Q for more information regarding this and related matters.
On September 20, 2006, we received formal notice from the IRS regarding its intent to begin an audit of our tax years 2004 and 2005. In connection with this normal recurring audit, the IRS has requested certain documentation with respect to stock options for our 2004 and 2005 tax years. We have produced various documents requested by the IRS and are currently in the process of responding to additional documentation requests.
In addition, in November 2006, two stockholder derivative lawsuits were filed against the Company, as a nominal defendant, and several of our current and former officers and directors in the United States District Court for the Western District of Pennsylvania. The two substantially identical stockholder derivative complaints allege that the individual defendants improperly backdated grants of stock options to several officers and directors in violation of our stockholder-approved stock option plans during the period 1996-2002, improperly recorded and accounted for backdated stock options in violation of generally accepted accounting principles, improperly took tax deductions based on backdated stock options in violation of the Code, produced and disseminated false financial statements and SEC filings to our stockholders and to the market that improperly recorded and accounted for the backdated option grants, concealed the alleged improper backdating of stock options and obtained substantial benefits from sales of Company stock while in the possession of material inside information. The complaints seek damages on behalf of the Company against certain current and former officers and directors and allege breach of fiduciary duty, unjust enrichment, securities law violations and other claims. The two lawsuits have been consolidated into a single action as In re Black Box Corporation Derivative Litigation, Master File No. 2:06-CV-1531-TMH, and plaintiffs filed a consolidated amended complaint on January 29, 2007. The parties have stipulated that responses by the defendants, including the Company, are due on or before August 1, 2007.
The stock options investigations and related litigation have imposed, and are likely to continue to impose, significant costs on us, both monetarily and in requiring attention by our management team. While we are unable to estimate the costs that we may incur in the future, these are likely to include:
professional fees in connection with the conduct of the investigations, the restatement of our financial statements and the defense of the litigation;
potential damages, fines, penalties or settlement costs; and
payments to, or on behalf of, our current and former officers and directors subject to the investigation or named in the litigation pursuant to our indemnification obligations (in certain circumstances these indemnification payments are recoverable if it is determined that the officer or director at issue acted improperly, but there is no assurance that we will be able to recover such payments).
While we expect that certain of such costs will be reimbursed pursuant to an insurance policy, at this point such costs have not been reimbursed.
In the course of our investigation, we have determined that a number of executives may have exercised options for which the application of Section 162(m) may apply. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes because we incorrectly applied the measurement date as defined in APB 25. If such options are deemed to be granted at less than fair market value, pursuant to Section 162(m), any compensation to our executive officers, including proceeds from options exercised in any given tax year in excess of $1.0 million, will be disallowed as a deduction for tax purposes. We estimate that the potential tax effected liability for the disallowed Section 162(m) deduction is $3.6 million. We may also incur interest and penalties if we were to incur any such tax liability, which could be material.
In addition, we are considering the application of Section 409A to those options for which we incorrectly applied the measurement date as defined in APB 25. It is possible that these options will be treated as having been granted at less than fair market value for federal income tax purposes and thus subject to Section 409A. Accordingly, we may adopt remedial measures to address the application of Section 409A. We do not currently know what impact any remedial measures, if adopted, would have on our results of operations, financial position or cash flows, although such impact could be material.
Adverse developments in the legal proceedings or the investigation arising out of our historical stock option granting practices or any other matter raised as a result thereof could have an adverse impact on our business and our stock price, including increased stock volatility.

61


Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
                                 
                    (c) Total Number     (d) Maximum Number  
                    of Shares (or     (or Approximate  
    (a) Total             Units) Purchased     Dollar Value) of  
    Number of     (b) Average     as Part of     Shares (or Units) that  
    Shares (or     Price Paid per     Publicly     May Yet Be  
    Units)     Share (or     Announced Plans     Purchased Under the  
Period   Purchased     Unit)     or Programs     Plans or Programs  
 
October 1, 2006 to October 29, 2006
    --       --       --       123,973 (1)
 
                               
October 30, 2006 to November 26, 2006
    60,028       43.64       60,028       1,063,945 (2)
 
                               
November 27, 2006 to December 30, 2006
    --       --       --       1,063,945
     
 
                               
Total
    60,028       43.64       60,028       1,063,945
 
 
(1)  
As of October 1, 2006, 123,973 shares were available for repurchase under repurchase programs approved by the Board of Directors and announced on November 20, 2003 and August 12, 2004.
 
(2)  
Amount includes an increase 1,000,000 shares in the repurchase program approved by the Board of Directors on November 7, 2006.
The repurchase programs have no expiration date and no programs were terminated prior to the full repurchase of the authorized amount.
Additional repurchases of stock may occur from time to time depending upon factors such as the Company’s cash flows and general market conditions. While the Company expects to continue to repurchase shares of the common stock for the foreseeable future, there can be no assurance as to the timing or amount of such repurchases.
Under the Company’s Credit Agreement, the Company is permitted to pay dividends on and repurchase common stock as long as no Event of Default or Potential Default (each as defined in the Credit Agreement) occurs or is continuing.
Item 6. Exhibits.
     
Exhibit    
Number
 
Description
 
   
10.1
  Waiver Letter dated February 28, 2007 by and among Black Box Corporation of Pennsylvania and Norstan, Inc., as Borrowers, the Company, the Guarantors parties thereto, the Lenders parties thereto and Citizens Bank of Pennsylvania (1)
 
   
10.2
  Waiver Letter dated May 28, 2007 by and among Black Box Corporation of Pennsylvania and Norstan, Inc., as Borrowers, the Company, the Guarantors parties thereto, the Lenders parties thereto and Citizens Bank of Pennsylvania (1)
 
   
10.3
  Waiver Letter dated June 11, 2007 by and among Black Box Corporation of Pennsylvania and Norstan, Inc., as Borrowers, the Company, the Guarantors parties thereto, the Lenders parties thereto and Citizens Bank of Pennsylvania (1)
 
   
10.4
  Description of Executive Officer Incentive Bonus Plan for Fiscal 2008 (1)
 
   
10.5
  Summary of Director Compensation (1)
 
   
21.1
  Subsidiaries of the Registrant (1)

62


Table of Contents

     
31.1
  Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities and Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 (1)
 
   
31.2
  Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities and Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 (1)
 
   
32.1
  Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)
 
(1)  
Filed herewith.

63


Table of Contents

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
             
    BLACK BOX CORPORATION
 
           
Dated: July 23, 2007
           
 
  By:   /s/ Michael McAndrew    
 
           
 
      Michael McAndrew, Vice President,
Chief Financial Officer, Treasurer, Secretary
and Principal Accounting Officer
   

64


Table of Contents

EXHIBIT INDEX
     
Exhibit    
Number
 
Description
 
   
10.1
  Waiver Letter dated February 28, 2007 by and among Black Box Corporation of Pennsylvania and Norstan, Inc., as Borrowers, the Company, the Guarantors parties thereto, the Lenders parties thereto and Citizens Bank of Pennsylvania (1)
 
   
10.2
  Waiver Letter dated May 28, 2007 by and among Black Box Corporation of Pennsylvania and Norstan, Inc., as Borrowers, the Company, the Guarantors parties thereto, the Lenders parties thereto and Citizens Bank of Pennsylvania (1)
 
   
10.3
  Waiver Letter dated June 11, 2007 by and among Black Box Corporation of Pennsylvania and Norstan, Inc., as Borrowers, the Company, the Guarantors parties thereto, the Lenders parties thereto and Citizens Bank of Pennsylvania (1)
 
   
10.4
  Description of Executive Officer Incentive Bonus Plan for Fiscal 2008 (1)
 
   
10.5
  Summary of Director Compensation (1)
 
   
21.1
  Subsidiaries of the Registrant (1)
 
   
31.1
  Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities and Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 (1)
 
   
31.2
  Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities and Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 (1)
 
   
32.1
  Certification of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (1)
 
(1) Filed herewith.

65